Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023351	s-dpteroe	— (—)	5265	5493	100.00%	Distribution not available
3023351	s-dpteroe	kU/l (u/ml)	4830	5297	1.85%
3023351	d.pteronys	— (—)	574	603	100.00%	Distribution not available
3023351	s-pölyerittely,igevasta-aineet	kU/l (u/ml)	387	393	0.00%
3023351	s-p�lyry	kU/l (u/ml)	247	251	0.00%
3023351	s-pölyerittely	kU/l (u/ml)	218	222	0.00%
3023351	s-pölyryh	kU/l (u/ml)	213	216	0.00%
3023351	s-pölyt	kU/l (u/ml)	183	183	0.00%
3023351	s-pöly-s	kU/l (u/ml)	144	165	0.00%
3023351	s-pölyerittely,igevasta-aineet	kU/l______ (u/ml)	144	146	0.00%
3023351	d.pteronys	kU/l (u/ml)	108	111	0.00%
3023351	s-dpteroe	kU/l______ (u/ml)	101	102	0.00%
3023351	pölyerittely,ige:vat(s-)	kU/l (u/ml)	79	83	0.00%
3023351	s-pölyryhmä	kU/l (u/ml)	77	77	0.00%
3023351	s-pölyryh	kU/l______ (u/ml)	11	11	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1338

4155

3.20

320.04

1.2

1.1

1.64

2.18

u/ml

1.25

754

1978

Other pulmonary diagnosis

1900

3364

2.90

318.33

1.1

1.93

2.43

u/ml

1.05

1094

1497

COPD differential diagnosis

1872

3321

2.89

312.58

1.1

1.88

2.43

u/ml

1.24

1079

1471

ILD differential diagnosis

1871

3320

2.89

312.24

1.1

1.88

2.43

u/ml

1.24

1079

1471

Excluding asthma or asthma-COPD overlap

1877

3364

2.86

307.88

1.1

1.86

2.43

u/ml

1.32

1080

1497

Suggestive for eosinophilic asthma

450

487

10.28

307.65

1.3

1.1

1.04

1.76

u/ml

0.94

332

240

Asthma and allergy

1256

1323

11.10

307.65

1.2

1.1

3.09

2.96

u/ml

0.09

905

592

2002

4851

4.35

307.65

1.2

1.1

2.02

2.31

u/ml

0.58

1318

2412

Asthma, hospital admissions , main diagnosis only

3604

7905

4.19

307.65

1.2

1.1

2.14

2.26

u/ml

0.25

2326

3901

Allergic rhinitis

2609

4184

7.08

307.65

1.2

1.1

2.60

2.25

u/ml

0.65

1707

2089

Asthma, hospital admission 2, infections

2312

5789

4.09

307.65

1.2

1.1

2.20

2.21

u/ml

0.02

1533

2867

Obesity related asthma

1142

2809

4.27

307.65

1.2

1.1

1.61

1.89

u/ml

0.46

693

1329

Chronic rhinitis, nasopharyngitis and pharyngitis

1215

2804

4.58

307.65

1.2

1.1

1.07

2.22

u/ml

4.80

739

1357

Desensitization to allergens

609

933

8.34

307.65

1.2

2.87

2.88

u/ml

0.01

415

502

Conjunctivitis

2736

8311

2.75

307.65

1.2

1.1

2.45

2.22

u/ml

0.43

1615

4372

Allergic conjunctivitis

2344

7530

3.14

307.65

1.2

1.1

2.42

2.21

u/ml

0.34

1390

3891

Asthma (diagnoses ohter than nonallergic)

3726

7735

4.10

307.65

1.2

1.1

2.22

2.23

u/ml

0.01

2419

3794

Asthma (only as main-diagnosis)

3333

3309

5.98

307.65

1.2

1.1

2.16

2.43

u/ml

0.49

2100

1466

Asthma, including avohilmo

4947

6287

4.55

307.65

1.2

1.1

2.17

2.24

u/ml

0.12

2924

3098

Allergic asthma (mode)

1716

2166

8.68

307.65

1.2

1.1

2.74

2.71

u/ml

0.02

1214

991

Asthma and allergy, excluding more controls

1256

1351

10.87

307.65

1.2

1.1

3.08

2.98

u/ml

0.07

906

608

Asthma, unspecified (mode)

1674

3007

4.17

307.65

1.2

1.1

1.71

2.43

u/ml

1.73

973

1340

Allergic asthma (mode), excluding more controls

1715

2173

8.64

307.65

1.2

1.1

2.74

2.72

u/ml

0.01

1214

989

Nasal polyp

667

1048

6.78

307.65

1.2

1.1

1.19

2.31

u/ml

1.88

451

509

Vasomotor and allergic rhinitis

2741

4148

7.23

307.65

1.2

1.1

2.56

2.50

u/ml

0.07

1756

2041

Asthma (only as main-diagnosis), excluding more controls

3314

3268

5.96

307.65

1.2

1.1

2.17

2.46

u/ml

0.54

2090

1444

Asthma, excluding more controls

3303

3268

5.49

307.65

1.2

1.1

2.18

2.46

u/ml

0.51

2056

1444

Atopic dermatitis

2459

6966

2.94

307.65

1.2

1.1

3.40

2.06

u/ml

5.05

1501

3551

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2269

7108

3.21

307.65

1.2

1.1

2.35

2.16

u/ml

0.32

1342

3651

Disorders of conjunctiva

2799

8540

2.62

307.65

1.2

1.1

2.43

2.19

u/ml

0.47

1650

4488

Pollen allergy

2040

2967

8.28

307.65

1.2

1.1

2.62

2.55

u/ml

0.08

1353

1506

Asthma (mode)

3359

3320

5.62

307.65

1.2

1.1

2.16

2.43

u/ml

0.48

2097

1471

Asthma

3339

3309

5.49

307.65

1.2

1.1

2.16

2.43

u/ml

0.49

2080

1466

Asthma, unspecified (mode), excluding more controls

1666

2971

4.17

307.65

1.2

1.1

1.72

2.46

u/ml

1.79

966

1320

Atopic dermatitis, strict definition with reimbursement

1570

4604

3.50

307.65

1.2

1.1

3.67

2.29

u/ml

3.62

1085

2383

Other diseases of upper respiratory tract

2898

5414

2.86

307.65

1.2

1.1

1.94

2.38

u/ml

1.23

1721

2639

Dermatitis and eczema

3101

7984

2.36

307.65

1.2

1.1

2.51

1.92

u/ml

2.10

1826

4083

Asthma/COPD (KELA code 203)

3695

6797

3.79

307.65

1.2

1.1

2.27

2.19

u/ml

0.14

2260

3318

Asthma-related infections

2312

5789

4.09

307.65

1.2

1.1

2.20

2.21

u/ml

0.02

1533

2867

Chronic sinusitis

1377

3599

3.99

307.65

1.2

1.1

0.92

2.18

u/ml

8.01

811

1721

Chronic lower respiratory diseases

4539

6819

3.65

307.65

1.2

1.1

2.29

2.19

u/ml

0.20

2752

3328

Atopic dermatitis, strict definition

1471

5099

3.00

303.89

1.2

1.1

3.81

2.31

u/ml

3.95

1029

2678

Cough

1266

3804

3.22

301.63

1.2

1.1

1.30

2.56

u/ml

6.06

755

1983

Asthma, hospital admissions 3, pneumonia

934

2582

3.73

285.96

1.2

1.1

2.51

1.96

u/ml

0.66

635

1285

Asthma-related pneumonia or sepsis

934

2582

3.73

285.96

1.2

1.1

2.51

1.96

u/ml

0.66

635

1285

Asthma-related pneumonia

931

2571

3.73

285.51

1.2

1.1

2.52

1.97

u/ml

0.65

633

1277

Undetermined asthma

472

757

6.62

282.61

1.2

1.1

1.12

2.18

u/ml

1.63

284

332

Undetermined asthma, excluding more controls

472

763

6.57

280.41

1.2

1.1

1.12

2.17

u/ml

1.62

284

336

Oral corticosteroids

2759

7499

2.20

278.71

1.2

1.1

1.97

2.12

u/ml

0.31

1652

3805

Childhood asthma (age<16)

762

1409

4.56

273.71

1.2

1.1

3.59

3.50

u/ml

0.05

513

652

Childhood asthma (age<16), excluding more controls

761

1411

4.55

272.36

1.2

1.1

3.59

3.54

u/ml

0.03

512

652

ILD medications: prednisolone, methylprednisolone, prednisone

2815

7596

2.10

249.67

1.2

1.1

1.96

2.20

u/ml

0.57

1656

3915

Diseases of the respiratory system

1412

2505

2.89

235.83

1.1

2.10

2.47

u/ml

0.54

791

1121

Biological medicines for asthma

247

238

13.97

235.11

1.3

1.1

4.05

2.07

u/ml

0.95

183

125

Abnormalities of breathing

2425

6650

2.13

224.19

1.2

1.1

2.00

2.54

u/ml

1.37

1385

3413

Inflammatory bowel disease treatment related agents

2832

8239

1.94

202.78

1.2

1.1

1.91

2.22

u/ml

0.83

1665

4269

ILD medications

2826

7979

1.94

201.59

1.2

1.1

2.10

2.28

u/ml

0.37

1655

4147

Deviated nasal septum

690

2076

3.42

186.09

1.2

1.1

1.50

2.07

u/ml

0.93

380

982

Childhood allergy (age < 16)

934

2778

3.00

182.11

1.2

1.1

3.54

2.95

u/ml

0.56

658

1470

Symptoms and signs involving the circulatory and respiratory systems

2528

6676

1.93

174.04

1.2

1.1

1.83

2.54

u/ml

2.87

1442

3422

First line medication for Crohn's disease

2701

7890

1.87

172.94

1.2

1.1

1.92

2.31

u/ml

1.12

1575

4092

FESS (DNB20)

478

1212

4.21

169.15

1.3

1.1

0.68

2.40

u/ml

6.39

295

617

Ethmoidectomy

484

1254

4.12

166.12

1.3

1.1

0.67

2.37

u/ml

6.58

300

638

Adverse effects, not elsewhere classified

774

2698

3.03

165.44

1.2

1.1

2.46

2.11

u/ml

0.43

546

1452

Conjunctivitis (acute, non atopic), including avohilmo

2244

7101

1.94

164.37

1.1

1.91

2.10

u/ml

0.42

1240

3683

Chronic diseases of tonsils and adenoids

1729

5255

2.11

161.53

1.1

2.10

2.43

u/ml

0.60

976

2553

Non-allergic asthma (mode), excluding more controls

452

1147

4.04

155.28

1.2

1.1

1.29

2.59

u/ml

2.14

255

527

Non-allergic asthma (mode)

452

1148

4.03

155.09

1.2

1.1

1.29

2.60

u/ml

2.16

255

526

Urticaria

969

4240

2.37

128.78

1.2

1.1

2.22

2.34

u/ml

0.14

619

2269

Urticaria and erythema

1076

4964

2.23

125.38

1.2

1.1

2.19

2.20

u/ml

0.00

687

2661

Other and unspecified effects of external causes

918

4015

2.37

122.33

1.2

1.1

2.32

2.31

u/ml

0.01

629

2155

Dyspnoea

1899

7610

1.83

121.05

1.2

1.1

1.78

2.07

u/ml

0.55

1108

3995

Dermatitis due to ingested food

319

754

4.80

120.01

1.4

1.1

3.74

3.71

u/ml

0.01

256

437

Acute upper respiratory infections

2206

7705

1.74

114.59

1.2

1.1

2.02

2.27

u/ml

0.53

1220

4043

Polypectomy (DHB20)

219

411

5.70

112.17

1.3

1.1

0.68

2.62

u/ml

2.94

161

215

Acute sinusitis

1377

6600

1.94

108.61

1.2

1.1

1.48

2.25

u/ml

2.76

760

3421

Acute upper respiratory infections of multiple and unspecified sites

1788

7423

1.78

105.45

1.2

1.1

2.28

2.33

u/ml

0.06

1014

3871

Diseases of the skin and subcutaneous tissue

2054

6019

1.73

101.65

1.1

2.51

1.92

u/ml

1.49

1215

3001

Insomnia

2023

8550

1.67

93.29

1.1

1.93

2.21

u/ml

0.64

1038

4563

Personal history of allergy to analgesic agent

18.88

91.97

1.6

1.2

0.41

2.45

u/ml

1.24

Diseases of the eye and adnexa

2009

6018

1.70

91.85

1.2

1.1

2.30

2.20

u/ml

0.14

1151

3151

Any reimbursement code in KELA

1678

4795

1.79

91.05

1.2

1.1

2.46

2.14

u/ml

0.52

951

2410

Dermatitis

1206

6329

1.89

90.81

1.1

2.62

1.89

u/ml

0.97

699

3211

Sleep disorders

2010

8501

1.65

88.64

1.1

1.97

2.23

u/ml

0.57

1037

4550

Bronchitis

2291

8716

1.59

85.93

1.2

1.1

2.26

2.22

u/ml

0.05

1302

4545

Pain in joint

1323

4456

1.85

85.32

1.1

1.72

2.50

u/ml

2.17

745

2383

2223

7068

1.61

84.10

1.2

1.1

1.92

2.25

u/ml

0.80

1225

3615

Sleep apnoea, including avohilmo

1902

7057

1.65

81.83

1.1

1.39

2.05

u/ml

2.77

986

3716

Personal history of allergy to drugs, medicaments and biological substances

101

123

10.16

80.08

1.5

1.1

0.40

4.46

u/ml

2.54

Other and unspecified dermatitis

1009

5338

1.92

79.89

1.2

1.1

2.73

1.86

u/ml

1.04

590

2721

D07AA Corticosteroids, weak (group I)

560

2383

2.45

79.89

1.2

1.1

3.74

2.63

u/ml

1.29

400

1326

Behavioural syndromes associated with physiological disturbances and physical factors

2049

8768

1.60

79.88

1.1

1.99

2.25

u/ml

0.58

1064

4749

Asthma mixed form (mode), excluding more controls

148

264

5.90

79.75

1.2

1.1

2.35

2.72

u/ml

0.13

119

Asthma mixed form (mode)

148

265

5.87

79.45

1.2

1.1

2.35

2.75

u/ml

0.14

118

Migraine

1420

6439

1.75

78.77

1.1

1.89

2.63

u/ml

2.08

792

3391

Sleep disorders (combined)

2211

7445

1.57

75.16

1.1

1.77

2.42

u/ml

2.54

1177

4017

Allergic contact dermatitis

381

1428

2.77

70.90

1.1

2.67

1.60

u/ml

0.75

215

713

Other acute lower respiratory infections

1138

6196

1.78

69.54

1.2

1.1

2.14

2.24

u/ml

0.12

705

3371

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2091

8801

1.54

68.52

1.1

1.83

2.32

u/ml

1.66

1141

4735

Medical observation and evaluation for suspected diseases and conditions

1332

3948

1.75

68.23

1.1

1.81

2.42

u/ml

1.26

818

1919

Headache

1557

7495

1.63

66.46

1.2

1.1

1.84

2.31

u/ml

1.12

841

3962

Dentofacial anomalies [including malocclusion]

1700

8474

1.59

66.35

1.2

1.1

2.05

2.19

u/ml

0.23

927

4483

Early onset COPD, excluding more controls

254

785

3.29

65.76

1.1

2.12

1.70

u/ml

0.24

157

342

Chronic laryngitis and laryngotracheitis

249

766

3.34

65.40

1.1

0.87

2.22

u/ml

2.70

130

366

Examination and observation for other reasons

1211

3935

1.76

65.15

1.1

1.74

2.42

u/ml

1.60

724

1914

Other and unspecified urticaria

563

2625

2.21

64.49

1.2

1.1

2.26

2.33

u/ml

0.05

358

1400

Asthma and opportunity respiratory infection

148

6.94

62.37

1.2

1.1

0.91

0.95

u/ml

0.03

Voice disturbances

531

2446

2.22

62.17

1.2

1.1

1.02

2.06

u/ml

2.87

300

1275

Sleep apnoea

1664

6722

1.58

60.49

1.1

1.22

1.99

u/ml

4.37

895

3499

Bronchiectasis

119

224

5.47

60.28

1.1

1.25

1.36

u/ml

0.05

118

Other special examinations and investigations of persons without complaint or reported diagnosis

1297

3948

1.68

58.40

1.1

2.19

2.42

u/ml

0.30

761

1919

Recurrent or chronic depression

909

3510

1.83

57.71

1.1

1.99

2.56

u/ml

0.87

488

1862

Other medical care

771

3513

1.86

54.73

1.2

1.1

3.01

1.85

u/ml

1.41

494

1876

Dermatographic urticaria

237

801

3.13

54.09

1.2

1.1

1.86

2.37

u/ml

0.34

152

417

Any death

144

3466

0.29

53.90

1.0

1.1

0.89

1.62

u/ml

2.11

1912

Acute bronchitis

778

4243

1.82

52.68

1.2

1.1

1.86

2.12

u/ml

0.31

459

2296

Migraine, single triptan purchase ok & required. ICD-code if available is included

1738

7929

1.50

51.35

1.1

2.19

2.34

u/ml

0.20

892

4239

Triptan medication for migraine, single purchase ok

1738

7929

1.50

51.35

1.1

2.19

2.34

u/ml

0.20

892

4239

Gastro-oesophageal reflux disease

1217

6441

1.61

51.17

1.2

1.1

1.49

2.02

u/ml

1.30

648

3402

Symptoms and signs involving speech and voice

583

2988

1.98

51.15

1.2

1.1

1.06

1.91

u/ml

2.38

323

1567

Episodal and paroxysmal disorders

2220

7896

1.44

50.06

1.1

1.80

2.56

u/ml

2.99

1220

4240

Pain in throat and chest

1608

6323

1.52

49.25

1.2

1.1

1.72

2.48

u/ml

2.59

898

3214

COPD/asthma/ILD related infections

1943

6688

1.47

48.63

1.2

1.1

1.97

2.25

u/ml

0.58

1070

3425

COPD/asthma related infections

1943

6688

1.47

48.63

1.2

1.1

1.97

2.25

u/ml

0.58

1070

3425

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

848

2390

1.81

48.50

1.1

2.03

2.88

u/ml

1.45

453

1244

Neurotic, stress-related and somatoform disorders

1875

8938

1.46

48.27

1.1

2.12

2.20

u/ml

0.13

1101

4650

Anxiety disorders

1880

8940

1.46

47.93

1.1

2.12

2.20

u/ml

0.12

1102

4654

COPD

379

1374

2.26

45.61

1.1

1.89

1.51

u/ml

0.31

232

674

Irritable bowel syndrome

614

3341

1.87

45.14

1.1

1.13

2.07

u/ml

3.38

317

1736

Idiopathic urticaria

113

266

4.71

45.13

1.2

2.32

3.74

u/ml

0.57

148

Abnormalities of heart beat

621

3276

1.86

45.12

1.1

1.64

2.42

u/ml

1.50

337

1684

Special screening examination for infectious and parasitic diseases

702

2887

1.81

43.54

1.1

1.55

2.61

u/ml

2.19

392

1333

Other chronic obstructive pulmonary disease

354

1290

2.26

42.97

1.1

1.91

1.56

u/ml

0.27

220

628

Exposure to unspecified factor

2009

9773

1.41

42.95

1.2

1.1

1.83

2.29

u/ml

1.17

1177

5190

Intestinal infectious diseases, including avohilmo, including avohilmo

2153

8628

1.40

42.77

1.1

1.70

2.35

u/ml

2.57

1168

4636

Other specific joint derangements/joint disorders

1679

7271

1.45

41.73

1.1

1.66

2.54

u/ml

3.73

924

3904

Pain (limb, back, neck, head abdominally)

1383

4589

1.52

41.64

1.1

2.11

2.54

u/ml

0.76

769

2490

All anxiety disorders

1503

8020

1.47

41.14

1.1

2.35

2.34

u/ml

0.00

889

4171

Depression or dysthymia

1139

3999

1.57

39.94

1.1

2.17

2.43

u/ml

0.33

621

2170

Temporomandibular joint disorders, including avohilmo

1122

7164

1.54

39.29

1.2

1.1

2.63

2.25

u/ml

0.47

630

3721

Dorsalgia

1961

7459

1.40

39.26

1.2

1.1

2.10

2.27

u/ml

0.28

1074

3943

Other soft tissue disorders, not elsewhere classified

1874

7642

1.41

38.38

1.1

1.91

2.40

u/ml

1.15

1054

4131

Anxiety (asthma-related co-morbidities)

1443

7621

1.46

37.33

1.1

2.28

2.37

u/ml

0.12

853

3941

Persons encountering health services for examination and investigation

1197

3948

1.53

37.30

1.1

2.20

2.42

u/ml

0.26

680

1919

Other headache syndromes

828

5155

1.62

36.78

1.2

1.1

1.41

2.31

u/ml

2.98

470

2639

Low back pain

1509

7127

1.44

36.64

1.2

1.1

2.15

2.25

u/ml

0.12

819

3742

Triptan medication for migraine, min. 3 purchases

1410

7318

1.46

36.61

1.1

1.76

2.34

u/ml

1.56

717

3831

Mycoses, including avohilmo

1774

9767

1.39

36.31

1.1

1.85

2.28

u/ml

1.13

957

5221

Other dorsopathies, not elsewhere classified

1982

7513

1.38

35.87

1.2

1.1

1.93

2.31

u/ml

0.84

1083

3982

Soft tissue disorders

2062

7775

1.37

35.25

1.1

2.01

2.41

u/ml

0.90

1142

4214

Atopic conjunctivitis

156

533

3.09

35.15

1.2

1.1

3.51

2.80

u/ml

0.23

305

Other inflammation of eyelid, including avohilmo

1025

6806

1.53

34.88

1.1

3.04

2.18

u/ml

1.14

558

3613

Coxibs

483

1327

1.93

34.83

1.1

2.04

3.23

u/ml

1.65

257

770

Eosinophilic disease (BM)

8.35

34.05

1.4

1.0

0.73

2.77

u/ml

1.19

Anxiety disorders, excluding more controls

1624

7443

1.41

33.99

1.1

2.16

2.22

u/ml

0.08

950

3861

Depression

1839

9037

1.37

33.41

1.1

2.03

2.21

u/ml

0.31

1046

4731

Myalgia

502

2822

1.81

33.33

1.2

1.1

1.56

2.14

u/ml

0.70

287

1460

Exposure to other specified factors

1611

10027

1.39

33.17

1.2

1.1

2.02

2.25

u/ml

0.45

925

5361

Functional dyspepsia

478

2651

1.83

33.12

1.1

1.20

1.99

u/ml

2.11

258

1376

Tonsillectomy and adenotomy

1522

7583

1.41

33.08

1.1

2.31

2.44

u/ml

0.18

838

4112

Codes for special purposes

1000

6622

1.51

32.88

1.2

1.1

1.53

2.16

u/ml

1.63

538

3578

Provisional assignment of new diseases of uncertain etiology

999

6618

1.51

32.81

1.2

1.1

1.53

2.15

u/ml

1.61

538

3576

Caries of enamel

1841

8886

1.37

32.57

1.1

2.46

2.06

u/ml

0.75

1046

4686

Parasetamol

1534

5542

1.41

31.43

1.1

2.41

2.55

u/ml

0.19

849

2934

Pain and other conditions associated with female genital organs and menstrual cycle

584

2905

1.72

31.03

1.1

2.25

2.82

u/ml

0.64

298

1547

Acetic acid derivatives and related substances

450

1240

1.90

30.74

1.1

2.23

3.07

u/ml

0.75

232

714

Conjunctivitis (acute, non atopic)

587

3512

1.69

30.69

1.1

2.46

2.33

u/ml

0.10

344

1898

Lower back pain or/and sciatica

1948

9078

1.34

30.68

1.2

1.1

2.10

2.15

u/ml

0.06

1059

4768

Other anxiety disorders

1158

6856

1.45

30.46

1.1

2.37

2.44

u/ml

0.07

693

3553

Other joint disorders

1914

7444

1.35

30.38

1.1

1.86

2.56

u/ml

2.39

1045

4008

Other disorders of lacrimal gland

602

3658

1.67

30.04

1.2

1.1

1.67

1.88

u/ml

0.27

330

1887

Bronchitis, not specified as acute or chronic

141

493

2.93

30.03

1.2

1.1

1.82

2.52

u/ml

0.38

229

Diseases of oesophagus, stomach and duodenum

1890

8356

1.34

29.76

1.1

1.59

2.19

u/ml

2.03

1038

4431

Abdominal and pelvic pain

1827

6806

1.36

29.70

1.1

2.15

2.36

u/ml

0.35

1023

3689

Diseases of the musculoskeletal system and connective tissue

1294

4553

1.44

29.52

1.1

1.92

2.64

u/ml

1.73

722

2482

Dorsopathies

2007

7670

1.33

29.19

1.2

1.1

2.12

2.35

u/ml

0.38

1094

4106

Mood [affective] disorders

1880

9095

1.33

28.38

1.1

1.97

2.20

u/ml

0.46

1064

4775

Symptoms and signs involving the digestive system and abdomen

1819

6807

1.35

28.35

1.1

2.07

2.36

u/ml

0.58

1021

3690

Mood disorders

1879

9095

1.33

27.92

1.1

1.97

2.20

u/ml

0.46

1064

4774

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1709

9982

1.34

27.89

1.1

1.96

2.24

u/ml

0.57

933

5384

Neurological diseases

1776

6662

1.35

27.73

1.1

2.18

2.60

u/ml

0.79

990

3576

Codeine

1765

7136

1.35

27.63

1.2

1.1

1.62

2.25

u/ml

2.24

976

3690

Malignant neoplasm

789

6939

0.66

27.48

1.1

1.75

1.96

u/ml

0.29

427

3642

Abnormal findings on diagnostic imaging of lung

508

2868

1.69

26.94

1.1

1.60

1.61

u/ml

0.01

289

1529

Disorders of lacrimal system

701

4460

1.56

26.87

1.2

1.1

1.63

2.02

u/ml

0.64

376

2318

Migraine with aura

631

4005

1.60

26.61

1.2

1.1

1.66

2.55

u/ml

2.34

362

2082

Opioids

1882

7377

1.33

26.46

1.2

1.1

1.74

2.39

u/ml

2.20

1045

3834

Malignant neoplasm

795

6928

0.67

26.46

1.1

1.74

1.96

u/ml

0.31

430

3633

Codeine or tramadol medication

1982

8247

1.31

26.29

1.1

1.66

2.17

u/ml

1.62

1082

4257

Solid cancers

748

6574

0.66

25.88

1.1

1.79

1.87

u/ml

0.08

404

3423

Neurological diseases, wide definition

808

2670

1.54

25.62

1.1

2.32

2.89

u/ml

0.76

464

1507

Diseases of middle ear and mastoid

1286

7665

1.38

25.56

1.2

1.1

2.23

2.43

u/ml

0.29

732

4136

Migraine without aura

579

3655

1.62

25.18

1.2

1.1

1.84

2.59

u/ml

1.18

329

1926

Soft tissue disorders related to use, overuse and pressure

398

2279

1.77

24.83

1.1

1.50

1.89

u/ml

0.44

217

1155

Malignant neoplasm, wide definition

857

7222

0.69

24.68

1.1

1.67

1.97

u/ml

0.47

461

3809

Other antidepressants

1737

6734

1.32

24.28

1.1

1.84

2.28

u/ml

0.99

943

3535

Malignant neoplasm, including Hilmo

863

7236

0.69

24.10

1.1

1.66

1.98

u/ml

0.52

466

3807

Gastrointestinal diseases

1365

5020

1.37

24.10

1.1

2.05

2.52

u/ml

1.01

750

2727

Candidiasis, including avohilmo

592

3791

1.58

24.02

1.2

1.1

1.64

2.14

u/ml

0.73

303

2018

Any event in cancer register

988

8107

0.71

23.99

1.1

1.94

2.05

u/ml

0.15

535

4276

Cystitis

1473

6541

1.35

23.89

1.1

1.86

2.16

u/ml

0.59

779

3493

Solid cancers, including Hilmo

820

6922

0.68

23.72

1.1

1.74

1.90

u/ml

0.22

440

3620

Non-allergic asthma

137

537

2.61

23.49

1.1

1.08

1.44

u/ml

0.22

280

Haemorrhage from respiratory passages

380

1925

1.76

23.21

1.2

1.1

2.22

2.18

u/ml

0.02

224

997

Certain infectious and parasitic diseases, including avohilmo

1288

4723

1.38

23.01

1.1

2.07

2.37

u/ml

0.44

701

2510

Covid-19 suspected case

515

3231

1.62

22.99

1.1

1.63

2.24

u/ml

0.92

263

1714

Migraine without aura and triptan purchases

464

2848

1.66

22.78

1.1

1.92

2.33

u/ml

0.43

258

1528

COPD (mode)

211

770

2.15

22.76

1.1

2.39

1.34

u/ml

0.63

123

351

Selective serotonin reuptake inhibitors

1726

6882

1.31

22.63

1.1

2.09

2.35

u/ml

0.45

935

3652

Depression medications

857

2950

1.48

22.59

1.1

2.75

2.67

u/ml

0.06

473

1544

Diseases of the ear and mastoid process

2150

8499

1.27

22.52

1.2

1.1

1.90

2.29

u/ml

1.06

1191

4490

Simple and mucopurulent chronic bronchitis

158

4.03

21.88

1.1

1.2

1.18

0.99

u/ml

0.12

Pain in limb

1522

7380

1.32

21.54

1.1

1.96

2.38

u/ml

0.78

849

3976

Mood disorders, excluding more controls

1645

7446

1.31

21.43

1.1

2.01

2.21

u/ml

0.32

918

3852

Migraine with aura and triptan purchases

439

2701

1.66

21.39

1.2

1.1

1.78

2.28

u/ml

0.71

252

1447

Nonsuppurative otitis media, including avohilmo

812

4900

1.45

21.38

1.2

1.1

2.96

2.62

u/ml

0.32

483

2679

Later onset COPD, excluding more controls

251

2.99

20.88

1.1

1.40

0.89

u/ml

0.32

128

Pruritus

208

1027

2.07

20.77

1.2

1.1

1.26

1.92

u/ml

0.88

105

513

Eosinophilia

4.99

20.66

1.4

1.1

0.73

2.10

u/ml

1.17

Speech therapy

359

2113

1.72

20.44

1.2

1.1

1.10

1.98

u/ml

1.39

171

1133

Other menopausal disorders

420

1401

1.69

20.21

1.1

1.29

1.99

u/ml

0.87

226

709

Persons encountering health services for specific procedures and health care

2002

9409

1.26

20.02

1.2

1.1

2.03

2.25

u/ml

0.39

1195

4973

Other nutritional deficiencies

1258

8700

1.33

19.97

1.1

1.72

2.19

u/ml

1.16

718

4559

Dysphagia

313

1785

1.77

19.91

1.2

1.1

1.71

1.64

u/ml

0.04

180

922

Hyperkinetic disorders, excluding more controls

479

2861

1.60

19.77

1.2

1.1

2.34

3.01

u/ml

0.72

292

1577

Other inflammation of eyelid

245

1303

1.91

19.73

1.1

2.47

2.32

u/ml

0.07

145

702

General symptoms and signs

1972

7845

1.27

19.63

1.2

1.1

1.98

2.35

u/ml

0.79

1094

4165

Injuries to the ankle and foot

1480

9797

1.30

19.62

1.2

1.1

1.89

2.30

u/ml

0.99

860

5210

Propionic acid derivatives

510

1616

1.60

19.58

1.1

2.62

3.37

u/ml

0.65

276

984

Other chronic obstructive pulmonary disease, including avohilmo

503

2650

1.57

19.50

1.1

2.26

1.46

u/ml

0.90

314

1414

Lichen simplex chronicus and prurigo

106

405

2.68

19.30

1.1

3.16

1.61

u/ml

0.45

217

Herpesviral [herpes simplex] infections, including avohilmo

550

3648

1.53

19.21

1.1

2.69

2.07

u/ml

0.63

313

1898

Allergic urticaria

207

1057

2.01

19.05

1.2

1.1

2.30

2.41

u/ml

0.06

130

583

Arthropathies

1878

7529

1.27

18.96

1.1

1.90

2.53

u/ml

1.92

1018

4081

Renal tubulo-interstitial diseases

845

8545

0.72

18.95

1.1

2.21

2.10

u/ml

0.10

462

4578

Injuries to the wrist and hand

1844

9733

1.26

18.88

1.1

1.53

2.32

u/ml

4.46

1018

5229

Acute bronchiolitis

259

1298

1.88

18.53

1.3

1.2

2.87

3.29

u/ml

0.22

199

800

Emphysema

160

3.67

18.27

1.2

1.1

2.82

1.23

u/ml

0.51

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

821

5131

1.40

18.16

1.1

1.56

1.79

u/ml

0.31

459

2724

Fenamates

222

780

1.96

18.15

1.1

1.66

3.08

u/ml

1.41

119

443

Heartburn

201

1034

1.98

17.95

1.2

1.1

2.01

2.09

u/ml

0.03

110

542

Other enthesopathies

468

3040

1.55

17.89

1.2

1.1

1.49

1.90

u/ml

0.49

241

1535

Suppurative and unspecified otitis media

910

5923

1.38

17.86

1.2

1.1

2.43

2.50

u/ml

0.06

509

3258

Mouth breathing

619

4258

1.47

17.80

1.1

1.43

2.14

u/ml

1.53

346

2395

Oxicams

276

862

1.83

17.79

1.1

0.98

2.71

u/ml

3.16

135

494

Rotator cuff syndrome

796

3910

1.41

17.72

1.1

1.50

1.83

u/ml

0.50

435

1982

Acne, including avohilmo

728

4177

1.43

17.70

1.1

2.52

2.77

u/ml

0.29

403

2310

Transport accidents

888

5415

1.38

17.45

1.1

1.99

2.44

u/ml

0.66

490

2802

Allergic colitis

133

605

2.39

17.36

1.3

1.2

4.45

3.26

u/ml

0.38

392

Pain in thoracic spine

278

1602

1.76

17.27

1.2

1.1

1.80

2.11

u/ml

0.29

162

807

Diaphragmatic hernia

388

2433

1.61

17.26

1.1

0.92

1.59

u/ml

2.28

237

1271

Subjective visual disturbances

421

2702

1.58

17.09

1.1

1.45

2.11

u/ml

0.89

246

1436

Inflammatory diseases of female pelvic organs

1239

6519

1.31

17.06

1.1

2.05

2.12

u/ml

0.09

665

3343

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1919

8220

1.25

16.99

1.1

1.67

2.34

u/ml

2.65

1141

4308

Symptoms and signs involving the skin and subcutaneous tissue

1183

8587

1.31

16.95

1.1

1.82

2.07

u/ml

0.47

672

4537

Disorders of eyelid, lacrimal system and orbit

1357

7759

1.29

16.71

1.1

2.03

2.07

u/ml

0.05

743

4100

Early onset COPD

254

1438

1.79

16.70

1.1

2.12

1.76

u/ml

0.21

157

767

Other viral diseases, including avohilmo

886

6509

1.36

16.62

1.2

1.1

1.65

2.55

u/ml

2.24

489

3592

Allergic contact dermatitis due to drugs in contact with skin

168

3.56

16.57

1.1

2.67

2.26

u/ml

0.10

Intestinal infectious diseases

1668

9950

1.25

16.32

1.2

1.1

1.97

2.27

u/ml

0.60

942

5340

Disorders of synovium and tendon

887

5572

1.36

16.31

1.1

1.72

2.08

u/ml

0.66

444

2905

Dermatophytosis, including avohilmo

1103

8283

1.31

16.29

1.1

1.93

2.11

u/ml

0.26

602

4381

Somatoform disorder

313

1896

1.68

16.24

1.2

1.1

1.20

1.91

u/ml

1.36

168

946

Schizophrenia

1925

0.38

16.24

1.1

3.07

1.99

u/ml

0.23

1025

Disturbance of activity and attention

488

3208

1.52

16.19

1.2

2.25

2.83

u/ml

0.65

303

1824

Shoulder lesions

1068

4840

1.33

16.09

1.1

1.61

1.88

u/ml

0.39

576

2480

Irregular menses

1091

6263

1.32

16.04

1.1

2.05

2.25

u/ml

0.26

596

3196

Hyperkinetic disorders

506

3356

1.50

15.99

1.2

2.22

2.89

u/ml

0.82

316

1907

Diabetes, insulin treatment (Kela reimbursement)

1010

7891

0.76

15.84

1.1

1.71

1.97

u/ml

0.41

528

4224

Disease of hard tissues of teeth, NOS

739

2757

1.41

15.82

1.1

1.76

2.15

u/ml

0.49

388

1334

Accidents

1446

5695

1.28

15.82

1.1

1.83

2.43

u/ml

1.50

786

2954

Vocal cord dysfunction

276

1428

1.73

15.69

1.2

1.1

1.65

1.97

u/ml

0.20

171

741

Follow-up examination after treatment for conditions other than malignant neoplasms

703

3342

1.41

15.64

1.2

1.1

1.28

2.37

u/ml

2.79

373

1612

Excessive attrition of teeth

1161

8936

1.29

15.46

1.1

1.93

2.20

u/ml

0.51

637

4737

Other external causes of accidental injury

1442

5695

1.28

15.44

1.2

1.1

1.82

2.43

u/ml

1.55

798

2954

Other diseases of lip and oral mucosa

652

4657

1.41

15.44

1.2

1.1

1.89

1.92

u/ml

0.03

363

2460

Other diseases of hard tissues of teeth

754

2804

1.40

15.43

1.1

1.76

2.15

u/ml

0.60

421

1372

All kidney diseases

1138

9799

0.77

15.41

1.1

1.95

2.15

u/ml

0.28

634

5244

Persons encountering health services in other circumstances, wide

1957

8222

1.23

15.21

1.1

1.98

2.34

u/ml

0.83

1149

4309

Other diseases of intestines

2000

9146

1.22

15.14

1.1

1.78

2.39

u/ml

1.91

1083

4953

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

976

7580

0.76

15.02

1.1

1.75

2.01

u/ml

0.41

514

4060

Acute pharyngitis

388

2503

1.56

14.92

1.2

1.1

2.15

2.93

u/ml

0.81

213

1389

Exfoliative dermatitis

5.95

14.80

1.2

11.29

1.33

u/ml

1.39

Visual disturbances

752

5537

1.37

14.80

1.1

1.36

2.13

u/ml

2.12

427

2993

External causes of morbidity and mortality

1228

4782

1.29

14.80

1.1

1.90

2.53

u/ml

1.35

670

2479

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

135

439

2.18

14.80

1.2

1.1

1.20

2.00

u/ml

0.57

233

Sciatica+with lumbago

791

5187

1.36

14.69

1.1

2.13

1.97

u/ml

0.15

443

2660

Anti-inflammatory and antirheumatic products, non-steroids

483

1618

1.51

14.67

1.1

2.63

3.37

u/ml

0.62

266

986

ILD, hospital admissions 1, main diag only

126

589

2.16

14.60

1.1

1.20

1.97

u/ml

0.64

329

Oedema, not elsewhere classified

428

2785

1.51

14.57

1.2

1.1

1.52

1.83

u/ml

0.34

239

1467

Acute suppurative otitis media

724

4960

1.38

14.50

1.2

1.1

2.33

2.64

u/ml

0.33

410

2727

Obesity

1150

8479

1.28

14.41

1.1

1.64

2.14

u/ml

1.22

655

4428

Obesity and other hyperalimentation

1152

8487

1.28

14.36

1.1

1.64

2.14

u/ml

1.25

657

4433

1435

6688

1.26

14.36

1.2

1.1

2.52

2.25

u/ml

0.34

855

3425

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1435

6688

1.26

14.36

1.2

1.1

2.52

2.25

u/ml

0.34

855

3425

Trochanteric bursitis

196

1077

1.84

14.35

1.1

0.90

1.98

u/ml

2.02

109

556

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

435

2931

1.51

14.32

1.2

1.1

1.69

2.22

u/ml

0.73

235

1508

Schizophrenia or delusion

253

4154

0.60

14.22

1.1

2.03

2.04

u/ml

0.01

154

2210

Paracetamol or NSAID medication

347

1091

1.62

14.14

1.2

1.1

3.22

3.58

u/ml

0.18

195

673

Other/unspecified dorsalgia

570

3989

1.42

14.12

1.1

1.87

2.11

u/ml

0.28

350

2080

Cervicocranial syndrome

173

922

1.91

14.01

1.2

1.1

1.77

2.28

u/ml

0.32

462

Schizophrenia, schizotypal and delusional disorders

255

4160

0.61

13.96

1.1

2.02

2.04

u/ml

0.01

155

2217

Disorders of skin appendages

971

7449

1.31

13.91

1.1

2.40

2.28

u/ml

0.12

545

3962

Enthesopathies of lower limb, excluding foot

370

2423

1.54

13.83

1.1

1.60

2.18

u/ml

0.83

197

1228

Injuries to the knee and lower leg

2088

9386

1.21

13.81

1.1

2.04

2.27

u/ml

0.43

1131

5044

Cervicalgia

299

1865

1.62

13.80

1.2

1.1

1.31

2.16

u/ml

1.08

161

935

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

715

4612

1.37

13.74

1.2

2.48

2.91

u/ml

0.47

421

2598

Other general symptoms and signs

153

785

1.99

13.71

1.2

0.77

3.16

u/ml

4.49

461

ILD, hospital admission 2, with pulmonary infections

376

2.42

13.63

1.2

1.1

1.34

1.88

u/ml

0.27

195

Disturbances of skin sensation

512

3591

1.44

13.59

1.2

1.1

1.69

1.99

u/ml

0.35

302

1867

Other bacterial diseases

940

8065

0.77

13.59

1.1

2.76

1.92

u/ml

1.25

575

4312

Other viral diseases, not elsewhere classified, including avohilmo

618

4455

1.40

13.54

1.2

1.1

1.55

2.45

u/ml

1.96

338

2483

Diabetes medication

1234

9025

0.79

13.25

1.1

1.74

2.12

u/ml

0.89

664

4807

Other and unspecified tonsillitis

789

4937

1.34

13.24

1.2

1.1

1.89

2.71

u/ml

1.75

432

2645

ILD, hospital admissions

135

674

2.02

13.18

1.1

1.15

1.78

u/ml

0.54

380

Other interstitial pulmonary diseases

135

674

2.02

13.18

1.1

1.15

1.78

u/ml

0.54

380

Acute laryngitis and tracheitis

332

2119

1.57

13.17

1.2

1.1

3.53

2.89

u/ml

0.39

193

1181

Other respiratory diseases principally affecting the interstitium

156

819

1.92

13.15

1.2

1.1

1.10

1.76

u/ml

0.69

469

COPD, hospital admissions

352

1929

1.54

13.10

1.1

1.92

1.44

u/ml

0.41

219

1035

Interstitial lung disease

135

676

2.02

13.07

1.1

1.15

1.78

u/ml

0.54

381

Interstitial lung disease endpoints

135

676

2.02

13.07

1.1

1.15

1.78

u/ml

0.54

381

Malignant neoplasm of breast

311

3096

0.64

12.92

1.1

1.82

1.58

u/ml

0.20

157

1546

Restless leg syndrome

219

1286

1.73

12.87

1.2

1.1

3.27

1.81

u/ml

0.87

116

678

Cervicobrachial syndrome

339

2214

1.55

12.86

1.2

1.1

1.36

1.98

u/ml

0.71

183

1098

Visual disturbances and blindness

777

5869

1.33

12.86

1.1

1.34

2.08

u/ml

2.12

444

3182

Chronic conjunctivitis

275

2.68

12.86

1.2

1.1

2.44

3.33

u/ml

0.18

162

COPD, early/later onset

354

1947

1.53

12.75

1.1

1.91

1.49

u/ml

0.35

220

1046

Malignant neoplasm of breast, HER2-negative

312

3091

0.65

12.66

1.1

1.81

1.58

u/ml

0.19

158

1544

Malignant neoplasm of digestive organs, including Hilmo

165

2171

0.56

12.63

1.1

2.47

1.40

u/ml

0.49

1181

Internal derangement of knee

568

4069

1.39

12.53

1.1

2.22

2.14

u/ml

0.06

299

2106

General examination and investigation of persons without complaint and reported diagnosis

983

3948

1.30

12.42

1.1

2.47

2.42

u/ml

0.05

566

1919

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

586

4279

1.38

12.35

1.2

1.1

2.25

2.46

u/ml

0.19

345

2298

Other intervertebral disc disorders

1240

5906

1.26

12.35

1.1

1.31

2.01

u/ml

2.68

686

3039

Other diseases of oesophagus

110

524

2.13

12.26

1.2

1.1

4.05

2.45

u/ml

0.43

286

Nummular dermatitis

106

501

2.15

12.09

1.1

1.26

2.32

u/ml

1.00

258

Excessive, frequent and irregular menstruation

763

3062

1.34

12.05

1.1

2.14

2.92

u/ml

1.21

407

1645

Ganglion

363

2447

1.50

11.92

1.1

2.05

2.13

u/ml

0.05

184

1232

Unspecified threat to breathing

123

3.61

11.87

1.3

1.2

0.35

2.37

u/ml

1.47

Other noninfective gastroenteritis and colitis

419

2905

1.46

11.86

1.2

1.1

2.67

2.31

u/ml

0.23

245

1643

Chronic gastritis

232

1414

1.65

11.77

1.1

0.60

1.63

u/ml

3.48

145

742

Malignant neoplasm of breast, including Hilmo

332

3172

0.67

11.70

1.1

1.69

1.63

u/ml

0.05

172

1580

Prurigo nodularis

118

3.49

11.62

1.1

1.72

1.30

u/ml

0.20

Malignant neoplasm of breast, HER2-negative, including Hilmo

333

3172

0.67

11.55

1.1

1.68

1.63

u/ml

0.04

173

1580

Genitourinary diseases

1064

4212

1.27

11.48

1.2

1.1

2.13

2.71

u/ml

1.01

602

2403

Dislocation, sprain and strain of joints and ligaments of knee

1140

8289

1.25

11.48

1.1

1.73

2.19

u/ml

1.16

600

4338

Diabetes, varying definitions

1251

8923

0.81

11.47

1.1

1.72

2.14

u/ml

1.02

667

4759

Diseases of oral cavity, salivary glands and jaws

726

2806

1.34

11.44

1.1

2.08

2.15

u/ml

0.06

411

1373

Diabetes mellitus

1262

8954

0.81

11.42

1.1

1.71

2.16

u/ml

1.14

674

4775

Injury, poisoning and certain other consequences of external causes

996

3912

1.28

11.41

1.1

1.99

2.51

u/ml

0.88

547

2031

Kela-code for severe mental illness

311

4639

0.67

11.37

1.1

2.32

2.02

u/ml

0.15

184

2469

Urinary track infection

1203

4837

1.25

11.29

1.1

1.81

2.30

u/ml

0.94

635

2539

Endometriosis of pelvic peritoneum

311

1864

1.54

11.29

1.1

1.58

2.47

u/ml

0.99

143

968

Inflammatory diseases of prostate (prostatitis)

133

700

1.92

11.24

1.2

1.1

1.30

2.35

u/ml

1.00

384

Diarrhoea and gastroenteritis of presumed infectious origin

1247

9061

1.23

11.20

1.2

1.1

2.04

2.28

u/ml

0.37

724

4883

Dislocation, sprain and strain of joints and ligaments at neck level

340

2297

1.50

11.18

1.2

1.1

2.02

2.31

u/ml

0.25

201

1204

Rosacea

221

1357

1.65

11.07

1.1

2.72

2.01

u/ml

0.34

120

703

Unspecified privation

175

1011

1.76

11.02

1.2

1.1

0.92

2.15

u/ml

3.29

122

527

Other and unspecified nonorganic psychotic disorders

177

2965

0.59

11.01

1.1

2.39

2.17

u/ml

0.08

109

1600

Other diseases of urinary system

1588

7398

1.21

10.94

1.1

1.93

2.25

u/ml

0.68

849

3969

Peritonsillar abscess

306

2029

1.52

10.91

1.1

1.56

2.53

u/ml

1.38

154

989

COPD, hospital admissions 1, only main diagnosis

245

1319

1.60

10.88

1.1

1.90

1.54

u/ml

0.24

153

737

Female infertility

586

2589

1.37

10.86

1.1

2.04

2.60

u/ml

0.65

294

1362

Disorders of the thyroid gland

1513

8137

1.21

10.78

1.1

1.98

2.12

u/ml

0.25

770

4349

Diseases of external ear

524

3849

1.37

10.67

1.2

1.1

2.74

2.08

u/ml

0.67

303

2106

Other and unspecified rosacea

156

881

1.80

10.66

1.1

2.45

2.12

u/ml

0.11

449

Vasomotor rhinitis (mode)

114

583

1.99

10.61

1.1

1.43

2.39

u/ml

0.40

319

Dermatitis due to substances taken internally

475

2.11

10.60

1.1

2.06

2.00

u/ml

0.03

249

Female infertility, cervical, vaginal, other or unspecified origin

533

2492

1.38

10.54

1.1

1.82

2.60

u/ml

1.01

267

1302

Noninflammatory disorders of female genital tract

802

3103

1.31

10.53

1.1

2.16

2.90

u/ml

1.23

431

1677

Unspecified chronic bronchitis

3.60

10.50

1.2

1.1

3.12

1.76

u/ml

0.26

Benign neoplasm: Colon

485

3301

1.38

10.50

1.1

1.62

1.46

u/ml

0.12

255

1759

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1414

0.44

10.47

1.1

0.81

1.36

u/ml

0.78

759

Psychiatric diseases

1565

6515

1.21

10.45

1.1

2.09

2.27

u/ml

0.27

864

3488

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

154

874

1.79

10.36

1.2

1.1

1.91

1.98

u/ml

0.04

458

Organic, including symptomatic, mental disorders

159

1912

0.58

10.33

1.1

0.60

1.56

u/ml

3.29

1044

Schizophrenia or delusion, excluding more controls

253

3804

0.65

10.31

1.1

2.03

2.12

u/ml

0.05

154

1980

Adenomyosis (Endometriosis of uterus)

187

1120

1.69

10.24

1.2

1.1

1.67

1.82

u/ml

0.08

568

All chronic kidney diseases

392

4394

0.71

10.21

1.1

2.36

2.03

u/ml

0.21

210

2433

Other arthrosis

653

3316

1.33

10.14

1.1

1.25

1.89

u/ml

1.42

372

1688

Tramadol

1188

5813

1.23

10.13

1.2

1.1

1.82

2.02

u/ml

0.25

674

3008

Fibromyalgia

177

1053

1.71

10.09

1.2

1.1

0.70

2.46

u/ml

4.03

526

Other extrapyramidal and movement disorders in other diseases

298

1999

1.50

10.07

1.2

1.1

2.79

1.86

u/ml

0.68

160

1057

Infective dermatitis

148

837

1.79

10.03

1.1

3.34

1.74

u/ml

0.80

424

Dental pulpitis, including avohilmo

1694

9153

1.19

10.03

1.2

1.1

1.95

2.25

u/ml

0.67

933

4789

Hypothyroidism, other/unspecified

1412

7713

1.21

9.92

1.1

2.20

2.09

u/ml

0.15

721

4115

Cervical disc disorders

410

2928

1.41

9.91

1.1

1.19

1.84

u/ml

1.07

230

1454

Lumbar disc prolapse

928

5480

1.26

9.87

1.1

1.43

1.94

u/ml

1.21

520

2828

Malignant neoplasm of digestive organs

147

1927

0.58

9.76

1.1

1.93

1.39

u/ml

0.24

1055

Generalized anxiety disorder

414

2975

1.41

9.75

1.2

1.1

1.80

2.61

u/ml

0.90

246

1532

Any gastric operation

1605

6760

1.20

9.68

1.1

2.34

2.49

u/ml

0.21

881

3668

GASTRO-related operations

1605

6760

1.20

9.68

1.1

2.34

2.49

u/ml

0.21

881

3668

Anomalies of dental arch relationship, including avohilmo

479

3198

1.37

9.51

1.2

1.1

2.50

2.69

u/ml

0.13

274

1800

Other reaction to severe stress, and adjustment disorders

748

5873

1.28

9.50

1.2

1.1

2.18

2.21

u/ml

0.03

460

3007

Other diseases of the respiratory system

181

1101

1.66

9.38

1.2

1.1

0.82

2.18

u/ml

2.89

103

623

Other respiratory disorders and diseases

181

1101

1.66

9.38

1.2

1.1

0.82

2.18

u/ml

2.89

103

623

Cerebrovascular diseases

441

4167

0.73

9.35

1.1

1.32

1.68

u/ml

0.48

224

2221

Disorders of tooth development and eruption

315

1759

1.47

9.32

1.1

1.49

2.37

u/ml

1.03

172

884

Hypothyreosis and Thyroxine purchase for inclusion criteria

1454

7983

1.20

9.31

1.1

2.18

2.04

u/ml

0.21

740

4250

Renal failure

198

2654

0.63

9.31

1.2

1.1

2.82

1.87

u/ml

0.42

114

1490

Hypertrophy of breast in women and men

334

2335

1.45

9.24

1.1

1.71

1.95

u/ml

0.19

154

1188

Hypothyroidism, strict autoimmune

1213

6568

1.22

9.23

1.1

2.23

2.07

u/ml

0.21

607

3490

Lichen simplex chronicus

210

2.58

9.21

1.2

1.1

4.26

1.65

u/ml

0.34

114

Dental operations

749

2997

1.29

9.19

1.1

1.76

1.96

u/ml

0.27

415

1538

Other and unspecified vaccines and biological substances

4.03

9.16

1.3

1.2

1.05

1.54

u/ml

0.25

Malaise and fatigue

735

4534

1.28

9.16

1.2

1.1

2.32

2.09

u/ml

0.20

415

2444

Dementia, including avohilmo

1237

0.52

9.16

1.1

0.79

1.37

u/ml

0.78

701

Other disorders of urethra and urinary system

1068

6065

1.23

9.13

1.1

2.03

2.09

u/ml

0.07

542

3192

Other bacterial diseases, including avohilmo

1226

9195

0.83

9.04

1.1

2.91

1.97

u/ml

1.71

731

4884

Alcohol dependence

142

2390

0.59

9.01

1.2

1.1

3.92

1.98

u/ml

0.63

1283

COPD related to multimorbidity

263

1480

1.51

8.98

1.1

1.30

1.42

u/ml

0.09

160

805

Disorders of other endocrine glands

730

5667

1.28

8.95

1.2

1.1

2.12

2.19

u/ml

0.06

400

3129

Biguanides

974

7219

0.81

8.93

1.1

1.49

1.91

u/ml

1.09

522

3757

Superficial injury of lower leg

457

3387

1.36

8.92

1.2

1.1

2.71

2.45

u/ml

0.16

253

1822

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1244

9449

1.21

8.92

1.1

1.75

2.40

u/ml

1.48

692

5054

Other disorders of white blood cells

385

2.12

8.87

1.3

1.1

0.80

2.82

u/ml

2.72

223

Insulin medication

514

5618

0.76

8.84

1.1

1.79

2.04

u/ml

0.27

276

3090

Type 2 diabetes

1125

7876

0.82

8.82

1.1

1.48

1.96

u/ml

1.53

595

4118

Unspecified acute lower respiratory infection

237

1563

1.53

8.81

1.2

1.1

1.73

2.21

u/ml

0.47

148

822

Pulmonary eosinophilia, not elsewhere classified

4.40

8.76

1.2

1.1

0.47

1.19

u/ml

0.92

Any dementia

938

0.46

8.74

1.2

1.1

0.67

1.19

u/ml

0.53

526

Other disorders of patella

296

2048

1.46

8.69

1.1

1.44

2.07

u/ml

1.02

149

1034

Pain, not elsewhere classified

454

3375

1.36

8.68

1.2

1.1

1.61

2.00

u/ml

0.59

262

1792

Any operation in hilmo

231

2.09

8.68

1.1

3.13

1.59

u/ml

0.55

103

Other gastritis (incl. Duodenitis)

223

1455

1.54

8.66

1.2

1.1

1.10

1.80

u/ml

1.42

134

752

Oesophagitis

323

2.20

8.63

1.2

1.1

0.98

2.11

u/ml

1.27

182

Benign neoplasm: Colon, unspecified

205

1313

1.57

8.63

1.2

1.1

1.83

1.48

u/ml

0.15

112

718

Drug-induced adrenocortical insufficiency

166

2.76

8.54

1.3

1.1

0.69

2.04

u/ml

1.16

Other disorders of eyelid

395

2711

1.38

8.52

1.1

1.32

1.66

u/ml

0.63

210

1415

Factors influencing health status and contact with health services

435

1588

1.38

8.50

1.1

2.66

2.60

u/ml

0.04

247

739

Any dementia, excluding more controls

893

0.46

8.50

1.2

1.1

0.71

1.28

u/ml

0.53

497

Uterine polyps

380

1589

1.41

8.46

1.1

1.41

2.12

u/ml

0.77

219

809

Other (not insulin) diabetes medications

1046

7440

0.82

8.42

1.1

1.49

1.91

u/ml

1.16

559

3880

Continuous positive airway pressure

265

1497

1.49

8.38

1.2

1.1

1.67

1.90

u/ml

0.14

149

872

Other and unspecified nerve root and plexus disorders, also in other diseases

298

2078

1.45

8.38

1.1

1.19

1.96

u/ml

1.25

160

1064

Cholinergic urticaria

4.91

8.32

1.3

1.1

3.81

3.78

u/ml

0.00

Panic disorder

345

2478

1.41

8.31

1.2

1.1

2.24

2.32

u/ml

0.05

205

1251

Degenerative diseases of the nervous system

855

0.44

8.26

1.2

1.1

0.46

1.18

u/ml

1.65

482

Spondylolisthesis/Spondylolysis

219

1440

1.53

8.25

1.1

1.38

1.92

u/ml

0.68

106

722

Striking against or struck by other objects

636

4984

1.28

8.23

1.2

1.1

2.86

2.35

u/ml

0.45

365

2790

Ovarian cyst

615

2722

1.30

8.18

1.2

1.1

1.50

2.68

u/ml

3.01

330

1437

Otitis externa

373

2722

1.38

8.10

1.2

1.1

3.19

2.19

u/ml

0.83

214

1476

Certain infectious and parasitic diseases

1718

7386

1.17

8.04

1.1

1.87

2.29

u/ml

1.01

961

3909

Oter anti-inflammatory and antirheumatic agents, non-steroids

175

588

1.64

8.03

1.2

1.1

1.44

2.40

u/ml

0.55

319

Other functional intestinal disorders

650

4653

1.27

7.99

1.1

1.80

2.25

u/ml

0.66

377

2571

Seborrhoeic dermatitis

127

737

1.74

7.98

1.2

1.1

3.32

1.68

u/ml

0.66

388

Other disorders of adrenal gland

500

1.93

7.97

1.2

1.1

1.57

2.92

u/ml

1.02

288

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

235

1565

1.51

7.91

1.2

1.96

2.77

u/ml

0.75

138

950

Nonorganic sleeping disorders, excluding more controls

408

3033

1.36

7.90

1.2

1.1

2.21

2.24

u/ml

0.02

222

1569

Unspecific neurodegenerative disorder

931

0.49

7.89

1.2

1.1

0.46

1.11

u/ml

1.63

540

Other enthesopathy of foot (+metatarsalgia)

161

1000

1.63

7.85

1.1

1.23

2.38

u/ml

1.54

507

Blepharochalasis

245

1666

1.48

7.84

1.1

1.29

1.49

u/ml

0.23

115

866

ILD, hospital admissions 3, with pneumonia sepsis

316

2.14

7.81

1.1

1.66

1.20

u/ml

0.17

165

Stroke, including SAH

315

3147

0.72

7.78

1.1

1.11

1.58

u/ml

0.60

156

1706

Viral warts, including avohilmo

437

3292

1.34

7.77

1.2

1.1

1.74

2.64

u/ml

1.55

215

1816

Type 2 diabetes, strict (exclude DM1)

1036

7241

0.83

7.64

1.1

1.52

1.91

u/ml

1.00

553

3768

Disorders of breast

825

5914

1.23

7.59

1.1

1.87

1.92

u/ml

0.06

427

3013

Mental and behavioural disorders due to alcohol, excluding acute intoxication

343

4628

0.73

7.58

1.1

2.67

1.94

u/ml

0.48

214

2457

Ocular pain

159

995

1.62

7.58

1.2

1.1

0.82

2.32

u/ml

4.24

543

Hypertrophy of breast

301

2147

1.42

7.56

1.1

1.68

1.90

u/ml

0.16

136

1083

Other disorders of eye and adnexa

250

1725

1.47

7.54

1.1

1.14

2.14

u/ml

2.75

146

928

Disorders of thyroid, IBD co-morbidities

319

1557

1.41

7.54

1.1

2.35

2.47

u/ml

0.07

166

836

Other degenerative diseases of the nervous system

120

1471

0.59

7.50

1.1

0.92

1.81

u/ml

1.42

746

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

830

6701

1.23

7.50

1.2

1.1

2.02

2.49

u/ml

0.77

495

3614

Covid-19 confirmed case

472

3603

1.32

7.49

1.2

1.1

1.28

2.10

u/ml

1.66

273

1938

Spondylosis

584

3569

1.28

7.48

1.1

1.67

1.82

u/ml

0.14

303

1798

Other contact dermatitis

121

707

1.74

7.48

1.2

1.1

1.91

1.69

u/ml

0.09

362

Disorders of sclera, cornea, iris and ciliary body

808

6589

1.23

7.47

1.1

2.29

1.97

u/ml

0.38

448

3503

Tinnitus

289

2049

1.42

7.46

1.1

0.88

1.79

u/ml

2.74

151

1077

Type 2 diabetes, definitions combined

1037

7229

0.83

7.44

1.1

1.52

1.91

u/ml

1.02

552

3767

Endometriosis

567

2559

1.30

7.43

1.1

1.49

2.63

u/ml

2.62

285

1338

Rheumatism, unspecified

158

990

1.61

7.42

1.2

1.1

1.19

1.86

u/ml

0.79

510

Dementia

1116

0.55

7.40

1.1

0.73

1.14

u/ml

0.50

632

Postmenopausal atrophic vaginitis

256

951

1.48

7.35

1.1

0.85

1.68

u/ml

1.69

137

486

Otalgia

163

1036

1.60

7.30

1.3

1.2

3.37

2.48

u/ml

0.34

601

Noninfective enteritis and colitis

743

6015

1.24

7.29

1.2

1.1

2.33

2.13

u/ml

0.18

395

3303

Unspecified mental disorder

412

5423

0.75

7.28

1.1

1.87

2.05

u/ml

0.12

244

2875

Alcohol use disorder, ICD-based

316

4327

0.73

7.28

1.2

1.1

2.60

1.87

u/ml

0.46

195

2303

Chondrocostal junction syndrome [Tietze]

327

2.10

7.27

1.2

1.1

3.01

3.00

u/ml

0.00

178

Lateral epicondylitis

192

1265

1.53

7.27

1.2

1.1

0.85

2.14

u/ml

3.17

635

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1077

0.46

7.21

1.1

0.68

1.31

u/ml

1.38

577

COPD, hospital admission 2, with asthma infections

221

1284

1.49

7.20

1.1

1.44

1.56

u/ml

0.07

140

700

Other and unspecified drugs and medicaments

128

768

1.69

7.20

1.2

1.1

2.06

2.11

u/ml

0.02

413

570

6264

0.79

7.19

1.1

2.58

1.98

u/ml

0.58

335

3336

Other disorders of breast

230

1578

1.47

7.17

1.2

1.1

2.32

1.99

u/ml

0.21

129

819

Hypothyroidism (congenital or acquired)

623

2754

1.28

7.15

1.2

1.1

2.40

2.59

u/ml

0.16

321

1455

Stroke, excluding SAH

280

2823

0.71

7.11

1.1

1.11

1.52

u/ml

0.45

141

1526

Hypermobility syndrome

136

836

1.67

7.08

1.2

1.1

2.22

2.70

u/ml

0.19

428

Polyp of the female genital tract

405

1711

1.35

7.03

1.1

1.51

2.14

u/ml

0.67

217

880

Embedded and impacted teeth

741

4892

1.24

6.99

1.1

2.76

2.69

u/ml

0.04

433

2666

Malignant neoplasm of breast, ER-positive, including Hilmo

223

2398

0.69

6.99

1.1

2.01

1.40

u/ml

0.50

120

1203

Diseases of salivary glands

471

3641

1.30

6.94

1.2

1.1

1.36

1.96

u/ml

1.49

250

1914

Herpesviral [herpes simplex] infections

188

1247

1.53

6.94

1.1

3.94

2.02

u/ml

1.09

125

661

Obesity, other/unspecified

591

4702

1.27

6.92

1.1

1.35

2.00

u/ml

1.49

350

2425

Disorders of muscles

152

964

1.59

6.85

1.2

1.1

1.96

2.55

u/ml

0.35

498

Recurrent aphthous stomatitis , including avohilmo

236

1642

1.45

6.85

1.1

2.16

2.14

u/ml

0.01

124

911

Malignant neoplasm of breast, HER-positive

223

2390

0.69

6.83

1.1

2.01

1.40

u/ml

0.50

120

1198

Liquid cancers, including Hilmo

188

2456

0.67

6.80

1.2

1.1

1.38

1.74

u/ml

0.24

103

1352

Type 2 diabetes, definitions combined, including avohilmo

1067

7308

0.84

6.78

1.1

1.54

1.92

u/ml

0.98

575

3806

Alzheimer disease, including avohilmo

734

0.47

6.77

1.2

1.1

0.30

1.00

u/ml

2.78

421

Other shoulder lesions

152

968

1.59

6.75

1.1

1.46

2.48

u/ml

0.98

488

3.55

6.74

1.2

1.1

0.24

1.31

u/ml

1.51

Adrenocortical insufficiency

337

2.04

6.74

1.2

1.1

0.62

2.63

u/ml

2.94

194

Olecranon bursitis

336

2.02

6.72

1.1

3.11

2.53

u/ml

0.14

179

Deforming dorsopathies

401

3047

1.32

6.70

1.1

2.61

2.35

u/ml

0.15

216

1607

All influenza

370

2781

1.34

6.69

1.2

1.1

2.25

2.15

u/ml

0.06

215

1562

Falls/tendency to fall

1905

8373

1.14

6.67

1.1

1.96

2.34

u/ml

0.91

1064

4435

Substance abuse

570

6622

0.80

6.65

1.1

2.54

2.00

u/ml

0.51

343

3507

Alcohol use disorder, Swedish definition

465

5414

0.78

6.64

1.1

2.36

1.92

u/ml

0.34

278

2865

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

869

4536

1.22

6.60

1.2

1.1

2.58

2.27

u/ml

0.32

493

2285

Radiculopathy

160

1035

1.56

6.59

1.2

1.1

1.05

2.07

u/ml

1.52

513

Hypothyroidism, levothyroxine purchases

613

2736

1.26

6.59

1.2

1.1

2.40

2.59

u/ml

0.16

315

1439

Hypothyroidism and >3 levothyroxin purchases

613

2736

1.26

6.59

1.2

1.1

2.40

2.59

u/ml

0.16

315

1439

530

5963

0.79

6.59

1.1

2.66

1.97

u/ml

0.66

316

3178

Occupational exposure to risk-factors

216

2.27

6.42

1.1

1.28

1.59

u/ml

0.20

118

Universal erythroderma, KELA reimbursement

3.19

6.39

1.1

3.70

0.93

u/ml

0.55

Fissure and fistula of anal and rectal regions

322

2389

1.36

6.38

1.1

0.92

2.11

u/ml

4.49

168

1264

Other complications of surgical and medical care, not elsewhere classified

147

942

1.58

6.38

1.2

1.1

1.23

2.33

u/ml

1.46

484

Care involving use of rehabilitation procedures

922

6949

1.20

6.38

1.1

1.06

2.14

u/ml

6.39

532

3687

Acute tubulo-interstitial nephritis

613

6387

0.81

6.32

1.1

2.10

1.99

u/ml

0.09

325

3441

Post-traumatic stress disorder

225

1582

1.45

6.29

1.2

1.1

2.65

2.75

u/ml

0.05

126

821

Carpal tunnel syndrome

794

5692

1.21

6.29

1.1

1.47

1.73

u/ml

0.37

399

2906

Metatarsalgia

142

906

1.59

6.29

1.1

1.28

2.31

u/ml

1.10

458

Nonsuppurative otitis media

551

3815

1.26

6.27

1.2

1.1

2.96

2.89

u/ml

0.04

342

2124

Extrapyramidal and movement disorders

384

2930

1.32

6.25

1.2

1.1

2.60

1.65

u/ml

0.87

208

1550

Mental and behavioural disorders due to psychoactive substance use

600

6785

0.81

6.25

1.1

2.54

2.03

u/ml

0.50

357

3600

Acute and transient psychotic disorders

1355

0.55

6.22

1.1

1.30

2.09

u/ml

0.85

710

Obesity due to excess calories

813

6776

1.21

6.15

1.1

1.93

2.14

u/ml

0.26

453

3556

Other/unspecified enthesopathies of lower limb, excluding foot

118

725

1.65

6.13

1.1

1.88

2.40

u/ml

0.28

356

Other and unspecified polyneuropathies, also in other diseases

160

1055

1.53

6.07

1.2

1.1

1.90

1.74

u/ml

0.07

566

Peripheral artery disease

129

1595

0.64

6.07

1.1

1.02

1.42

u/ml

0.64

880

Appendicitis, broad definition

1160

8931

1.17

6.07

1.1

1.95

2.04

u/ml

0.11

590

4693

Other obstetric conditions, not elsewhere classified

874

4612

1.21

6.07

1.2

1.1

2.57

2.26

u/ml

0.33

496

2314

Unspecified/other endometriosis

209

1429

1.45

6.05

1.1

1.53

2.55

u/ml

1.03

110

745

Persons encountering health services in other circumstances

674

5466

1.23

6.04

1.1

1.85

2.44

u/ml

0.98

350

2907

Infections with a predominantly sexual mode of transmission, including avohilmo

893

6875

1.20

6.03

1.2

1.1

1.80

2.49

u/ml

1.66

454

3653

Crossbite

231

1516

1.43

6.01

1.2

3.48

3.24

u/ml

0.09

154

942

Other and unspecified disorders of vitreous body

383

2874

1.31

5.97

1.1

0.97

1.48

u/ml

1.20

211

1477

Keratitis

521

4161

1.26

5.97

1.1

2.93

1.96

u/ml

1.06

295

2205

Injuries to the neck

405

3139

1.30

5.96

1.2

1.1

2.16

2.29

u/ml

0.11

237

1672

Acute appendicitis, no complications

927

7801

1.19

5.86

1.1

2.16

2.05

u/ml

0.11

464

4089

Endocrine, nutritional and metabolic diseases

1603

7090

1.15

5.84

1.1

2.15

2.50

u/ml

0.65

874

3850

Mental retardation, wide definition

828

0.45

5.83

1.3

1.2

0.83

2.93

u/ml

3.29

561

Diseases of appendix

1162

8948

1.16

5.81

1.1

1.95

2.04

u/ml

0.11

591

4701

Certain disorders involving the immune mechanism

258

1880

1.38

5.81

1.1

1.48

2.08

u/ml

0.52

144

1015

Nerve, nerve root and plexus disorders

1550

8152

1.14

5.80

1.1

1.68

1.95

u/ml

0.53

825

4252

Periodontitis

1093

8113

0.86

5.79

1.1

2.04

1.86

u/ml

0.25

645

4178

Other maternal disorders predominantly related to pregnancy

1054

5624

1.18

5.77

1.2

1.1

2.59

2.01

u/ml

0.83

523

2885

Panniculitis affecting regions of neck and back

273

2.05

5.77

1.2

1.1

6.31

1.92

u/ml

0.64

138

Contact urticaria

5.14

5.74

1.1

6.52

0.88

u/ml

0.58

Other bacterial intestinal infections, including avohilmo

290

2155

1.35

5.74

1.1

1.31

2.00

u/ml

1.16

171

1130

Erysipelas, including avohilmo

647

5829

0.82

5.72

1.1

2.64

1.70

u/ml

1.36

385

3027

Haemorrhoids and perianal venous thrombosis

366

2791

1.31

5.72

1.1

2.67

1.92

u/ml

0.40

187

1478

Infections of the skin and subcutaneous tissue

963

8064

1.18

5.71

1.1

2.53

2.14

u/ml

0.46

558

4385

Benign neoplasm of colon, rectum, anus and anal canal

569

3886

1.24

5.71

1.1

1.53

1.58

u/ml

0.05

299

2044

Insulin, combination of fast acting with intermediate-acting or long-acting

514

5791

0.80

5.71

1.1

1.79

1.99

u/ml

0.20

276

3185

Mental and behavioural disorders due to alcohol

467

5580

0.79

5.70

1.1

2.80

2.00

u/ml

0.69

280

2966

Diseases of male genital organs

658

2699

1.23

5.67

1.2

1.1

1.73

2.48

u/ml

1.20

375

1587

Gingivitis and periodontal diseases

1510

6819

1.15

5.67

1.1

2.15

2.00

u/ml

0.22

860

3572

Spinal osteochondrosis

3.04

5.66

1.2

1.1

0.24

4.42

u/ml

1.49

Congenital malformations, deformations and chromosomal abnormalities

1118

9132

1.17

5.66

1.1

1.88

2.41

u/ml

0.98

629

4909

Other diseases of intestine

145

952

1.53

5.65

1.2

1.1

1.85

1.68

u/ml

0.06

508

Other symptoms and signs involving the circulatory and respiratory systems

474

1.77

5.65

1.2

1.1

1.56

2.63

u/ml

0.77

249

Dizziness and giddiness

1021

6778

1.17

5.64

1.1

1.48

2.02

u/ml

1.33

579

3552

Chronic periodontitis, including avohilmo

1092

8098

0.86

5.64

1.1

2.04

1.86

u/ml

0.26

643

4168

Ischaemic Stroke, excluding all haemorrhages

252

2530

0.73

5.64

1.1

1.16

1.60

u/ml

0.44

127

1371

Other sleep disorders

159

1067

1.50

5.63

1.2

1.1

1.51

2.16

u/ml

0.68

539

Meniscus derangement

669

3644

1.22

5.60

1.1

1.50

1.92

u/ml

0.79

362

1863

Polycystic ovarian syndrome, consortium definition

1307

6508

1.16

5.60

1.1

2.00

2.23

u/ml

0.34

705

3347

Acute appendicitis

1099

8782

1.16

5.58

1.1

1.94

2.04

u/ml

0.14

562

4611

Erosion of teeth , including avohilmo

520

4191

1.25

5.57

1.1

1.85

2.17

u/ml

0.32

293

2250

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

978

6473

1.18

5.56

1.1

2.33

1.95

u/ml

0.60

460

3352

Mental retardation

812

0.46

5.56

1.3

1.2

0.83

2.98

u/ml

3.37

552

Stomatitis and related lesions

325

2472

1.33

5.54

1.1

1.77

2.06

u/ml

0.32

180

1351

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

292

2.00

5.53

1.2

1.1

2.70

2.63

u/ml

0.02

146

Fibroblastic disorders

206

1456

1.42

5.52

1.1

0.96

1.91

u/ml

1.75

114

744

Alzheimer disease

616

0.47

5.51

1.2

1.1

0.26

0.88

u/ml

4.05

348

Fall on same level involving ice and snow

818

6889

1.19

5.50

1.1

1.67

2.02

u/ml

0.60

445

3655

N06DA Anticholinesterases

756

0.51

5.49

1.2

1.1

0.61

1.07

u/ml

0.79

436

Use of anticholinesterases

756

0.51

5.49

1.2

1.1

0.61

1.07

u/ml

0.79

436

Cervical polyps

117

738

1.60

5.49

1.1

0.70

1.68

u/ml

2.41

375

Other systemic involvement of connective tissue

312

2362

1.33

5.46

1.2

1.1

1.59

1.88

u/ml

0.26

178

1243

Benign neoplasm of other and ill-defined parts of digestive system

171

1172

1.47

5.44

1.2

1.1

1.77

1.98

u/ml

0.12

613

Viral pneumonia

174

1198

1.47

5.43

1.2

1.1

1.59

2.59

u/ml

1.07

119

655

Heart failure, not strict

540

4471

0.81

5.41

1.1

1.95

1.75

u/ml

0.16

297

2423

Acute renal failure

1241

0.57

5.40

1.1

2.25

1.80

u/ml

0.13

689

Other and unspecified visual disturbances

140

924

1.53

5.39

1.2

1.1

1.06

2.24

u/ml

1.98

488

Candidiasis

213

1525

1.41

5.38

1.2

1.1

1.33

2.05

u/ml

0.89

112

801

Other spirochaetal diseases, including avohilmo

441

3501

1.27

5.37

1.1

2.21

1.89

u/ml

0.25

242

1879

Other disorders of bone

317

2415

1.32

5.36

1.2

1.1

2.48

2.15

u/ml

0.28

186

1281

Impingement syndrome of shoulder

233

1692

1.38

5.36

1.1

1.34

1.73

u/ml

0.27

122

872

Polyuria

216

1549

1.40

5.36

1.1

1.48

1.88

u/ml

0.46

128

808

Dipeptidyl peptidase 4 (DPP-4) inhibitors

288

2992

0.75

5.34

1.1

1.91

1.64

u/ml

0.21

143

1605

Inflammatory disease of uterus

272

2030

1.35

5.34

1.2

1.1

2.29

2.00

u/ml

0.14

146

1043

Superficial injury of hip and thigh

171

1177

1.46

5.32

1.2

1.1

2.91

2.01

u/ml

0.37

629

Abrasion of teeth

493

3969

1.25

5.32

1.1

1.45

1.87

u/ml

0.79

267

2036

Vulvovaginal ulceration/inflammation in other diseases

154

1043

1.50

5.31

1.2

1.1

2.57

2.56

u/ml

0.01

527

Other systemic involvement of connective tissue (FG)

309

2303

1.32

5.30

1.2

1.1

1.62

1.79

u/ml

0.15

175

1182

Selective deficiency of immunoglobulin G [IgG] subclasses

3.40

5.28

1.2

0.75

2.52

u/ml

—

Dialysis, with operation codes

998

0.53

5.27

1.3

1.1

2.04

2.05

u/ml

0.00

569

Obsessive-compulsive disorder

186

1309

1.44

5.26

1.1

2.06

2.75

u/ml

0.64

105

699

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

701

5836

1.20

5.25

1.1

1.29

1.82

u/ml

1.22

410

3030

Nontoxic goitre/thyroid nodule

291

2198

1.33

5.20

1.1

0.97

1.56

u/ml

1.08

159

1152

Complications of procedures, not elsewhere classified

1162

8129

1.15

5.19

1.1

1.56

2.00

u/ml

1.07

649

4221

Type 2 diabetes, wide definition

671

5083

0.83

5.18

1.1

1.18

1.78

u/ml

1.94

359

2646

Other spirochaetal diseases

431

3429

1.26

5.17

1.1

2.27

1.86

u/ml

0.32

233

1839

ILD medications: immunosuppressive drugs

904

6989

1.17

5.15

1.1

2.38

2.15

u/ml

0.20

478

3612

Septicaemia

273

3295

0.75

5.13

1.1

3.32

1.75

u/ml

1.07

166

1835

Lichen ruber planus, wide definition including periferal and oral lichen planus

241

1774

1.37

5.13

1.1

1.67

1.75

u/ml

0.05

144

928

Hypothyroidism, strict autoimmune, 3 medication purchases required

1278

7504

1.15

5.11

1.1

2.13

2.02

u/ml

0.15

632

3971

All influenza (not pneumonia)

233

1709

1.37

5.10

1.2

1.1

1.86

2.30

u/ml

0.50

133

946

Other noninflammatory disorders of vulva and perineum

157

1075

1.48

5.09

1.1

1.47

2.21

u/ml

0.75

545

Other specified/unspecified soft tissue disorders

286

1.95

5.08

1.1

1.13

2.37

u/ml

1.01

153

Viral and other specified intestinal infections, including avohilmo

632

5054

1.21

5.04

1.2

1.1

1.83

2.75

u/ml

1.99

338

2823

STROKE

461

3854

0.80

5.03

1.1

1.12

1.74

u/ml

1.34

247

2019

Umbilical hernia

333

2577

1.30

5.02

1.1

1.42

2.16

u/ml

1.09

195

1360

Hernia of abdominal wall

512

4166

1.23

5.01

1.1

1.72

1.80

u/ml

0.09

283

2208

Complications of medical and surgical care

985

7624

1.16

5.00

1.1

1.44

1.98

u/ml

1.45

566

3964

Nonorganic sleeping disorders

408

3243

1.27

5.00

1.2

1.1

2.21

u/ml

0.00

222

1706

Other diseases of anus and rectum

320

2454

1.30

4.99

1.1

1.27

1.95

u/ml

1.47

174

1305

Trigger finger

175

1229

1.43

4.94

1.1

1.28

2.19

u/ml

1.39

624

Urticaria due to cold and heat

2.77

4.94

1.2

1.1

4.24

2.56

u/ml

0.39

Other infestations, including avohilmo

106

2.61

4.94

1.1

5.33

3.52

u/ml

0.17

Other septicaemia, including avohilmo

235

2963

0.74

4.92

1.1

3.08

1.76

u/ml

0.73

141

1649

Implicit viral Sepsis, including avohilmo

357

2788

1.28

4.92

1.2

1.1

1.75

1.85

u/ml

0.09

206

1521

Menorrhagia

503

2264

1.25

4.91

1.1

1.68

2.41

u/ml

1.08

265

1187

Benign neoplasm: Liver

222

2.08

4.89

1.1

1.64

2.73

u/ml

0.58

114

Bacterial pneumonia (organism specified)

475

3476

1.24

4.88

1.1

1.60

1.93

u/ml

0.29

295

1841

Postviral fatigue syndrome

139

2.43

4.85

1.2

1.1

0.16

3.13

u/ml

2.89

Lyme disease

422

3377

1.26

4.85

1.1

2.26

1.87

u/ml

0.30

232

1801

Lyme disease, including avohilmo

422

3377

1.26

4.85

1.1

2.26

1.87

u/ml

0.30

232

1801

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

446

1.74

4.84

1.2

1.1

2.54

2.66

u/ml

0.03

250

Injury of muscle and tendon at shoulder and upper arm level

340

2650

1.29

4.84

1.1

1.66

1.72

u/ml

0.04

180

1410

Other/unspecified soft tissue disorders related to use, overuse and pressure

264

1.97

4.84

1.1

0.60

2.92

u/ml

2.35

138

Exposure to other and unspecified forces of nature

3.11

4.83

1.1

1.2

1.05

1.58

u/ml

0.23

Concussion

883

5860

1.17

4.82

1.2

1.1

1.78

2.57

u/ml

2.00

499

3144

Nausea and vomiting

377

2904

1.27

4.82

1.2

1.1

1.42

2.42

u/ml

1.62

220

1631

Contracture of joint

2.96

4.82

1.1

0.52

3.36

u/ml

1.21

Spirochaetal infections, other/unspecified, including avohilmo

425

3408

1.25

4.80

1.1

2.26

1.87

u/ml

0.31

234

1820

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

994

0.55

4.79

1.2

1.1

1.58

1.80

u/ml

0.10

542

Mycoses

373

2949

1.27

4.77

1.1

1.84

2.03

u/ml

0.17

202

1573

Deep bite

287

1928

1.32

4.76

1.2

3.37

2.99

u/ml

0.17

175

1171

Benign neoplasm: Duodenum

2.65

4.76

1.4

1.1

2.06

1.36

u/ml

0.21

Postmenopausal bleeding

216

814

1.39

4.75

1.1

0.67

1.51

u/ml

2.23

107

423

Food allergy

5.01

4.75

1.4

1.3

1.30

2.06

u/ml

—

Sequelae of other external causes

478

1.70

4.73

1.2

1.1

2.83

2.17

u/ml

0.22

261

Alcohol withdrawal state with delirium

428

0.32

4.73

1.1

0.58

2.06

u/ml

—

237

Other skin changes

209

1526

1.38

4.72

1.1

3.39

2.00

u/ml

0.98

112

818

COPD-related respiratory insufficiency

402

1.75

4.72

1.1

1.98

1.80

u/ml

0.05

220

Polyneuropathies and other disorders of the peripheral nervous system

191

1374

1.40

4.71

1.2

1.1

2.43

1.81

u/ml

0.30

115

732

Substance abuse, excluding more controls

570

5735

0.83

4.71

1.1

2.54

2.13

u/ml

0.36

343

2964

Benign neoplasm: Liver/bile ducts

246

2.00

4.70

1.1

1.59

2.43

u/ml

0.46

130

Dysplasia of cervi uteri

420

2362

1.26

4.67

1.1

2.47

2.51

u/ml

0.02

214

1227

Congenital malformations of trachea and bronchus

2.67

4.66

1.2

3.07

2.57

u/ml

0.08

Other septicaemia

229

2879

0.75

4.59

1.1

3.13

1.79

u/ml

0.73

139

1596

Explicit Sepsis, including avohilmo

341

3913

0.79

4.58

1.1

3.04

1.91

u/ml

0.80

197

2170

Atherosclerosis, excluding cerebral and coronary sclerosis

112

1327

0.66

4.55

1.1

1.00

1.31

u/ml

0.52

739

Explicit Sepsis

330

3814

0.78

4.53

1.1

3.10

1.92

u/ml

0.83

193

2127

Pleural plaque

180

2.12

4.53

1.2

1.1

1.53

1.07

u/ml

0.30

104

Contact with other specified venomous animals

3.15

4.49

1.2

1.1

0.75

1.33

u/ml

0.47

Cardiovascular diseases

1484

7002

1.13

4.49

1.2

1.1

2.69

2.43

u/ml

0.30

832

3801

Artrosis, including avohilmo

1168

5597

1.15

4.48

1.1

1.83

1.91

u/ml

0.09

605

2923

Superficial injury of wrist and hand

404

3255

1.25

4.45

1.2

1.1

1.13

2.51

u/ml

5.06

235

1805

Transplanted organ and tissue status

1045

0.58

4.45

1.2

1.41

2.24

u/ml

0.35

615

Condition for Implicit Sepsis (Organ dysfunction codes)

943

7520

0.87

4.43

1.1

1.79

1.99

u/ml

0.27

527

4050

Antihypertensive medication - note that there are other indications

1434

6653

1.13

4.42

1.2

1.1

2.29

2.49

u/ml

0.29

780

3649

Superficial injury of thorax

196

1435

1.38

4.40

1.1

2.22

2.08

u/ml

0.07

114

766

Viral infections characterized by skin and mucous membrane lesions

623

5239

1.19

4.37

1.2

1.1

2.57

2.19

u/ml

0.36

371

2884

Impacted teeth

564

4038

1.21

4.37

1.2

1.1

3.26

2.91

u/ml

0.21

329

2226

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1327

9436

0.89

4.37

1.2

1.1

1.96

2.25

u/ml

0.49

742

5068

Retained placenta and membranes, without haemorrhage

186

1354

1.39

4.36

1.1

2.02

1.93

u/ml

0.05

103

663

Malignant neoplasm of respiratory system and intrathoracic organs

772

0.56

4.36

1.1

0.53

1.24

u/ml

2.27

434

Other viral diseases

579

4830

1.20

4.35

1.2

1.1

1.53

2.48

u/ml

2.02

330

2698

Ulcer of vagina/vulva

333

1.81

4.35

1.2

1.1

2.46

3.25

u/ml

0.18

179

Other specified disorders of external ear

184

2.09

4.33

1.1

4.02

1.69

u/ml

0.46

108

Bicipital tendinitis

303

1.84

4.33

1.1

1.04

2.07

u/ml

0.56

160

Lesion of ulnar nerve

172

1237

1.40

4.31

1.1

1.05

2.26

u/ml

2.74

641

Examination and encounter for administrative purposes

437

1.68

4.29

1.2

1.1

1.40

2.16

u/ml

0.41

207

Nephropathy related operations

985

0.57

4.29

1.2

1.1

1.53

2.18

u/ml

0.25

563

Benign lipomatous neoplasm

313

2457

1.28

4.28

1.1

1.35

1.86

u/ml

0.41

163

1302

Disorders of ocular muscles, binocular movement, accommodation and refraction

854

7323

1.16

4.27

1.2

1.1

1.51

2.40

u/ml

2.43

478

3997

Persons encountering health services in circumstances related to reproduction

1038

6082

1.15

4.26

1.1

2.32

2.35

u/ml

0.03

591

3308

Galactorrhea

115

2.44

4.26

1.1

2.28

2.67

u/ml

0.11

Mental retardation, excluding more controls

706

0.51

4.26

1.3

1.2

0.85

2.63

u/ml

2.28

458

Other bursopathies

131

901

1.46

4.20

1.1

2.85

2.63

u/ml

0.07

458

Xerosis cutis

2.71

4.19

1.1

0.30

2.11

u/ml

2.01

Melanocytic naevi

478

3946

1.22

4.18

1.1

1.87

2.06

u/ml

0.18

255

2095

Injury of muscle and tendon at hip and thigh level

144

1011

1.44

4.17

1.2

1.1

1.61

2.33

u/ml

0.45

522

Benign neoplasm: Choroid

381

1.72

4.15

1.1

0.20

1.73

u/ml

3.12

209

Respiratory insufficiency

186

2.05

4.15

1.2

1.1

0.56

1.17

u/ml

0.88

Gluteal tendinitis

322

1.79

4.15

1.1

0.65

1.90

u/ml

1.12

159

Cholecystectomy

851

6251

1.16

4.15

1.1

1.40

1.75

u/ml

0.75

445

3219

Benign neoplasm: Ascending colon

105

692

1.53

4.15

1.1

4.87

1.39

u/ml

0.94

379

Appendectomy

1041

8703

1.14

4.15

1.1

2.06

2.10

u/ml

0.03

529

4541

Secondary uncertain malignant neoplasm

771

0.53

4.14

1.1

2.06

1.96

u/ml

0.03

432

Malignant neoplasm of bronchus and lung

625

0.52

4.14

1.1

0.49

1.27

u/ml

2.31

346

Diagnoses used for exclusion with ILD

237

1803

1.32

4.12

1.1

1.29

2.11

u/ml

0.73

122

959

Epiphora

116

2.37

4.12

1.1

0.72

2.47

u/ml

—

Faecal incontinence

504

1.62

4.11

1.2

1.1

0.38

1.44

u/ml

2.46

262

Immunodeficiencies

514

1.62

4.10

1.1

0.90

3.18

u/ml

3.73

300

Thyroiditis, ILD-related definition

191

1412

1.37

4.10

1.1

2.45

2.38

u/ml

0.04

738

Sub-endpoint used in defining T1D endpoints

287

3587

0.78

4.07

1.1

2.41

2.25

u/ml

0.08

149

2000

Nonalcoholic fatty liver disease

146

1033

1.43

4.07

1.1

1.73

1.96

u/ml

0.21

531

Flat foot [pes planus] (acquired)

122

835

1.47

4.05

1.1

1.51

2.39

u/ml

0.81

428

Other deformities of toe(s)

224

1.95

4.04

1.1

0.80

2.74

u/ml

1.71

119

Symptoms and signs involving the nervous and musculoskeletal systems

771

6647

1.16

4.03

1.2

1.1

2.24

2.03

u/ml

0.22

474

3581

Insulin, intermediate and long-acting

456

5313

0.83

4.01

1.1

1.91

1.97

u/ml

0.05

246

2918

Otitis externa, unspecified

187

1383

1.36

4.01

1.2

1.1

3.99

2.34

u/ml

0.96

115

745

Disturbances of smell and taste

304

1.80

4.00

1.1

1.29

1.70

u/ml

0.25

160

Endometriosis ASRM stages 1,2

314

2493

1.27

4.00

1.1

1.56

1.81

u/ml

0.21

145

1287

Ehlers-Danlos syndrome, including avohilmo

192

2.06

3.99

1.2

1.1

1.04

2.95

u/ml

1.02

110

Acute nasopharyngitis (common cold)

168

1212

1.39

3.98

1.1

3.39

2.58

u/ml

0.26

661

Localized swelling, mass and lump of skin and subcutaneous tissue

412

3369

1.23

3.97

1.1

1.21

2.09

u/ml

2.15

227

1806

Other immunodeficiencies

132

2.28

3.96

1.2

1.1

1.24

4.52

u/ml

1.71

Adhesive capsulitis of shoulder

161

1163

1.39

3.96

1.2

1.1

1.73

1.90

u/ml

0.06

589

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1071

0.61

3.95

1.2

1.1

5.97

2.27

u/ml

0.65

560

Other diseases of peritoneum

298

1.80

3.94

1.2

1.1

0.94

1.56

u/ml

0.47

160

Atypical facial pain

449

1.65

3.94

1.2

1.1

0.48

1.50

u/ml

2.13

244

Budesonide

194

1446

1.35

3.94

1.1

1.56

2.22

u/ml

0.44

721

Mental and behavioural disorders due to opioids

553

0.46

3.91

1.0

1.1

4.96

3.01

u/ml

0.17

296

Ehlers-Danlos syndrome

153

2.19

3.90

1.2

1.1

1.12

3.01

u/ml

0.83

Other local infections of skin and subcutaneous tissue

142

1009

1.42

3.88

1.1

3.72

2.49

u/ml

0.47

542

malignant neoplasm of female genital organs, including Hilmo

1217

0.65

3.86

1.1

0.90

1.43

u/ml

0.65

644

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

414

1.67

3.85

1.2

1.1

2.36

2.68

u/ml

0.10

217

Congenital malformations of the respiratory system, including avohilmo

280

1.84

3.85

1.2

2.54

2.53

u/ml

0.00

184

Benign neoplasms

1691

8319

1.11

3.83

1.1

2.37

2.26

u/ml

0.14

909

4480

Chondropathies

239

1844

1.31

3.83

1.2

1.1

2.66

2.25

u/ml

0.28

142

972

Benign neoplasm: Sigmoid colon

141

1002

1.41

3.82

1.1

1.34

1.56

u/ml

0.12

548

Complications predominantly related to the puerperium

475

3960

1.21

3.81

1.1

3.27

1.98

u/ml

1.11

256

2038

Diverticular disease of intestine

708

3775

1.17

3.80

1.1

1.07

1.76

u/ml

2.10

368

1956

Polyarthrosis

169

1113

1.37

3.80

1.1

1.20

1.38

u/ml

0.16

568

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

406

3333

1.22

3.79

1.2

1.1

2.14

2.03

u/ml

0.07

232

1794

Synovial cyst of popliteal space [Baker]

430

1.64

3.78

1.1

1.90

2.23

u/ml

0.13

226

Benign neoplasm: Small intestine

167

2.06

3.77

1.3

1.1

2.09

1.25

u/ml

0.35

Erysipelas

411

4296

0.82

3.76

1.1

2.62

1.59

u/ml

1.28

259

2245

Diseases of arteries, arterioles and capillaries

412

3667

0.82

3.75

1.1

1.38

1.66

u/ml

0.39

222

1953

Unspecified fall

703

5945

1.16

3.75

1.2

1.1

2.81

2.17

u/ml

0.72

404

3301

malignant neoplasm of male genital organs

107

944

0.68

3.74

1.1

1.43

1.63

u/ml

0.11

526

Other otitis externa (chronic)

638

1.52

3.73

1.1

4.53

2.29

u/ml

0.56

356

Endometriosis of ovary

238

1732

1.30

3.73

1.1

1.27

2.21

u/ml

1.03

116

893

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

739

6268

1.16

3.72

1.1

1.32

1.89

u/ml

1.39

430

3272

Other acute skin changes due to ultraviolet radiation

196

1.97

3.70

1.2

1.1

1.92

2.02

u/ml

0.03

106

Persistent delusional disorders

597

0.50

3.69

1.2

1.1

0.24

2.20

u/ml

5.38

317

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

404

1.66

3.68

1.1

2.35

2.58

u/ml

0.06

239

Sulfonylureas

988

0.65

3.68

1.0

1.1

0.94

1.24

u/ml

0.33

555

Systemic connective tissue disorders

383

3136

1.23

3.67

1.2

1.1

1.53

1.90

u/ml

0.44

228

1646

Hypersensitivity pneumonitis due to organic dust

2.58

3.66

1.3

1.1

1.39

0.63

u/ml

—

Other and unspecified mental retardation

446

0.43

3.66

1.2

1.3

0.92

2.69

u/ml

1.19

337

Colonic or urogenital fistula

327

2635

1.25

3.66

1.1

0.96

1.98

u/ml

3.75

171

1390

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

614

5193

1.18

3.65

1.1

1.33

2.39

u/ml

4.57

354

2841

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

939

0.64

3.63

1.1

0.44

1.32

u/ml

3.52

533

Disorders of vitreous body

451

3569

1.20

3.63

1.1

0.94

1.54

u/ml

1.86

247

1834

Dementia in Alzheimer disease

301

0.36

3.61

1.4

1.1

0.08

0.93

u/ml

—

164

Other specified/unspecified bacterial intestinal infections

483

1.59

3.61

1.1

1.85

2.06

u/ml

0.10

266

Other/unspecified enthesopathies, not elsewhere classified

586

1.53

3.60

1.3

1.1

2.11

2.53

u/ml

0.16

304

Pain associated with micturition

152

1108

1.38

3.60

1.1

3.29

2.14

u/ml

0.44

602

Psoas tendinitis

3.18

3.60

1.1

1.60

2.77

u/ml

—

Redundant prepuce, phimosis and paraphimosis

269

2090

1.27

3.59

1.1

1.62

2.58

u/ml

0.89

150

1199

Seborrhoeic keratosis

208

1588

1.32

3.59

1.1

1.34

1.55

u/ml

0.17

100

838

Cerebrovascular diseases (FINNGEN)

291

2553

0.80

3.59

1.1

1.52

1.78

u/ml

0.21

149

1324

Liquid cancers

160

2041

0.74

3.57

1.1

1.59

1.77

u/ml

0.09

1121

Abnormal findings in secretions and smears from cervix uteri vagina vulva

914

5914

1.14

3.57

1.1

2.28

1.98

u/ml

0.41

438

3036

Coronary artery bypass grafting

670

0.60

3.56

1.0

1.1

4.47

1.15

u/ml

0.76

378

Other and specified injuries of hip and thigh

144

2.12

3.56

1.1

1.40

2.95

u/ml

0.59

Other and unspecified acute skin changes due to ultraviolet radiation

2.53

3.56

1.1

3.81

2.63

u/ml

0.19

Disorders of refraction and accommodation

533

4502

1.19

3.55

1.2

1.1

1.49

2.42

u/ml

2.71

297

2493

Idiopathic pulmonary fibrosis

227

1.86

3.55

1.1

0.84

1.69

u/ml

0.83

127

Complications associated with artificial fertilization

258

1.83

3.55

1.1

2.61

2.67

u/ml

0.02

128

Otitis media, unspecified

282

2068

1.27

3.54

1.3

1.1

2.46

3.09

u/ml

0.39

185

1210

Suppurative otitis media, unspecified

302

1.76

3.53

1.0

1.2

3.23

2.88

u/ml

0.08

178

Severe mental retardation

0.00

3.53

0.0

1.2

—

3.02

—

Sequelae of external causes of morbidity and mortality

276

2193

1.26

3.51

1.2

1.1

1.44

1.91

u/ml

0.55

170

1167

Nontoxic multinodular goitre

172

1283

1.35

3.50

1.1

0.99

1.56

u/ml

0.70

666

Disorders of vitreous body and globe

461

3647

1.20

3.50

1.1

0.93

1.55

u/ml

1.98

251

1883

Lichen planus, including avohilmo

192

1456

1.33

3.50

1.1

1.77

1.78

u/ml

0.00

112

755

Any mental disorder

1679

7637

1.10

3.47

1.1

2.23

2.24

u/ml

0.00

948

4009

Other and unspecified local infections of skin and subcutaneous tissue

135

972

1.40

3.47

1.1

3.90

2.55

u/ml

0.50

522

Schizoaffective disorder

950

0.61

3.46

1.2

1.1

2.71

2.06

u/ml

0.12

500

Congenital malformations of the respiratory system

253

1.83

3.46

1.2

2.62

2.50

u/ml

0.03

169

Immunodeficiency with predominantly antibody defects

282

1.77

3.45

1.1

0.64

2.58

u/ml

2.61

171

Defects in the complement system

2.44

3.44

1.2

0.35

4.19

u/ml

1.93

Benign neoplasm: Transverse colon

528

1.54

3.44

1.1

1.97

1.84

u/ml

0.04

297

Zoster [herpes zoster], including avohilmo

566

4662

1.17

3.43

1.1

1.64

1.86

u/ml

0.21

310

2444

Mild mental retardation

415

0.42

3.43

1.4

1.2

0.81

3.46

u/ml

2.86

270

Contraceptive management

726

4406

1.16

3.41

1.1

1.74

2.22

u/ml

0.80

381

2281

Alzheimer disease, excluding more controls

354

0.49

3.41

1.3

1.1

0.27

1.55

u/ml

2.13

202

Implicit fungal Sepsis, including avohilmo

482

1.57

3.41

1.2

1.1

3.16

2.22

u/ml

0.21

256

Disorders of vestibular function (Vertigo)

476

3903

1.19

3.40

1.2

1.1

1.44

1.81

u/ml

0.47

267

2017

Female genital prolapse

319

1424

1.25

3.40

1.1

1.27

1.98

u/ml

1.05

158

731

Other symptoms and signs involving the digestive system and abdomen

203

1559

1.31

3.40

1.2

1.1

1.02

1.96

u/ml

1.80

112

833

L04AD Calcineurin inhibitors

1308

0.67

3.40

1.2

2.64

2.35

u/ml

0.07

763

Oxycodone

224

2450

0.78

3.39

1.1

2.27

1.69

u/ml

0.37

121

1280

Injuries to the abdomen, lower back, lumbar spine and pelvis

513

4289

1.18

3.38

1.1

2.47

2.16

u/ml

0.24

302

2305

Benign thyroid growths and nodules

332

2512

1.23

3.36

1.1

0.96

1.71

u/ml

1.78

181

1311

Later onset COPD

100

546

1.47

3.35

1.1

1.38

1.13

u/ml

0.14

312

Other diseases of stomach and duodenum

344

1.67

3.34

1.2

1.1

2.21

1.46

u/ml

0.20

190

Other acquired deformities of ankle and foot

3.00

3.34

1.0

1.1

0.06

2.48

u/ml

—

Bacterial pneumonia, not elsewhere classified

421

3082

1.20

3.33

1.1

1.72

1.95

u/ml

0.16

268

1638

Haemangioma, any site

118

837

1.42

3.32

1.2

1.1

3.08

2.29

u/ml

0.25

458

Benign paroxysmal vertigo

283

2271

1.25

3.32

1.1

1.11

1.80

u/ml

1.06

157

1176

Female infertility, tubal origin

527

1.54

3.30

1.2

1.1

2.38

2.07

u/ml

0.09

266

Toxic effect of contact with venomous animals

432

1.60

3.29

1.1

2.08

3.14

u/ml

0.48

240

Diabetic nephropathy, excluding more controls

788

0.63

3.29

1.1

0.67

1.36

u/ml

1.03

424

235

1850

1.28

3.29

1.2

1.1

2.20

2.21

u/ml

0.01

140

933

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

546

0.51

3.28

1.2

1.1

5.70

2.23

u/ml

0.47

307

Persistent mood disorders

259

2062

1.26

3.28

1.2

1.1

1.67

2.02

u/ml

0.25

139

1066

Other puerperal infections

189

1450

1.32

3.28

1.1

4.31

2.28

u/ml

0.95

115

747

Benign neoplasm of middle ear and respiratory system

479

1.56

3.27

1.1

1.09

1.69

u/ml

0.53

267

Primary_lymphoid and hematopoietic malignant neoplasms

111

1560

0.71

3.27

1.2

1.1

2.14

2.03

u/ml

0.04

872

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

472

1.57

3.27

1.1

2.02

2.92

u/ml

0.43

240

Myotonic disorders

2.67

3.27

1.3

1.1

0.47

2.17

u/ml

—

Other disorders of conjunctiva

117

830

1.42

3.27

1.1

2.08

2.05

u/ml

0.01

445

Influenza and pneumonia

1753

9889

1.10

3.26

1.2

1.1

2.46

2.19

u/ml

0.42

1038

5246

Delirium, not induced by alcohol and other psychoactive substances

464

0.47

3.25

1.1

0.61

1.85

u/ml

—

247

Spondylopathies

923

4823

1.13

3.23

1.1

1.85

u/ml

0.00

481

2464

Acne

295

2380

1.25

3.23

1.2

1.1

2.16

2.99

u/ml

0.90

187

1317

Other disorders of cornea

110

775

1.43

3.22

1.1

4.40

1.87

u/ml

0.82

393

Valvular heart disease excluding rheumatic fever

321

2803

0.82

3.22

1.1

3.90

1.61

u/ml

1.17

175

1573

Hernia of abdominal wall, postoperative

204

1569

1.30

3.21

1.1

1.78

1.63

u/ml

0.12

108

820

L04AA Selective immunosuppressants

204

2613

0.78

3.21

1.1

1.78

2.01

u/ml

0.09

106

1407

Haemangioma and lymphangioma, any site

129

936

1.39

3.20

1.2

1.1

2.88

2.38

u/ml

0.16

517

Substance use, excluding alcohol

211

2690

0.78

3.20

1.2

1.1

2.50

2.03

u/ml

0.20

126

1431

Lichen planus

120

859

1.41

3.20

1.1

2.08

1.92

u/ml

0.06

462

Disorders of choroid and retina

678

5448

0.87

3.19

1.1

1.61

1.77

u/ml

0.18

365

2854

Bacterial infection, other or unspecified

401

4039

0.83

3.17

1.1

2.35

1.68

u/ml

0.46

231

2192

Hallux rigidus

112

793

1.42

3.17

1.1

1.42

1.50

u/ml

0.03

419

Single spontaneous delivery

462

2888

0.84

3.17

1.1

2.62

2.14

u/ml

0.49

261

1528

Type 1 diabetes

288

3536

0.81

3.16

1.1

2.39

2.34

u/ml

0.03

150

1981

Other arrhythmias

924

6121

1.13

3.16

1.1

1.43

1.91

u/ml

1.31

494

3215

Dental caries, including avohilmo

953

4322

1.13

3.16

1.1

2.02

1.93

u/ml

0.10

529

2203

Bacterial Sepsis

304

3079

0.81

3.15

1.1

2.57

1.83

u/ml

0.56

183

1710

Fall on and from stairs and steps

330

2710

1.22

3.15

1.2

1.1

1.76

2.01

u/ml

0.20

189

1451

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

252

1.77

3.14

1.1

1.20

1.99

u/ml

0.42

146

Unspecified event, undetermined intent

268

1.75

3.13

1.3

1.1

1.41

2.62

u/ml

0.61

144

Whooping cough, including avohilmo

269

1.76

3.13

1.2

1.1

2.33

3.71

u/ml

0.51

145

Sacrococcygeal disorders, not elsewhere classified

298

1.70

3.13

1.2

1.1

0.52

2.42

u/ml

2.86

155

Testicular hypofunction

329

1.67

3.11

1.1

3.23

2.05

u/ml

0.28

171

Other factor of the environment

2.28

3.11

1.1

3.01

2.09

u/ml

0.20

Autoimmune diseases excluding thyroid diseases

1463

8706

0.91

3.10

1.1

1.98

2.28

u/ml

0.46

804

4739

Melanocytic naevi of eyelid, including canthus

2.75

3.10

1.2

1.1

0.92

1.11

u/ml

—

Open wound of wrist and hand

696

5884

1.15

3.08

1.1

1.83

2.29

u/ml

0.75

373

3143

Other abnormal uterine and vaginal bleeding

279

1614

1.25

3.07

1.1

1.35

2.23

u/ml

1.32

148

852

Use of pramipexole

191

1477

1.30

3.07

1.2

1.1

2.16

1.84

u/ml

0.14

779

Autoimmune diseases excluding thyroid diseases, strict definition

1429

8539

0.91

3.07

1.1

2.00

2.28

u/ml

0.41

786

4643

Testicular dysfunction

377

1.61

3.06

1.1

3.15

2.43

u/ml

0.17

195

Emotional disorders starting during childhood or adolecense, excluding more controls

154

1126

1.35

3.05

1.2

3.35

2.98

u/ml

0.11

683

Drug-induced headache, not elsewhere classified

2.87

3.05

1.4

1.1

1.55

2.01

u/ml

—

Use of biperiden

397

0.45

3.03

1.1

0.60

2.08

u/ml

2.01

221

Benign mammary dysplasia

141

1047

1.35

3.03

1.1

1.78

1.89

u/ml

0.05

543

malignant neoplasm of male genital organs, including Hilmo

118

979

0.72

3.02

1.1

1.42

1.58

u/ml

0.10

544

Other orthopaedic follow-up care

433

1.56

3.02

1.1

0.55

2.30

u/ml

2.76

218

Pterygium

100

2.22

3.01

1.0

1.1

0.45

1.30

u/ml

0.87

ILD-related respiratory insufficiency

100

2.22

3.00

1.2

1.1

0.88

2.21

u/ml

0.67

Separation of retinal layers (serosa)

309

1.67

3.00

1.1

3.87

1.62

u/ml

0.35

168

Other disorders starting during childhood or adolecense, excluding more controls

162

1178

1.33

2.99

1.2

2.16

2.79

u/ml

0.41

715

Caries of dentine, including avohilmo

1094

5013

1.12

2.99

1.1

2.21

2.08

u/ml

0.14

614

2598

Bruxism

235

1.79

2.99

1.1

0.61

2.57

u/ml

2.05

119

Fever of other and unknown origin

815

6248

1.13

2.99

1.1

1.24

2.32

u/ml

4.74

481

3360

Diseases of inner ear

557

4599

1.16

2.98

1.1

1.32

1.73

u/ml

0.68

317

2390

Thyroiditis

104

738

1.42

2.97

1.1

2.18

1.99

u/ml

0.07

397

Pedestrian injured in collision with pedal cycle

257

1.74

2.97

1.1

0.64

2.56

u/ml

2.53

147

Malignant neoplasm of bronchus and lung, including Hilmo

746

0.63

2.96

1.1

0.40

1.15

u/ml

3.20

418

Malignant neoplasm of breast, HER-negative

110

1459

0.72

2.96

1.1

1.22

1.28

u/ml

0.04

755

Mental and behavioural disorders due to use of other stimulants, including caffeine

471

0.50

2.96

1.2

1.1

0.73

2.69

u/ml

2.87

246

Cluster headache, wide

397

1.58

2.94

1.1

1.70

2.70

u/ml

0.42

196

Inhalation and ingestion of food causing obstruction of respiratory tract

2.44

2.94

1.6

1.2

4.70

4.18

u/ml

0.05

Other symptoms and signs involving the nervous and musculoskeletal systems

568

4922

1.16

2.93

1.2

1.1

1.91

1.99

u/ml

0.06

341

2628

Non-selective monoamine reuptake inhibitors

362

2899

1.20

2.92

1.2

1.1

1.27

1.84

u/ml

1.19

220

1459

Residual foreign body in soft tissue

518

1.50

2.91

1.2

1.1

1.40

2.84

u/ml

1.10

264

Malignant neoplasm of pancreas, including Hilmo

336

0.41

2.91

1.0

1.1

2.29

1.46

u/ml

—

179

Heart failure, strict

263

2256

0.81

2.91

1.1

1.32

1.45

u/ml

0.08

143

1258

Superficial injury of shoulder and upper arm

169

1298

1.31

2.90

1.2

1.1

3.43

2.42

u/ml

0.39

690

Pleural plaque without asbestos

2.52

2.87

1.3

1.2

2.50

1.42

u/ml

0.41

Bacterial pneumoniae

448

3347

1.18

2.87

1.1

1.65

1.98

u/ml

0.27

282

1780

Injury of muscle and tendon at lower leg level

179

1388

1.30

2.86

1.2

1.1

1.82

2.28

u/ml

0.30

755

False labour

695

3785

1.15

2.86

1.1

2.17

2.20

u/ml

0.02

351

1947

Impetigo

105

754

1.41

2.85

1.3

1.2

4.46

2.95

u/ml

0.38

453

Type 1 diabetes, wide definition

261

3198

0.81

2.85

1.1

2.57

2.27

u/ml

0.16

137

1782

MS-disease / Multiple Sclerosis

964

0.66

2.84

1.1

1.18

2.16

u/ml

0.77

516

Coeliac disease

180

1399

1.30

2.84

1.1

2.50

2.37

u/ml

0.05

106

769

Other disorders of male genital organs

353

1.61

2.84

1.1

1.67

2.46

u/ml

0.41

199

Spirochaetal infections, other/unspecified

694

1.42

2.84

1.1

3.04

2.22

u/ml

0.26

387

All-cause Heart Failure

258

2212

0.81

2.83

1.1

1.34

1.46

u/ml

0.07

140

1235

Benign neoplasm: Skin of ear and external auricular canal

179

1.86

2.83

1.1

1.82

1.59

u/ml

0.12

COPD, hospital admissions 3, with asthma pneumonia sepsis

142

911

1.34

2.83

1.1

0.85

1.59

u/ml

1.25

508

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1144

8518

0.90

2.81

1.1

1.94

2.09

u/ml

0.21

631

4587

Achilles tendinitis

118

864

1.37

2.81

1.1

2.08

2.27

u/ml

0.10

422

Exposure to other and unspecified inanimate mechanical forces

128

951

1.36

2.80

1.2

1.1

1.42

2.56

u/ml

1.20

523

Injuries to the thorax

499

4295

1.16

2.80

1.1

1.98

2.00

u/ml

0.02

289

2291

Kidney transplant status

553

0.55

2.78

1.4

1.2

2.46

2.29

u/ml

0.03

332

Ptosis of eyelid

613

1.44

2.78

1.1

1.12

1.78

u/ml

0.59

336

Other disorders of veins

469

3960

1.17

2.76

1.1

1.69

1.66

u/ml

0.02

260

2008

Cholecystitis

111

806

1.38

2.76

1.2

1.1

0.67

2.03

u/ml

3.37

419

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

446

3819

1.18

2.76

1.2

1.1

1.44

2.37

u/ml

1.90

222

2022

Perforation of tympanic membrane

129

961

1.35

2.76

1.1

2.79

2.54

u/ml

0.07

528

Other and unspecified disorders of autonomic nervous system

3.15

2.76

1.1

1.2

2.28

1.87

u/ml

—

Diseases of pulp and periapical tissues and dental caries

851

3877

1.13

2.76

1.1

1.92

2.03

u/ml

0.14

477

1954

Benign neoplasm of eye and adnexa

103

740

1.40

2.75

1.1

0.74

2.03

u/ml

2.84

405

Excessive vomiting in pregnancy

160

1233

1.31

2.74

1.1

3.46

2.10

u/ml

0.42

624

Osteopathies and chondropathies

681

5483

1.14

2.74

1.2

1.1

2.45

1.99

u/ml

0.53

396

2922

Chronic kidney disease

137

1739

0.76

2.73

1.2

1.1

2.98

1.75

u/ml

0.41

968

Sequelae of cerebrovascular disease

144

1614

0.76

2.73

1.1

0.91

1.45

u/ml

1.16

877

Iron deficiency

544

1.48

2.73

1.2

1.1

1.56

3.13

u/ml

1.22

282

Bacterial infection, other or unspecified, including avohilmo

495

4693

0.86

2.72

1.1

2.41

1.80

u/ml

0.48

280

2524

Arthrosis

905

4430

1.12

2.70

1.1

2.11

2.00

u/ml

0.10

488

2246

Diseases of tongue

405

1.54

2.69

1.1

0.39

2.33

u/ml

2.65

180

Other/unspecified synovitis and tenosynovitis

138

1043

1.33

2.68

1.1

1.70

2.47

u/ml

0.49

531

Other diseases of pleura

331

2399

1.20

2.68

1.1

1.28

1.74

u/ml

0.68

187

1319

Impacted cerumen

110

803

1.38

2.68

1.1

1.2

1.56

2.31

u/ml

0.31

476

Disorder of lipoprotein metabolism, unspecified

601

1.44

2.68

1.0

1.1

0.78

1.56

u/ml

1.32

348

Secondary polycythaemia

133

1.98

2.67

1.2

1.1

0.57

1.72

u/ml

0.85

Fracture of femur

1200

0.72

2.67

1.1

2.08

1.95

u/ml

0.05

671

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.25

2.66

1.3

1.1

1.27

3.36

u/ml

—

Early lumbar disc prolapse, operated

190

1502

1.28

2.66

1.1

2.52

u/ml

0.00

110

746

Enlarged lymph nodes

206

1642

1.26

2.66

1.2

1.1

1.92

2.08

u/ml

0.11

132

880

Rash and other nonspecific skin eruption

121

899

1.36

2.65

1.2

1.1

1.51

2.34

u/ml

0.77

504

Infections, IBD-co-morbidities

206

1148

1.27

2.65

1.1

1.37

2.44

u/ml

1.51

123

633

Malignant neoplasm of pancreas

265

0.38

2.65

1.0

1.1

3.19

1.63

u/ml

—

137

Endometriosis of rectovaginal septum and vagina

662

1.42

2.64

1.2

1.1

1.66

1.99

u/ml

0.11

327

Other mycoses, not elsewhere classified/unspecified, including avohilmo

148

1.93

2.64

1.1

0.94

2.71

u/ml

1.21

Viral pneumonia (known virus, not influenza)

206

1.77

2.64

1.3

1.2

0.39

2.75

u/ml

2.90

127

Dyshidrosis [pompholyx]

170

1.86

2.63

1.1

2.78

2.84

u/ml

0.01

Crowding of teeth, including avohilmo

286

1959

1.22

2.63

1.2

3.99

3.16

u/ml

0.42

197

1170

Right bundle-branch block

162

1.87

2.63

1.1

3.45

1.66

u/ml

0.35

Hypertrophy of tongue papillae

100

2.14

2.62

1.1

0.43

1.39

u/ml

1.30

Other specified disorders of muscle

199

1.78

2.62

1.1

1.62

2.07

u/ml

0.21

111

223

1612

1.25

2.62

1.1

1.46

1.32

u/ml

0.11

123

888

Other viral hepatitis, including avohilmo

886

0.66

2.62

1.2

1.1

1.16

2.45

u/ml

1.33

462

Premenstrual syndrome

215

1.76

2.61

1.1

3.93

2.77

u/ml

0.18

110

Alzheimer’s disease, strict definition

482

0.58

2.61

1.3

1.1

0.28

0.92

u/ml

3.06

265

Collagenous colitis

109

799

1.37

2.61

1.1

0.87

2.03

u/ml

1.56

430

malignant neoplasm of female genital organs

1043

0.69

2.61

1.1

0.96

1.35

u/ml

0.40

544

Exclusions for E4_PCOS_CONSORTIUM

1097

7539

0.91

2.60

1.1

2.55

2.13

u/ml

0.54

551

4034

Pneumonia due to other infectious organisms, not elsewhere classified

192

1.79

2.60

1.1

4.98

2.44

u/ml

0.32

102

Malignant neoplasm of brain, including Hilmo

399

0.50

2.59

1.3

1.1

5.48

2.11

u/ml

0.33

233

Acute otitis externa, noninfective

121

2.02

2.58

1.2

1.1

1.98

2.51

u/ml

0.13

Deficiency of other B group vitamins

114

2.05

2.58

1.1

0.99

2.28

u/ml

0.55

Maternal care for other conditions predominantly related to pregnancy

452

3799

1.17

2.58

1.1

2.78

2.20

u/ml

0.41

238

1950

Retinal breaks without detachment

143

1093

1.31

2.58

1.1

1.23

1.64

u/ml

0.38

579

Abnormal involuntary movements

160

1243

1.29

2.57

1.1

2.44

2.04

u/ml

0.19

108

664

Sexual dysfunction

164

1.86

2.56

1.1

1.2

0.78

2.04

u/ml

0.86

Cluster headache, strict

387

1.54

2.56

1.1

1.74

2.63

u/ml

0.35

188

Alcoholic liver disease

578

0.59

2.56

1.1

1.65

1.36

u/ml

0.11

321

Persons encountering health services for specific procedures, not carried out

132

1001

1.33

2.54

1.2

1.1

1.32

2.47

u/ml

1.41

508

Exclusions for E4_PCOS_BROAD

284

2355

1.21

2.54

1.2

2.89

2.28

u/ml

0.37

158

1353

Type 1 diabetes, wide definition, subgroup 1

256

3100

0.82

2.54

1.1

2.62

2.26

u/ml

0.19

134

1726

Pericarditis

216

1.73

2.53

1.2

1.1

4.89

2.65

u/ml

0.24

120

Major coronary heart disease event excluding revascularizations

334

2619

0.84

2.53

1.1

2.20

1.52

u/ml

0.47

175

1433

Procedures for purposes other than remedying health state

209

1.75

2.53

1.2

1.1

0.78

1.16

u/ml

0.34

106

Non-rheumatic valve diseases

318

2705

0.84

2.53

1.1

3.91

1.60

u/ml

1.16

173

1501

Anogenital herpesviral [herpes simplex] infection, including avohilmo

240

1962

1.23

2.52

1.2

1.1

2.11

2.53

u/ml

0.37

118

1035

Excessive earwax

732

5904

1.13

2.52

1.1

2.13

2.03

u/ml

0.10

406

3211

Supplementary factors related to causes of morbidity and mortality classified elsewhere

446

3848

1.16

2.51

1.2

1.1

2.26

2.27

u/ml

0.01

278

2082

Abnormal findings on diagnostic imaging of breast

2.15

2.51

1.3

1.1

0.29

1.67

u/ml

—

Deep bite that required surgery

137

1.95

2.50

1.0

1.1

0.94

2.82

u/ml

1.09

Secondary and unspecified malignant neoplasm of lymph nodes

549

0.58

2.50

1.2

1.1

2.46

2.13

u/ml

0.09

305

Oral lichen planus, including avohilmo , including avohilmo

519

1.46

2.50

1.1

2.06

2.03

u/ml

0.01

286

Primary hyperparathyroidism

635

1.41

2.50

1.1

0.49

1.45

u/ml

1.91

363

Malignant neoplasm of skin

328

2638

0.84

2.50

1.1

1.02

1.48

u/ml

0.83

185

1397

Viral pneumonia (unknown virus, not influenza)

636

1.41

2.50

1.2

1.1

2.48

2.44

u/ml

0.02

337

Noninfectious colitis NAS

189

1505

1.26

2.50

1.2

1.1

2.24

2.16

u/ml

0.03

105

820

Cluster headache, wide,, including avohilmo

637

1.41

2.49

1.1

2.34

2.48

u/ml

0.05

321

Disorders of parathyroid gland

153

1172

1.29

2.48

1.2

1.1

1.49

1.48

u/ml

0.00

632

Implicit Sepsis

759

6253

0.89

2.48

1.1

1.67

1.97

u/ml

0.44

433

3381

Demyelinating diseases of the central nervous system

1111

0.70

2.48

1.1

1.15

2.17

u/ml

1.05

586

Other noninflammatory disorders of vagina

102

747

1.38

2.48

1.1

0.95

2.24

u/ml

1.47

378

Other disorders of penis

120

900

1.34

2.48

1.2

1.03

2.71

u/ml

2.88

551

Sicca syndrome [Sjögren]

671

1.40

2.47

1.2

1.1

1.06

1.80

u/ml

1.00

346

317

1.58

2.46

1.2

1.1

5.52

2.46

u/ml

0.47

160

Gonarthrosis

702

3514

1.13

2.46

1.1

1.93

1.88

u/ml

0.04

385

1758

Certain conditions originating in the perinatal period

266

1957

1.22

2.45

1.2

2.65

3.30

u/ml

0.39

172

1187

Pediculosis, acariasis and other infestations, including avohilmo

339

2871

1.19

2.44

1.1

2.35

2.60

u/ml

0.16

195

1556

Type 1 diabetes, strict (exclude DM2)

146

1865

0.77

2.44

1.1

1.2

3.32

2.75

u/ml

0.19

1081

Intracranial injury

832

6968

1.11

2.44

1.2

1.1

1.58

2.22

u/ml

1.45

477

3794

Other and unspecified trigeminal disorders

110

2.04

2.43

1.1

1.43

2.06

u/ml

0.27

Calculus of kidney and ureter

278

2311

1.21

2.43

1.2

1.1

1.15

1.98

u/ml

1.27

164

1235

Habitual aborter

321

1.59

2.43

1.1

1.08

2.44

u/ml

1.24

156

Subacute thyroiditis

336

1.57

2.43

1.1

0.23

2.07

u/ml

3.82

177

Peroneal tendinitis

160

1.85

2.43

1.1

1.30

2.44

u/ml

0.68

Insulin, fast-acting

350

4108

0.85

2.42

1.1

2.21

2.09

u/ml

0.08

179

2274

Insulin, fast-acting or short human

350

4108

0.85

2.42

1.1

2.21

2.07

u/ml

0.09

179

2273

Keratoconus

235

1.69

2.42

1.1

10.20

2.45

u/ml

1.03

130

Urethritis and urethral syndrome

160

1.84

2.42

1.2

1.1

4.74

2.20

u/ml

0.43

Tracheo-bronchomalasia

2.61

2.41

1.2

1.1

1.03

2.09

u/ml

—

Other demyelinating diseases of the central nervous system

490

0.56

2.41

1.1

0.74

2.57

u/ml

1.85

248

Patellar tendinitis

198

1.75

2.39

1.1

1.66

2.61

u/ml

0.32

101

Pre-eclampsia or poor fetal growth

450

5150

0.87

2.38

1.1

2.68

2.04

u/ml

0.58

216

2634

Hordeolum and other deep inflammation of eyelid

702

1.38

2.38

1.2

1.1

3.30

2.71

u/ml

0.19

387

Palmar fascial fibromatosis [Dupuytren]

582

1.41

2.38

1.1

0.72

1.65

u/ml

1.22

321

Malignant neoplasm of skin, including Hilmo

367

2880

0.85

2.38

1.1

0.99

1.45

u/ml

0.99

205

1510

Disorders of iron metabolism

118

1.98

2.38

1.1

0.60

2.73

u/ml

—

Neuralgia and neuritis, unspecified

418

1.50

2.38

1.1

1.50

2.31

u/ml

0.49

211

Other neurological diseases

599

5251

0.88

2.38

1.1

1.46

1.84

u/ml

0.54

340

2798

Muscle strain

322

1.57

2.37

1.2

1.1

0.79

3.15

u/ml

2.56

171

Disorders of eyelid in diseases classified elsewhere

267

1.63

2.37

1.2

1.1

2.17

2.71

u/ml

0.22

146

Benign neoplasm: Other and unspecified parts of mouth

198

1.74

2.37

1.1

10.58

2.29

u/ml

0.85

104

Other and unspecified mood [affective] disorders

150

1172

1.29

2.36

1.1

1.64

2.40

u/ml

0.74

625

Autonomic disorders

206

1.72

2.36

1.1

0.96

2.33

u/ml

0.99

111

Malignant neoplasm of breast, ER-negative, including Hilmo

135

1631

0.77

2.36

1.1

0.98

1.28

u/ml

0.33

835

Abnormal results of function studies

116

874

1.34

2.36

1.1

1.52

2.32

u/ml

0.42

477

Presence of cardiac and vascular implants and grafts

193

1763

0.80

2.36

1.1

2.32

1.45

u/ml

0.46

108

983

Heart failure,strict

258

2172

0.83

2.36

1.1

1.35

1.31

u/ml

0.02

140

1207

Hypertrophic disorders of skin

102

756

1.36

2.34

1.1

2.82

2.43

u/ml

0.16

402

Benign lipomatous neoplasm of other sites/unspecified

452

1.47

2.33

1.1

0.37

1.61

u/ml

3.07

247

Benign neoplasm of mouth and pharynx

109

815

1.35

2.33

1.1

3.76

2.00

u/ml

0.53

428

Cluster headache, strict, including avohilmo

621

1.40

2.32

1.1

2.38

2.53

u/ml

0.04

311

Type 1 diabetes, definitions combined

148

1873

0.78

2.32

1.1

1.2

3.32

2.74

u/ml

0.20

1088

Complications of labour and delivery

1005

5067

1.10

2.32

1.1

2.19

2.03

u/ml

0.18

548

2575

Inflammatory disorders of breast

124

948

1.32

2.31

1.2

1.1

2.37

2.53

u/ml

0.06

497

Congenital malformations of the musculoskeletal system, not elsewhere classified

232

1.68

2.29

1.2

1.01

3.61

u/ml

1.61

144

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

154

1211

1.28

2.29

1.1

0.69

1.95

u/ml

4.13

632

Mixed conductive and sensorineural hearing loss

706

1.37

2.28

1.1

2.16

1.96

u/ml

0.04

394

Other/unspecified disorders of vestibular function

254

1.63

2.28

1.2

1.1

1.42

1.94

u/ml

0.18

138

Other erythematous conditions

262

1.62

2.28

1.1

2.60

2.26

u/ml

0.08

141

Peripheral arterial reconstruction

535

0.60

2.28

1.3

1.1

2.38

1.44

u/ml

0.28

293

Hard cardiovascular diseases

857

5604

0.90

2.28

1.1

1.97

1.81

u/ml

0.16

440

3040

Implicit Sepsis, including avohilmo

918

7222

0.91

2.27

1.1

1.81

2.02

u/ml

0.29

513

3884

Polyarthritis, unspecified

278

1.60

2.27

1.1

0.77

3.11

u/ml

2.54

149

Care involving dialysis

570

0.61

2.27

1.4

1.2

2.51

2.35

u/ml

0.03

321

Lesion of plantar nerve

390

1.50

2.26

1.2

1.1

1.25

1.52

u/ml

0.12

204

Type1 diabetes, definitions combined, early onset

112

1460

0.75

2.26

1.1

1.2

3.30

2.88

u/ml

0.11

873

Abnormal blood-pressure reading, without diagnosis

366

1.52

2.26

1.2

1.1

0.24

3.02

u/ml

3.57

200

Polyarthropathies

791

5639

0.90

2.26

1.1

1.12

2.33

u/ml

5.96

410

2980

Type 1 diabetes, strict definition

132

1686

0.77

2.25

1.2

3.64

2.62

u/ml

0.35

982

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

199

1615

1.24

2.25

1.2

1.1

1.20

2.14

u/ml

1.93

129

897

Haemorrhage in early pregnancy

480

4083

1.15

2.24

1.2

1.1

1.38

1.95

u/ml

1.04

237

2086

Plantar fascial fibromatosis

115

873

1.33

2.24

1.1

0.87

2.24

u/ml

1.99

433

Other acquired deformities of musculoskeletal system and connective tissue

351

1.53

2.23

1.2

1.1

1.74

2.02

u/ml

0.12

189

Psychotic depression

574

1.40

2.23

1.2

1.1

2.12

u/ml

0.00

303

Inflammation of lacrimal passages (acute and unspecified)

114

1.96

2.22

1.3

1.1

0.70

1.93

u/ml

0.57

Hyperplasia of prostate

233

1074

1.22

2.22

1.1

1.52

1.96

u/ml

0.31

129

587

Pulmonary embolism

226

1860

1.22

2.22

1.1

1.01

1.74

u/ml

1.61

121

984

Acute lymphadenitis

101

755

1.35

2.21

1.1

1.47

2.56

u/ml

0.75

405

Pulmonary heart disease

226

1861

1.22

2.21

1.1

1.01

1.74

u/ml

1.60

121

986

Acute generalized exanthematous pustulosis

434

1.47

2.21

1.1

1.52

2.66

u/ml

0.59

243

Use of disulfiram, acamprosate or naltrexone

901

0.69

2.21

1.2

1.1

1.17

2.41

u/ml

1.58

469

Other female pelvic inflammatory diseases

195

1584

1.24

2.20

1.1

2.87

2.00

u/ml

0.37

791

Mental and behavioural disorders due to cannabinoids

513

0.59

2.20

1.2

4.96

2.44

u/ml

0.31

275

Other diseases of liver

212

1740

1.22

2.17

1.1

1.89

1.74

u/ml

0.13

115

927

Rheumatic fever incl heart disease

122

1.90

2.17

1.1

0.90

1.56

u/ml

0.48

Other and unspecified follicular disorders

420

1.47

2.15

1.2

1.1

2.32

2.58

u/ml

0.08

224

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

292

1.58

2.14

1.2

0.92

3.70

u/ml

2.13

170

Drug-induced cataract

182

1.73

2.14

1.4

1.1

2.59

1.48

u/ml

0.19

106

Lifestyle-related condition

2.04

2.14

1.1

3.35

1.84

u/ml

0.31

Atrial septal defect

674

0.65

2.13

1.1

1.2

5.26

3.03

u/ml

0.27

467

Other viral diseases, not elsewhere classified

330

2816

1.17

2.13

1.2

1.09

2.51

u/ml

5.35

185

1602

Viral hepatitis, including avohilmo

964

0.71

2.13

1.2

1.1

1.06

2.30

u/ml

1.44

504

Cellulitis

294

2493

1.18

2.13

1.1

1.82

2.11

u/ml

0.18

169

1350

Acute epiglottitis

109

1.96

2.13

1.2

1.1

0.88

3.41

u/ml

1.34

Short Achilles tendon (acquired)

205

1.68

2.13

1.2

1.1

1.44

3.12

u/ml

0.82

105

Medial epicondylitis

307

1.55

2.12

1.3

1.1

0.38

2.13

u/ml

2.61

158

Metabolic disorders

1154

7525

0.92

2.12

1.1

1.42

2.06

u/ml

1.71

640

4005

Biomechanical lesions, not elsewhere classified

339

1.52

2.12

1.3

1.1

0.77

2.14

u/ml

1.43

183

Other superficial mycoses, including avohilmo

197

1611

1.23

2.12

1.1

1.34

2.23

u/ml

1.29

108

855

Other and unspecified injuries of lower leg

125

969

1.30

2.12

1.1

1.84

2.66

u/ml

0.51

538

Pleural plaque with presence of asbestos

130

1.85

2.12

1.2

0.48

1.32

u/ml

1.79

Other viral hepatitis

822

0.69

2.12

1.2

1.1

1.19

2.56

u/ml

1.35

419

Other benign neoplasms of uterus

205

1.67

2.11

1.1

6.64

1.51

u/ml

0.87

115

Mental and behavioural disorders due to sedatives or hypnotics

810

0.69

2.11

1.1

0.62

2.49

u/ml

4.29

432

Hypertrophic scar

701

1.36

2.11

1.1

2.95

2.53

u/ml

0.16

371

Malignant neoplasm of prostate

100

787

0.75

2.11

1.1

1.34

1.46

u/ml

0.06

435

Eustachian salpingitis and obstruction

153

1219

1.27

2.10

1.1

4.24

2.48

u/ml

0.57

636

Disorders of orbit

373

1.49

2.09

1.1

0.74

2.12

u/ml

1.58

205

Chronic periodontitis, complicated

451

5004

0.88

2.09

1.1

1.57

1.77

u/ml

0.20

274

2579

Type of accident

404

3519

1.15

2.07

1.2

1.1

2.17

2.22

u/ml

0.03

247

1914

Infections with a predominantly sexual mode of transmission

586

5218

1.12

2.07

1.1

1.56

2.18

u/ml

1.20

291

2747

Event of undetermined intent

106

807

1.33

2.07

1.2

1.1

1.18

2.32

u/ml

1.38

426

Cardiomyopathy (excluding other)

749

0.68

2.06

1.3

1.1

0.92

1.48

u/ml

0.80

427

LeFortI or BSSO operation

559

1.39

2.06

1.1

2.74

2.56

u/ml

0.03

291

Monoamine oxidase A inhibitors

114

876

1.31

2.06

1.1

0.92

2.11

u/ml

2.31

449

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

901

0.71

2.05

1.1

3.09

1.66

u/ml

0.35

503

Scleritis and episcleritis

635

1.37

2.05

1.1

1.56

2.44

u/ml

0.38

330

Need for other prophylactic measures

584

1.38

2.05

1.2

0.66

2.26

u/ml

3.00

349

Personality disorders, excluding more controls

448

3927

1.14

2.04

1.2

1.1

1.31

2.45

u/ml

4.08

266

2015

Speech and linguistic disorders, excluding more controls

203

1570

1.22

2.03

1.3

1.2

2.91

2.85

u/ml

0.02

137

947

Hypogonadotropic hypogonadism

303

1.54

2.03

1.2

1.1

5.19

2.05

u/ml

0.72

167

Insulin, fast-acting (human)

148

1847

0.80

2.02

1.1

1.52

2.28

u/ml

0.80

991

Type 1 diabetes, strict definition, subgroup 1

127

1605

0.78

2.02

1.1

1.2

3.73

2.52

u/ml

0.42

935

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

217

1801

1.21

2.00

1.1

1.17

2.12

u/ml

2.19

139

1002

Benign neoplasm: Skin of eyelid, including canthus

131

1029

1.28

2.00

1.1

3.21

2.08

u/ml

0.38

540

Other hammer toe(s) (acquired)

116

814

1.30

2.00

1.1

0.76

1.57

u/ml

1.31

432

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1254

9121

0.92

1.99

1.2

1.1

1.58

2.13

u/ml

1.41

722

4873

Other abnormal products of conception

702

4151

1.11

1.99

1.1

1.55

2.23

u/ml

1.42

340

2126

Other bursitis of hip

119

1.87

1.98

1.1

4.19

2.48

u/ml

0.26

Major anomalies of jaw size

305

1.53

1.98

1.2

1.1

2.59

2.20

u/ml

0.10

177

Dermatitis herpetiformis

105

1.93

1.97

1.1

1.04

1.93

u/ml

0.55

Acute alcohol intoxication

221

2643

0.83

1.97

1.1

2.18

2.01

u/ml

0.10

128

1408

Other congenital malformations of skin, including avohilmo

134

1060

1.27

1.97

1.1

1.49

2.41

u/ml

0.86

581

Poor fetal growth

199

2398

0.82

1.97

1.1

3.84

2.14

u/ml

0.99

104

1228

Hyperparathyroidism

123

950

1.28

1.96

1.1

0.52

1.47

u/ml

2.81

517

Other diseases of gallbladder

241

1.59

1.96

1.4

1.1

3.64

2.10

u/ml

0.19

117

Unspecified kidney failure

438

0.59

1.96

1.5

1.1

0.52

1.94

u/ml

2.53

251

Spinal stenosis

367

2342

1.16

1.96

1.1

1.31

1.61

u/ml

0.33

200

1177

Viral hepatitis

902

0.71

1.96

1.2

1.1

1.09

2.43

u/ml

1.52

467

Familial hypercholesterolemia, with ischemic heart disease

273

1.54

1.94

1.1

0.72

1.41

u/ml

0.77

148

Diseases of the digestive system

473

4150

1.13

1.94

1.2

1.1

2.44

1.98

u/ml

0.41

270

2276

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

150

1.77

1.94

1.1

1.01

3.35

u/ml

1.22

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

598

1.36

1.94

1.1

1.28

1.65

u/ml

0.31

327

Generalized skin eruption due to drugs and medicaments

380

1.46

1.94

1.1

1.72

2.51

u/ml

0.31

211

Non-Hodgkin lymphoma, all, including Hilmo

703

0.68

1.94

1.0

1.1

3.89

1.79

u/ml

0.35

408

Melanoma in situ

195

1.65

1.93

1.1

0.90

2.14

u/ml

0.75

105

Brachial plexus disorders

146

1170

1.26

1.92

1.1

2.23

2.25

u/ml

0.01

584

Ectropion of eyelid

2.12

1.92

1.1

0.21

1.08

u/ml

—

Extracorporeal dialysis

397

0.58

1.92

1.4

1.1

3.47

2.44

u/ml

0.15

228

Other specified/unspecified disorders of bone/cartilage

196

1.65

1.91

1.1

3.66

1.75

u/ml

0.59

109

Other articular cartilage disorders

128

1.82

1.91

1.1

1.48

2.40

u/ml

—

Emotional disorders and disorders of social functioning with onset specific to childhood

171

1370

1.24

1.91

1.2

3.17

3.07

u/ml

0.03

832

Sarcoidosis

139

1108

1.26

1.91

1.1

1.22

1.97

u/ml

0.43

569

Car occupant injured in other and unspecified transport accidents

306

2632

1.17

1.91

1.1

2.62

2.32

u/ml

0.16

155

1394

Myocardial infarction

245

2028

0.84

1.90

1.1

2.71

1.53

u/ml

0.68

132

1094

Sequelae of injuries, of poisoning and of other consequences of external causes

299

2567

1.17

1.90

1.1

1.87

2.00

u/ml

0.08

176

1373

Alzheimer’s disease (Late onset)

389

0.61

1.89

1.3

1.1

0.30

0.83

u/ml

2.25

211

260

1.56

1.89

1.1

1.15

1.79

u/ml

0.47

142

Chronic viral hepatitis

697

0.68

1.89

1.2

1.1

1.17

2.56

u/ml

1.17

357

Cardiomyopathies, Primary/intrinsic

711

0.69

1.89

1.3

1.1

0.67

1.63

u/ml

2.50

413

Bitten or struck by other mammals

201

1670

1.21

1.89

1.2

1.1

1.15

2.51

u/ml

3.54

125

873

Diabetic nephropathy

852

0.72

1.89

1.1

0.67

1.63

u/ml

1.61

463

Ventral hernia

218

1823

1.20

1.88

1.1

1.99

1.89

u/ml

0.07

112

966

Tic and related disorders

311

1.52

1.87

1.2

2.48

3.13

u/ml

0.19

211

Other disorders of prostate

107

1.88

1.86

1.1

0.64

2.42

u/ml

0.93

Other and unspecified injuries of ankle and foot

604

1.36

1.86

1.2

1.1

2.41

2.94

u/ml

0.10

323

Bullous disorders

317

1.49

1.86

1.1

1.27

1.92

u/ml

0.56

171

Syncope and collapse

507

3765

1.13

1.86

1.1

2.16

2.03

u/ml

0.10

265

2019

Acute gastritis

433

1.42

1.85

1.1

0.57

1.74

u/ml

2.16

236

Amputation

393

0.58

1.85

1.2

1.1

0.75

1.74

u/ml

0.88

211

KRA_PSY_EATING, excluding more controls

206

1704

1.21

1.85

1.1

2.06

3.17

u/ml

1.11

117

909

Contact with machinery

106

821

1.30

1.84

1.1

0.90

2.25

u/ml

2.65

447

Complications of surgical and medical care, not elsewhere classified

1400

8701

1.07

1.84

1.1

1.50

2.06

u/ml

1.89

791

4539

Astigmatism

121

954

1.28

1.84

1.2

2.45

2.92

u/ml

0.23

581

Actinic keratosis

174

1296

1.22

1.83

1.1

1.40

1.21

u/ml

0.13

723

Viral meningitis, including avohilmo

469

1.40

1.83

1.1

0.98

3.09

u/ml

2.93

254

Presence of other functional implants

379

2964

0.87

1.83

1.2

1.1

1.39

1.55

u/ml

0.18

180

1607

Other and unspecified erythematous conditions

238

1.57

1.83

1.1

2.92

2.46

u/ml

0.09

127

Fracture at wrist and hand level

510

4539

1.12

1.82

1.2

1.1

1.68

2.43

u/ml

1.09

289

2481

Decubitus ulcer and pressure area

249

0.48

1.82

1.1

4.82

2.49

u/ml

—

139

Postpartum care and examination

264

1939

0.85

1.82

1.1

2.67

2.34

u/ml

0.18

133

959

Other abnormal auditory perceptions

116

1.85

1.81

1.3

1.1

1.36

2.06

u/ml

0.23

Bulimia nervosa (incl. atypical)

643

1.34

1.80

1.2

1.1

1.99

2.67

u/ml

0.35

334

Malignant neoplasm of head and neck

377

0.58

1.80

1.2

1.1

0.14

1.52

u/ml

3.98

201

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

369

1.44

1.79

1.0

1.1

5.44

1.49

u/ml

0.94

201

Other predominantly sexually transmitted diseases, not elsewhere classified

327

2845

1.16

1.78

1.2

1.1

1.24

2.26

u/ml

1.87

166

1509

Pneumonia due to Streptococcus pneumoniae

296

1.50

1.78

1.0

1.1

6.64

3.00

u/ml

0.38

160

Pulmonary heart disease, diseases of pulmonary circulation

241

2044

1.18

1.78

1.1

0.96

1.77

u/ml

2.12

133

1092

Symptoms and signs concerning food and fluid intake

127

1010

1.26

1.77

1.2

1.1

2.53

2.41

u/ml

0.04

579

Abnormal findings on diagnostic imaging of other body structures

141

1137

1.25

1.77

1.2

1.1

1.24

2.30

u/ml

0.89

603

Hyperlipidaemia, other/unspecified

276

2126

1.17

1.77

1.1

0.68

1.44

u/ml

2.29

144

1147

Ménière disease

565

1.35

1.77

1.2

1.1

1.90

1.74

u/ml

0.05

315

conjunctival haemorrhage

404

1.42

1.76

1.1

2.29

1.78

u/ml

0.14

222

Focal epilepsy

198

2360

0.84

1.76

1.2

1.1

2.60

2.28

u/ml

0.14

109

1345

Sequelae of injuries of upper limb

124

987

1.26

1.76

1.2

1.1

1.38

2.09

u/ml

0.50

532

Other epidermal thickening

363

1.44

1.76

1.2

1.1

0.77

2.11

u/ml

1.86

198

Other neurotic disorders

289

1.50

1.75

1.4

1.1

0.40

1.59

u/ml

1.87

147

Crushed, pushed or stepped on by crowd or human stampede

152

1240

1.24

1.75

1.2

1.1

2.85

2.52

u/ml

0.08

689

Atrial septal defect, secundum type

551

0.66

1.75

1.1

1.2

5.91

2.95

u/ml

0.34

385

Ulcerative colitis (strict definition, require KELA)

181

2174

0.83

1.75

1.1

1.41

2.18

u/ml

0.95

1175

Malignant neoplasm of corpus uteri, including Hilmo

460

0.63

1.75

1.2

1.1

0.74

1.07

u/ml

0.29

256

Ill-defined and unknown causes of mortality

361

0.58

1.74

1.0

1.1

0.86

1.86

u/ml

—

203

Glucosamine medication

261

1778

1.17

1.74

1.1

0.67

1.24

u/ml

2.14

153

968

Other bacterial intestinal infections

172

1419

1.22

1.74

1.1

1.21

2.00

u/ml

1.11

107

754

Alzheimer’s disease (Late onset), excluding more controls

228

0.57

1.73

1.3

1.1

0.34

1.53

u/ml

1.32

134

Chalazion

143

1159

1.24

1.73

1.1

3.65

2.26

u/ml

0.39

612

Caught, crushed, jammed or pinched in or between objects

655

1.33

1.73

1.2

1.1

0.94

2.73

u/ml

2.93

357

Superficial injury of abdomen, lower back and pelvis

227

1924

1.19

1.73

1.1

3.49

2.23

u/ml

0.54

125

1037

Delivery

494

2916

0.89

1.72

1.1

2.85

2.19

u/ml

0.64

287

1546

Suicide or other Intentional self-harm

296

3411

0.86

1.72

1.1

1.70

2.18

u/ml

0.40

164

1813

Implicit bacterial Sepsis

246

2468

0.85

1.72

1.1

1.83

1.71

u/ml

0.08

152

1363

Abnormalities of forces of labour

174

1442

1.21

1.71

1.1

2.76

1.95

u/ml

0.33

705

Effects of air pressure and water pressure

2.26

1.71

1.2

1.1

2.09

1.66

u/ml

—

Abscess of external ear

111

1.83

1.71

1.1

1.2

4.39

3.44

u/ml

0.10

Benign neoplasm: Parotid gland

483

1.37

1.71

1.2

1.1

0.84

1.99

u/ml

1.53

269

Disorders of oesophagus in diseases classified elsewhere

2.02

1.70

1.2

1.1

1.12

1.14

u/ml

—

Sequelae with surgical and medical care as external cause

189

1578

1.20

1.70

1.1

0.76

1.91

u/ml

4.09

112

853

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

493

1.39

1.70

1.2

1.3

2.04

3.03

u/ml

0.61

342

Cardiac murmurs and other cardiac sounds

150

1211

1.23

1.70

1.2

1.1

3.04

3.15

u/ml

0.03

670

Chronic myeloproliferative disease

0.00

1.69

0.0

1.2

—

1.56

—

Helminthiases

149

1.70

1.69

1.3

1.2

3.13

2.66

u/ml

0.06

Other and unspecified hypertrophic disorders of skin

2.15

1.68

1.0

1.1

1.69

2.63

u/ml

—

Malignant neoplasm of prostate, including Hilmo

110

823

0.79

1.68

1.1

1.33

1.42

u/ml

0.05

452

Misadventures to patients during surgical and medical care

148

1208

1.23

1.68

1.1

1.26

2.24

u/ml

1.02

634

Localized skin eruption due to drugs and medicaments

1.92

1.67

1.1

1.2

0.07

2.30

u/ml

—

Viral warts

153

1256

1.23

1.66

1.2

1.1

1.04

2.50

u/ml

3.23

695

Colorectal cancer, including Hilmo

117

1363

0.80

1.66

1.2

1.1

1.80

1.33

u/ml

0.19

728

Carcinoma in situ of skin of other and unspecified parts of face

180

1.62

1.66

1.1

0.55

0.86

u/ml

0.40

100

Bacterial intestinal infections, IBD co-morbidities

172

1427

1.21

1.66

1.1

1.26

1.96

u/ml

0.94

105

763

Familial hypercholesterolemia

667

1.31

1.65

1.1

0.58

1.91

u/ml

3.22

386

Scabies, including avohilmo

297

2583

1.16

1.65

1.1

1.89

2.77

u/ml

0.93

175

1398

Myocardial infarction, strict

223

1857

0.85

1.65

1.1

2.14

1.38

u/ml

0.51

119

1011

Gastric ulcer

101

790

1.28

1.65

1.1

0.86

1.78

u/ml

1.69

431

Unspecified maternal hypertension

206

1.59

1.64

1.1

2.87

2.88

u/ml

0.00

100

Retention of urine

173

1679

0.83

1.63

1.2

1.1

1.36

1.79

u/ml

0.50

100

903

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

245

1.52

1.63

1.2

1.1

0.50

1.95

u/ml

1.62

130

Procreative management

622

4650

1.10

1.63

1.2

1.1

1.79

2.32

u/ml

0.87

376

2555

Tooth eruption problems

390

3339

1.13

1.63

1.1

1.2

2.63

2.92

u/ml

0.21

238

1916

Focal epilepsy, mode (most common among epilepsy diagnosis)

166

1994

0.83

1.63

1.2

1.1

3.04

2.37

u/ml

0.27

1136

770

0.72

1.63

1.2

1.3

3.00

3.27

u/ml

0.05

528

Other congenital malformations of skin

532

1.35

1.62

1.1

1.2

1.55

2.77

u/ml

0.76

310

Amblyopia ex anopsia

628

1.32

1.62

1.1

1.2

1.07

2.97

u/ml

2.48

383

Other prurigo

2.10

1.61

1.2

1.1

0.38

2.05

u/ml

—

Dislocation, sprain and strain of joints and ligaments of thorax

320

1.45

1.61

1.2

1.1

1.18

3.30

u/ml

2.15

173

Diseases of arteries, arterioles and capillaries (FINNGEN)

181

1491

0.83

1.61

1.2

1.1

1.44

1.74

u/ml

0.21

106

791

Drug-induced osteoporosis

2.03

1.60

1.2

0.52

2.08

u/ml

—

Tic and related disorders

322

1.46

1.60

1.2

1.3

2.48

2.57

u/ml

0.02

212

Acne vulgaris

215

1828

1.18

1.60

1.2

1.1

2.12

2.91

u/ml

0.71

141

998

Other retinal disorders

483

4085

0.90

1.60

1.1

1.83

1.73

u/ml

0.07

255

2199

Urolithiasis

283

2457

1.15

1.60

1.2

1.1

1.14

1.90

u/ml

1.16

166

1309

Other specified/unspecified arthritis

324

2841

1.14

1.59

1.1

0.75

2.01

u/ml

6.37

163

1495

Other diseases of blood and blood-forming organs, wide

227

1939

1.17

1.59

1.2

1.1

1.55

1.96

u/ml

0.29

139

1057

Additional codes for the location of defect, injury or illness

533

1.34

1.59

1.1

2.80

2.65

u/ml

0.03

306

Dental caries

287

2353

1.15

1.59

1.3

1.1

2.00

2.24

u/ml

0.14

193

1154

Lesion of sciatic nerve

106

1.80

1.59

1.1

0.45

1.29

u/ml

0.97

Viral meningitis

431

1.38

1.59

1.1

1.07

2.94

u/ml

2.31

229

Embedded teeth, including avohilmo

208

1768

1.19

1.58

1.1

2.36

2.53

u/ml

0.10

127

975

Other infective otitis externa

542

1.34

1.58

1.2

1.1

0.74

2.71

u/ml

3.92

296

Scleritis

114

1.78

1.58

1.1

0.47

3.05

u/ml

1.93

Fitting and adjustment of other devices

258

1958

1.16

1.58

1.2

1.1

1.36

1.69

u/ml

0.27

148

1039

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

603

1.32

1.58

1.1

1.76

2.19

u/ml

0.18

327

Skin changes due to chronic exposure to nonionizing radiation

184

1396

1.19

1.57

1.1

1.35

1.20

u/ml

0.10

100

776

Inflammatory disease of cervix uteri

448

1.37

1.57

1.2

1.1

0.75

1.60

u/ml

1.00

224

Constipation

1163

7344

1.07

1.57

1.1

1.51

2.10

u/ml

1.56

623

3993

Other inflammation of vagina/vulva

544

1.34

1.57

1.1

1.43

2.36

u/ml

0.49

267

Other peripheral vertigo

595

1.32

1.56

1.1

0.50

1.71

u/ml

2.85

331

213

1817

1.18

1.56

1.1

0.95

2.31

u/ml

3.35

134

909

Melanocytic naevi, other sites/unspecified

112

896

1.26

1.56

1.1

1.93

2.18

u/ml

0.16

479

Atrial fibrillation and flutter

281

2086

0.87

1.56

1.1

2.04

1.64

u/ml

0.21

149

1094

Cleft lip, lip and palate or palate

258

0.53

1.56

1.1

1.2

11.31

3.81

u/ml

—

146

Schizotypal disorder

259

0.53

1.56

1.2

1.1

2.47

2.82

u/ml

—

140

Viral infections of the central nervous system, including avohilmo

104

825

1.27

1.56

1.1

1.81

2.14

u/ml

0.16

441

Corneal ulcer

249

2148

1.16

1.56

1.1

2.54

2.16

u/ml

0.24

136

1132

Impacted maxillary canine

218

1.57

1.55

1.1

1.2

4.37

4.11

u/ml

0.03

140

Maxillary retrognathism

324

1.45

1.55

1.2

5.37

3.82

u/ml

0.19

195

Spinal instabilities

216

1.54

1.55

1.0

1.1

0.42

1.59

u/ml

1.36

114

Open wound of lower leg

190

1604

1.19

1.55

1.1

2.68

2.49

u/ml

0.08

118

899

Other disorders of Eustachian tube

265

1.49

1.55

1.3

1.1

5.18

2.71

u/ml

0.34

143

Sulfasalazine

311

2726

1.14

1.55

1.1

1.13

1.83

u/ml

1.21

150

1349

Medicines for HER+ breast cancer

280

2991

0.87

1.54

1.1

2.08

1.53

u/ml

0.53

155

1504

Maternal care for other known or suspected fetal problems

478

3331

0.90

1.54

1.1

2.90

2.28

u/ml

0.51

230

1727

Other disorders of pigmentation

357

1.41

1.53

1.3

1.1

4.03

2.49

u/ml

0.23

200

Other benign neoplasms of skin

367

3254

1.13

1.53

1.1

2.75

1.83

u/ml

0.69

183

1717

Chronic suppurative otitis media, including avohilmo

110

881

1.26

1.53

1.2

1.47

2.53

u/ml

0.71

512

Ulcerative colitis (strict definition, all Crohn cases excluded)

152

1827

0.83

1.52

1.1

1.64

2.25

u/ml

0.54

975

Hyperhidrosis

383

1.40

1.52

1.2

1.1

2.09

2.93

u/ml

0.32

189

Aplastic and other anaemias

282

2955

0.87

1.52

1.1

2.73

1.66

u/ml

0.68

153

1623

Implicit bacterial Sepsis, including avohilmo

295

2802

0.87

1.52

1.1

2.09

1.67

u/ml

0.37

183

1542

Non-small cell lung cancer

342

0.61

1.51

1.0

1.1

0.73

1.27

u/ml

—

187

Acute inflammation of orbit

2.05

1.51

1.2

0.21

3.12

u/ml

—

Juvenile osteochondrosis

487

1.35

1.51

1.1

1.2

1.22

3.35

u/ml

1.65

263

Status epilepticus

244

0.53

1.51

1.1

0.18

2.39

u/ml

—

140

Colorectal adenocarcinoma

940

0.76

1.50

1.2

1.1

1.14

1.21

u/ml

0.04

513

Lymphoid leukaemia

332

0.60

1.50

1.4

1.2

1.03

2.34

u/ml

1.21

212

Osteoporosis

171

1316

1.20

1.50

1.2

1.1

1.79

u/ml

0.00

730

Coronary atherosclerosis

417

2942

0.89

1.49

1.1

2.30

1.57

u/ml

0.61

231

1571

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.96

1.49

1.0

1.1

1.00

2.31

u/ml

—

Anomalies of pupillary function

235

1.51

1.49

1.2

1.1

3.30

3.20

u/ml

0.02

131

Neuromuscular dysfunction of bladder

635

1.30

1.49

1.2

1.1

0.64

1.85

u/ml

3.26

345

Contusion of toe(s) with damage to nail

132

1.70

1.48

1.3

1.1

3.42

2.53

u/ml

0.11

Superficial injury of ankle and foot

239

2067

1.16

1.48

1.2

1.1

1.78

2.61

u/ml

0.80

140

1132

Parkinson's disease

524

0.69

1.48

1.1

1.13

1.45

u/ml

0.15

287

Heterophoria

137

1129

1.22

1.47

1.2

0.82

2.56

u/ml

4.14

652

Benign neoplasm: Vagina

1.87

1.47

1.1

0.99

1.97

u/ml

—

Diving or jumping into water causing injury other than drowning or submersion

2.18

1.47

1.2

1.1

3.11

1.39

u/ml

—

Benign neoplasm: Other/unspecified site

1.86

1.47

1.1

0.81

1.99

u/ml

—

Parkinson's disease, including avohilmo

547

0.69

1.47

1.1

1.16

1.42

u/ml

0.13

300

Caries of dentine

248

2071

1.16

1.47

1.2

1.1

2.01

2.37

u/ml

0.19

164

1016

Dilated cardiomyopathy

605

0.71

1.47

1.3

1.1

0.73

2.07

u/ml

2.84

341

Cerebral cysts

655

1.29

1.46

1.2

1.1

4.16

2.50

u/ml

0.34

359

Other and/or unspecified nontoxic goitre

576

1.31

1.45

1.1

0.64

1.85

u/ml

2.10

305

Severe combined immunodeficiency [SCID] with reticular dysgenesis

3.22

1.45

1.2

1.3

0.94

1.94

u/ml

—

Cardiac arrest

301

0.62

1.45

1.0

1.1

0.22

1.79

u/ml

3.50

174

Carcinoma in situ, bladder

102

1.77

1.45

1.1

0.39

1.06

u/ml

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

197

2303

0.85

1.45

1.1

1.93

2.15

u/ml

0.12

1247

Bleeding

812

6152

0.92

1.44

1.2

1.1

2.13

1.84

u/ml

0.34

465

3317

Heart failure and antihypertensive medication

166

1283

0.84

1.44

1.1

1.70

1.63

u/ml

0.03

690

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

180

2118

0.85

1.44

1.1

1.41

2.21

u/ml

1.00

1145

Sacroiliitis, not elsewhere classified

649

1.29

1.43

1.1

0.78

2.52

u/ml

3.20

330

Carcinoma in situ of other and unspecified sites

110

1.74

1.43

1.1

0.39

1.05

u/ml

—

Whooping cough

1.83

1.43

1.2

1.1

2.40

4.13

u/ml

—

Postdysenteric arthropathy

1.89

1.42

1.1

0.23

2.15

u/ml

—

Non-ischemic cardiomyopathy

141

1346

0.83

1.42

1.1

0.53

1.55

u/ml

3.91

771

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

217

2512

0.86

1.41

1.1

1.95

2.27

u/ml

0.17

120

1322

Bilateral sagittal split ramus osteotomy operation

458

1.35

1.41

1.1

3.44

2.58

u/ml

0.11

238

Fall on same level

1898

9603

1.05

1.41

1.2

1.1

1.83

2.32

u/ml

1.29

1076

5127

Oligomenorrhoea

458

1.35

1.41

1.1

2.21

2.75

u/ml

0.20

234

Other abnormalities of plasma proteins

1.87

1.41

1.1

0.71

2.27

u/ml

—

Other and unspecified mononeuropathies of lower limb

189

1.55

1.41

1.1

0.41

1.95

u/ml

1.74

Superficial injury of forearm

165

1391

1.19

1.41

1.1

4.23

2.43

u/ml

0.71

768

Acute alcohol intoxication, ICD10

200

2329

0.86

1.40

1.2

1.1

2.32

2.17

u/ml

0.09

119

1248

Stenosis and insufficiency of lacrimal passages

703

1.27

1.40

1.2

1.1

1.57

2.46

u/ml

0.40

384

878

0.76

1.40

1.2

3.04

3.39

u/ml

0.07

597

Other noninflammatory disorders of uterus, except cervix

165

923

1.20

1.40

1.1

1.39

1.76

u/ml

0.17

471

Palindromic rheumatism

2.11

1.39

1.2

1.1

1.90

2.85

u/ml

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

170

1412

1.19

1.39

1.2

2.03

2.90

u/ml

0.70

105

866

Injury of muscle and tendon at ankle and foot level

247

1.47

1.39

1.1

1.59

3.15

u/ml

0.60

131

Benign neoplasm: Other and unspecified parts of small intestine

2.10

1.39

1.1

1.82

1.96

u/ml

—

Use of other anti-dementia drugs

502

0.72

1.39

1.2

1.1

0.25

0.91

u/ml

3.70

280

Use of memantine

502

0.72

1.39

1.2

1.1

0.25

0.91

u/ml

3.70

280

Supernumerary ureter

0.00

1.39

0.0

1.1

—

3.91

—

Other specified and unspecified disorders of eye and adnexa

280

1.44

1.39

1.1

1.18

1.46

u/ml

0.19

150

Episcleritis

546

1.31

1.39

1.2

1.1

1.91

2.55

u/ml

0.20

285

Alopecia areata

331

1.41

1.39

1.1

2.59

3.11

u/ml

0.12

178

Focal epilepsy, strict definition

175

2056

0.85

1.38

1.2

1.1

2.53

2.43

u/ml

0.04

1180

Chronic ulcer of skin, not elsewhere classified

361

0.63

1.38

1.2

1.1

1.16

1.95

u/ml

0.45

197

Complications following infusion, transfusion and therapeutic injection

104

1.75

1.38

1.3

1.2

1.75

2.63

u/ml

0.27

Glaucoma suspect

272

2383

1.14

1.38

1.1

2.03

1.57

u/ml

0.23

130

1282

Heart failure and coronary heart disease

172

1422

0.85

1.38

1.2

1.1

1.76

1.25

u/ml

0.22

817

Other and unspecified iridocyclitis

442

1.34

1.38

1.2

1.1

0.65

3.03

u/ml

4.36

246

Fentanyl

456

0.68

1.38

1.2

1.1

0.74

1.65

u/ml

1.32

243

Anosmia

174

1.55

1.38

1.1

0.54

1.53

u/ml

1.09

Fasciculation

112

1.73

1.37

1.1

1.2

0.31

2.33

u/ml

—

Injuries to the hip and thigh

482

3915

1.11

1.37

1.1

2.14

1.88

u/ml

0.22

274

2123

Other congenital malformations, including avohilmo

243

2118

1.15

1.36

1.1

1.2

2.51

2.26

u/ml

0.13

152

1201

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

1.36

0.0

1.2

—

2.69

—

DVT of lower extremities and pulmonary embolism

321

2834

1.13

1.36

1.1

0.99

1.64

u/ml

1.99

172

1503

Autoimmune thyroiditis

232

1.49

1.36

1.1

4.27

2.65

u/ml

0.26

127

Other bursitis of knee

1.78

1.36

1.1

0.26

2.82

u/ml

—

Other ill-defined and unspecified causes of mortality

323

0.62

1.36

1.1

0.86

1.68

u/ml

—

182

Other benign neoplasm of uterus: Other parts/unspecified

1.84

1.36

1.2

1.1

6.51

0.95

u/ml

—

Other congenital malformations of the digestive system, including avohilmo

110

890

1.24

1.35

1.2

2.76

3.20

u/ml

0.13

583

Mucosal proctocolitis

135

1618

0.83

1.35

1.0

1.1

0.78

2.16

u/ml

2.58

856

Amputation of toe

273

0.58

1.35

1.2

1.1

0.33

1.53

u/ml

2.27

147

Melanocytic naevi of lower limb, including hip

470

1.33

1.35

1.1

3.28

2.42

u/ml

0.17

252

Tongue abnormality

409

1.35

1.1

0.36

2.18

u/ml

3.13

224

Glomerular diseases

131

1575

0.83

1.35

1.2

1.1

1.76

2.02

u/ml

0.12

875

Other disorders of the musculoskeletal system and connective tissue

134

1113

1.21

1.34

1.2

1.1

1.07

1.87

u/ml

1.31

592

Non-follicular lymphoma

454

0.68

1.34

1.0

1.1

6.28

2.18

u/ml

0.44

268

Malignant neoplasm of ovary, including Hilmo

418

0.67

1.34

1.0

1.1

0.80

1.61

u/ml

0.97

227

Intracranial trauma

950

5982

1.07

1.34

1.2

1.1

1.81

2.64

u/ml

1.93

538

3209

Tic disorders

318

1.42

1.34

1.2

1.3

2.55

2.65

u/ml

0.03

213

Phobic anxiety disorders

277

2435

1.14

1.34

1.1

3.30

2.62

u/ml

0.29

164

1253

Dialysis

345

0.63

1.34

1.5

1.1

2.59

2.01

u/ml

0.09

219

Malignant neoplasm of rectum

465

0.69

1.33

1.2

1.1

2.31

1.30

u/ml

0.34

253

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1085

7310

0.94

1.33

1.1

1.59

1.91

u/ml

0.60

580

3792

Other arthritis (FG)

384

3449

1.12

1.33

1.1

0.82

1.91

u/ml

6.12

199

1807

Guttate psoriasis

113

1.71

1.33

1.1

5.13

1.72

u/ml

0.45

456

1.34

1.33

1.2

1.28

3.18

u/ml

2.22

274

Benign neoplasm of bone and articular cartilage

111

907

1.23

1.32

1.1

1.86

2.32

u/ml

0.17

489

Myocarditis

445

1.33

1.32

1.2

1.1

1.29

1.60

u/ml

0.22

244

Other specified/unspecified hearing loss

532

1.30

1.32

1.2

1.1

0.74

2.03

u/ml

2.28

302

Atrophic disorders of skin

177

1510

1.18

1.32

1.1

2.41

1.90

u/ml

0.23

100

790

Trigeminal neuralgia

489

1.32

1.1

0.51

2.04

u/ml

2.98

253

Ankle and foot

1.88

1.32

1.1

14.48

1.78

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1382

8717

1.06

1.31

1.1

1.45

2.13

u/ml

2.58

794

4574

Androgenic alopecia

1.79

1.31

1.1

0.43

2.42

u/ml

—

Other specified/unspecified dorsopathies

242

1.46

1.31

1.2

1.1

3.72

1.75

u/ml

0.25

127

Other bullous disorders

185

1.53

1.30

1.1

1.10

2.64

u/ml

1.07

101

Use of donepezil

419

0.68

1.30

1.1

0.74

0.79

u/ml

0.04

227

Other endocrine disorders

130

1038

1.21

1.29

1.2

2.64

3.00

u/ml

0.13

687

Oral lichen planus

153

1.58

1.29

1.2

1.1

3.91

1.34

u/ml

0.48

Carcinoma in situ of other and unspecified digestive organs

185

1.52

1.29

1.1

3.84

1.65

u/ml

0.26

Sleep disorders, other/unspecified

474

1.32

1.29

1.2

1.1

2.57

2.73

u/ml

0.04

260

Hypertensive Renal Disease

1.77

1.29

1.0

1.1

0.87

1.94

u/ml

—

Benign neoplasm of other and unspecified female genital organs

327

1.39

1.29

1.2

1.1

3.06

1.60

u/ml

0.52

178

Follicular cysts of skin and subcutaneous tissue

209

1811

1.16

1.29

1.1

1.25

2.02

u/ml

0.91

111

959

Other disorders involving the immune mechanism, not elsewhere classified

319

1.39

1.28

1.2

1.1

3.15

2.49

u/ml

0.12

178

Other diseases of blood and blood-forming organs

465

1.32

1.28

1.2

1.1

1.45

2.05

u/ml

0.26

251

Chronic suppurative otitis media

677

1.26

1.28

1.1

1.77

2.63

u/ml

0.40

382

Malignant neoplasm of stomach, including Hilmo

218

0.55

1.28

1.1

11.53

1.58

u/ml

—

112

Myopia

239

2094

1.15

1.27

1.1

1.59

2.17

u/ml

0.78

129

1112

Tobacco use

536

1.30

1.27

1.2

1.1

6.23

2.68

u/ml

0.55

287

Ulcer of lower limb, not elsewhere classified

725

0.76

1.27

1.1

3.12

1.76

u/ml

0.51

398

Foreign body in alimentary tract

501

1.31

1.27

1.2

1.07

3.06

u/ml

1.66

291

Sequelae of injuries of lower limb

115

948

1.22

1.27

1.1

1.74

2.12

u/ml

0.21

493

Papulosquamous disorders

433

3926

1.11

1.27

1.1

2.54

1.85

u/ml

0.48

248

2053

Other condition

189

1628

1.17

1.27

1.2

1.1

2.63

2.09

u/ml

0.24

121

850

Raynaud syndrome

121

1003

1.21

1.27

1.1

0.85

2.23

u/ml

3.60

517

Other superficial mycoses

261

1.43

1.26

1.2

1.1

0.95

2.97

u/ml

1.70

144

Myositis

146

1.59

1.26

1.2

1.1

1.46

2.83

u/ml

0.62

Viral Sepsis

208

1804

1.16

1.26

1.2

1.1

2.03

1.86

u/ml

0.11

131

993

Abnormal findings on examination of blood, without diagnosis

437

3584

1.10

1.26

1.1

2.04

1.96

u/ml

0.05

231

1956

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

115

1.67

1.26

1.1

4.77

1.21

u/ml

—

Varicose veins

466

3865

0.91

1.25

1.1

2.23

1.61

u/ml

0.50

220

1971

Other diseases caused by chlamydiae, including avohilmo

212

1.49

1.25

1.1

1.89

2.41

u/ml

0.18

113

Respiratory tuberculosis, not confirmed

1.75

1.25

1.2

1.1

2.06

1.29

u/ml

0.31

Benign neoplasm: salivary glands, exclude unknown (D119)

546

1.29

1.25

1.2

1.1

0.80

2.01

u/ml

1.85

302

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

188

1.52

1.25

1.1

1.2

2.00

3.34

u/ml

0.31

126

Cramp and spasm

459

1.32

1.24

1.2

1.1

1.48

2.25

u/ml

0.48

253

Benign neoplasm: Cerebral meninges

555

1.28

1.24

1.1

0.65

1.14

u/ml

0.63

306

Erythema nodosum

245

1.44

1.24

1.2

1.1

1.93

2.81

u/ml

0.31

132

Disorders of lipoprotein metabolism and other lipidaemias

808

5275

0.93

1.24

1.1

1.13

1.84

u/ml

2.25

455

2761

Venous thromboembolism

462

4049

1.10

1.24

1.1

1.16

1.69

u/ml

1.36

254

2129

Tooth agenesis EXCLUDE clefts and syndromes

110

907

1.23

1.24

1.2

1.76

3.34

u/ml

1.21

537

Peripheral artery operations in Hilmo

469

0.70

1.24

1.2

1.1

1.05

1.58

u/ml

0.45

252

Poisoning by drugs, medicaments and biological substances

321

3583

0.89

1.23

1.2

1.1

1.90

2.27

u/ml

0.30

191

1916

Radial styloid tenosynovitis [de Quervain]

619

1.27

1.23

1.1

2.46

2.43

u/ml

0.01

313

Contact with heat and hot substances

655

1.26

1.23

1.1

1.2

2.29

2.60

u/ml

0.11

372

Hirsprung

0.00

1.22

0.0

1.2

—

2.17

—

Varicose veins of other sites

504

1.30

1.22

1.1

2.54

2.01

u/ml

0.18

267

Diseases caused by chlamydiae, including avohilmo

205

1.49

1.22

1.1

1.88

2.40

u/ml

0.18

109

Noonan syndrome

0.00

1.22

0.0

1.1

—

1.79

—

Other hearing loss

179

1491

1.16

1.21

1.2

1.1

0.82

1.69

u/ml

2.20

100

800

Emotional disorders starting during childhood or adolescence

156

1320

1.18

1.21

1.2

3.41

3.21

u/ml

0.06

800

Benign neoplasm of major salivary glands

593

1.27

1.21

1.2

1.1

0.75

1.88

u/ml

1.90

331

Obstructed labour due to maternal pelvic abnormality

162

1385

1.17

1.21

1.1

1.69

1.67

u/ml

0.01

683

Horner syndrome

1.85

1.20

1.2

1.1

0.28

2.41

u/ml

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

197

1.49

1.20

1.0

1.1

0.58

2.18

u/ml

1.59

101

Other congenital malformations

172

1479

1.17

1.20

1.2

2.97

2.34

u/ml

0.29

113

878

Valvular operations

841

0.78

1.20

1.1

4.74

1.87

u/ml

0.65

505

Benign neoplasm: Stomach

523

1.29

1.20

1.1

0.89

1.42

u/ml

0.44

282

Maternal care related to the fetus and amniotic cavity and possible delivery problems

828

4526

1.07

1.19

1.1

2.41

2.14

u/ml

0.29

419

2326

Anogenital herpesviral [herpes simplex] infection

120

1002

1.21

1.19

1.2

1.1

2.07

2.53

u/ml

0.26

530

Delayed milestone in childhood

656

0.76

1.19

1.3

2.60

3.33

u/ml

0.21

487

Exposure to other and unspecified man-made environmental factors

206

1.47

1.19

1.1

4.29

2.94

u/ml

0.22

119

Benign intracranial hypertension

182

1.52

1.19

1.2

2.84

3.43

u/ml

0.14

101

All pneumoniae

1587

9802

1.05

1.19

1.2

1.1

2.42

2.15

u/ml

0.37

955

5191

Abnormal findings on diagnostic imaging of central nervous system

498

1.29

1.18

1.1

4.04

2.70

u/ml

0.24

273

Other disorders starting during childhood or adolescence

166

1414

1.17

1.18

1.2

2.08

3.04

u/ml

0.77

102

885

Overexertion and strenuous or repetitive movements

125

1048

1.20

1.18

1.1

0.79

2.22

u/ml

2.00

556

Benign neoplasm: Adrenal gland

463

1.30

1.17

1.1

0.87

1.63

u/ml

0.99

250

Other keratitis

153

1306

1.18

1.17

1.2

1.1

1.39

2.08

u/ml

0.73

671

Other salmonella infections, including avohilmo

385

1.33

1.17

1.2

1.1

2.65

2.36

u/ml

0.09

206

Unattended death

0.00

1.16

0.0

1.2

—

1.72

—

Non-small cell lung cancer, including Hilmo

543

0.74

1.16

1.1

0.51

1.36

u/ml

2.32

308

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

239

2098

1.14

1.16

1.1

1.2

1.28

2.70

u/ml

2.74

144

1240

Sudden idiopathic hearing loss

659

1.25

1.16

1.2

1.1

1.17

2.18

u/ml

0.92

356

Colorectal cancer

103

1195

0.83

1.16

1.2

1.1

0.93

1.20

u/ml

0.27

645

Mixed specific developmental disorders

685

0.77

1.16

1.2

1.3

4.58

2.78

u/ml

0.37

482

Chronic mastoiditis

110

1.65

1.16

1.1

0.21

1.53

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

1574

9780

1.05

1.15

1.2

1.1

2.35

2.17

u/ml

0.24

948

5178

Malignant neoplasm of renal pelvis, including Hilmo

0.00

1.15

0.0

1.1

—

1.31

—

Implicit viral Sepsis

206

1801

1.15

1.2

1.1

2.04

1.86

u/ml

0.12

130

992

Benign neoplasm: Larynx

150

1.54

1.15

1.1

0.37

1.96

u/ml

—

L02BG Aromatase inhibitors

196

2216

0.87

1.14

1.1

1.87

1.43

u/ml

0.30

110

1141

Special screening examination for other diseases and disorders

140

1188

1.18

1.14

1.1

3.11

2.64

u/ml

0.22

593

Malignant neoplasm of head and neck, including Hilmo

484

0.72

1.14

1.2

1.1

1.60

1.67

u/ml

0.02

262

Other symptoms and signs involving the urinary system

751

1.23

1.14

1.1

1.41

2.45

u/ml

0.93

392

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

435

3972

1.10

1.14

1.1

2.58

1.86

u/ml

0.68

237

2148

Dislocation, sprain and strain of joint and ligaments of hip

216

1.44

1.14

1.2

1.1

0.27

1.79

u/ml

2.06

117

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

422

1.31

1.13

1.1

1.32

1.72

u/ml

0.21

229

Benign neoplasm: Scapula and long bones of upper limb

1.73

1.13

1.1

0.34

1.71

u/ml

—

Chronic iridocyclitis

459

0.71

1.12

1.1

3.24

2.71

u/ml

0.07

258

Degenerative macular diseases

466

1.29

1.12

1.1

1.85

1.41

u/ml

0.17

256

Background retinopathy and retinal vascular changes

119

1.61

1.12

1.0

1.2

0.33

1.99

u/ml

—

severe traumatic brain injury, does not include concussion

111

1327

0.83

1.12

1.2

1.1

2.18

1.99

u/ml

0.06

722

Barrett oesophagus

225

1.43

1.12

1.1

1.23

1.75

u/ml

0.22

123

Other protozoal intestinal diseases, including avohilmo

268

1.40

1.12

1.1

0.67

3.61

u/ml

2.89

146

Certain zoonotic bacterial diseases, including avohilmo

217

1.44

1.12

1.2

1.1

4.23

3.07

u/ml

0.11

122

Lung cancer and mesothelioma

387

1.29

1.11

1.1

0.38

1.13

u/ml

2.24

190

Pregnancy, childbirth and the puerperium

381

2194

0.90

1.11

1.1

3.13

2.72

u/ml

0.28

211

1173

Conotruncal defects

350

0.67

1.11

1.2

1.3

17.68

2.47

u/ml

1.44

247

Benign neoplasm: Caecum

520

1.27

1.11

1.1

1.35

1.66

u/ml

0.16

283

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.69

1.11

1.3

1.1

3.20

2.90

u/ml

—

Malignant neoplasm of corpus uteri

400

0.70

1.11

1.2

1.1

0.74

1.15

u/ml

0.36

225

Other congenital malformations of tongue, mouth and pharynx

416

1.32

1.10

1.2

1.3

2.04

3.02

u/ml

0.56

291

Small fibre neuropathy

168

1.50

1.10

1.4

1.1

0.96

1.88

u/ml

0.66

Supernumerary teeth EXCLUDE clefts and syndromes

1.82

1.10

1.2

1.1

1.70

3.85

u/ml

—

Respiratory tuberculosis, not confirmed, including avohilmo

1.67

1.10

1.2

1.1

2.06

1.28

u/ml

0.32

Viral infections of the central nervous system

737

1.23

1.10

1.1

1.98

2.28

u/ml

0.13

398

Contact with other hot fluids

390

1.32

1.10

1.1

1.2

1.51

2.90

u/ml

0.88

227

Atrial fibrillation and flutter with reimbursement

181

1312

0.87

1.09

1.1

2.77

1.48

u/ml

0.59

101

698

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

144

1.54

1.09

1.0

1.2

0.12

2.33

u/ml

2.33

Coxarthrosis [arthrosis of hip](FG)

390

2949

0.91

1.09

1.1

1.68

1.73

u/ml

0.04

192

1515

Other abnormal findings of blood chemistry

381

1.32

1.09

1.1

0.83

2.46

u/ml

1.90

214

Intestinal malabsorption

425

1.30

1.09

1.1

2.95

2.28

u/ml

0.12

240

Reactive arthropathies

810

1.22

1.09

1.1

0.96

2.70

u/ml

2.96

415

Speech and linguistic disorders

224

1898

1.14

1.09

1.2

2.84

2.74

u/ml

0.05

151

1158

Macular pucker

620

1.24

1.09

1.1

0.64

1.32

u/ml

1.25

344

Early lumbar disc prolapse operation

193

1690

1.15

1.09

1.1

2.52

2.26

u/ml

0.11

112

859

5-aminosalicylic acid

272

2432

1.12

1.08

1.1

1.54

1.92

u/ml

0.30

131

1244

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

304

1.36

1.08

1.2

1.1

3.49

2.55

u/ml

0.16

169

Open bite

133

1134

1.18

1.08

1.2

1.30

2.93

u/ml

2.27

673

Other and unspecified corneal deformities and disorders

261

1.39

1.08

1.1

1.11

1.76

u/ml

0.35

148

Hypertensive diseases

1046

6247

0.94

1.08

1.1

2.04

1.90

u/ml

0.16

587

3254

Other specified/unspecified spondylopathies

1.70

1.08

1.1

3.56

0.91

u/ml

—

Status post-ami

747

0.81

1.07

1.1

2.43

1.14

u/ml

0.49

417

Ischemic heart diseases

821

5212

0.94

1.07

1.1

1.93

1.83

u/ml

0.10

423

2838

Spermatocele

304

1.35

1.07

1.2

1.1

1.88

2.42

u/ml

0.23

163

Thyroiditis, unspecified

137

1.55

1.07

1.2

1.1

0.75

2.19

u/ml

—

Other and unspecified diseases of blood and blood-forming organs

153

1.51

1.07

1.2

1.1

2.72

1.62

u/ml

0.22

Benign neoplasm of other and unspecified endocrine glands

127

1078

1.18

1.06

1.1

0.80

2.22

u/ml

3.49

576

Benign neoplasm: Rectum, anus and anal canal

128

1087

1.18

1.06

1.2

1.1

0.73

1.60

u/ml

2.25

596

Attention to artificial openings

217

0.60

1.06

1.1

1.2

2.75

2.61

u/ml

—

132

Leiomyoma of uterus

728

4371

0.93

1.06

1.1

1.92

1.68

u/ml

0.24

352

2204

Benign neoplasm: Rectum

115

968

1.19

1.06

1.2

1.1

0.68

1.57

u/ml

2.16

535

Right ventricular outflow tract obstruction

238

0.61

1.06

1.1

1.3

28.95

2.78

u/ml

—

174

Basal cell carcinoma

264

2014

0.89

1.05

1.1

0.74

1.29

u/ml

1.62

152

1091

Presbyopia

732

1.22

1.05

1.1

0.76

1.68

u/ml

1.29

367

Parkinson's disease, strict definition

465

0.73

1.05

1.1

1.20

1.23

u/ml

0.01

256

Disorders of mineral metabolism

669

1.23

1.04

1.1

0.79

1.94

u/ml

2.24

381

Campylobacter enteritis

229

1.41

1.04

1.2

1.1

0.89

3.03

u/ml

1.76

116

Other congenital malformations of the digestive system

774

1.22

1.04

1.2

2.90

3.25

u/ml

0.09

503

Congenital malformations of breast, including avohilmo

307

1.35

1.04

1.2

2.36

3.27

u/ml

0.33

160

Other peripheral vascular diseases

715

1.22

1.04

1.1

0.85

2.51

u/ml

3.54

375

Viral infections of central nervous system, not elsewhere classified/unspecified

1.76

1.04

1.1

6.12

1.45

u/ml

—

Oral leukoplakia, including avohilmo

146

1.52

1.03

1.1

2.60

1.90

u/ml

—

Lactose intolerance

359

1.32

1.03

1.1

1.2

1.86

3.21

u/ml

0.36

205

Female infertility, associated with anovulation

168

1464

1.15

1.03

1.1

3.06

2.59

u/ml

0.22

760

342

1.33

1.03

1.1

0.96

2.89

u/ml

2.29

148

Lesion of radial nerve

238

1.39

1.03

1.2

1.1

9.72

1.93

u/ml

0.66

130

Amenorrhoea

137

1176

1.17

1.03

1.1

2.20

2.75

u/ml

0.19

627

Other aneurysm

221

1.41

1.02

1.1

0.11

1.72

u/ml

2.81

119

Juvenile arthritis (FINNGEN)

863

0.80

1.02

1.1

1.2

1.09

2.81

u/ml

2.41

500

Seronegative juvenile rheumatoid arthritis

344

0.69

1.01

1.0

1.2

1.43

3.69

u/ml

—

189

Hypoplasia of dental enamel

406

0.71

1.01

1.5

1.3

1.27

4.02

u/ml

2.04

315

Melanocytic naevi of other and unspecified parts of face

627

1.24

1.01

1.2

1.1

0.89

2.51

u/ml

2.64

329

Chondromalacia

239

1.39

1.01

1.3

1.1

1.49

2.04

u/ml

0.29

132

Single delivery by forceps and vacuum extractor

308

2032

0.90

1.01

1.1

3.76

2.19

u/ml

0.89

156

1070

Alcohol-induced chronic pancreatitis

415

0.72

1.01

1.0

1.1

1.35

2.22

u/ml

0.43

222

Benign neoplasm: Vulva

139

1.52

1.01

1.2

1.1

4.79

1.88

u/ml

0.51

Viral encephalitis, not elsewhere classified/unspecified

139

1.52

1.01

1.0

1.2

0.12

1.70

u/ml

3.53

Acute pancreatitis (for exclusion)

129

1505

0.86

1.01

1.2

1.1

1.34

1.96

u/ml

0.66

789

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

461

0.74

1.01

1.1

2.14

1.32

u/ml

0.30

250

Vitamin deficiency

413

1.29

1.00

1.1

2.80

2.67

u/ml

0.03

229

Vitamin deficiency, wide

413

1.29

1.00

1.1

2.80

2.67

u/ml

0.03

229

Exposure to other and unspecified animate mechanical forces

467

1.28

1.00

1.1

1.2

3.02

2.66

u/ml

0.06

263

Other sexually transmitted chlamydial diseases, including avohilmo

248

2221

1.12

1.00

1.2

1.1

2.13

2.97

u/ml

0.66

131

1193

Ovarian hyperstimulation (induction)

318

1.34

1.00

1.1

2.90

2.99

u/ml

0.02

159

Injuries to unspecified part of trunk, limb or body region

121

1030

1.18

1.00

1.1

2.61

2.32

u/ml

0.08

563

Hypertension

1047

6233

0.95

1.00

1.1

2.04

1.91

u/ml

0.16

588

3246

Other specified and unspecified personality disorders

136

1170

1.17

0.99

1.2

1.1

0.65

2.22

u/ml

5.08

601

Pneumonia, organism unspecified

1344

8778

1.05

0.99

1.2

1.1

2.33

2.05

u/ml

0.38

810

4668

Burn and corrosion confined to eye and adnexa

223

1.40

0.99

1.1

2.07

1.88

u/ml

0.06

123

Malignant neoplasm of urinary organs, including Hilmo

517

0.75

0.99

1.1

1.54

1.38

u/ml

0.05

289

Contusion of ankle

566

1.25

0.99

1.2

1.1

1.62

2.79

u/ml

0.65

306

Acute peritonitis

379

0.71

0.99

1.3

1.1

1.51

1.94

u/ml

0.17

217

Polyglandular dysfunction

0.00

0.99

0.0

1.0

—

1.84

—

Other leukaemias of specified cell type

0.00

0.99

0.0

1.1

—

1.67

—

Use of rivastigmine

320

0.68

0.99

1.3

1.1

0.28

0.90

u/ml

2.49

174

IgA nephropathy (IgA glomerulonephritis)

181

1.45

0.99

1.1

4.90

2.53

u/ml

0.26

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.99

0.0

1.1

—

1.21

—

Neuromyelitis optica

0.00

0.99

0.0

1.2

—

1.27

—

Maternal care for known or suspected abnormality of pelvic organs

523

3270

1.08

0.98

1.1

2.99

2.12

u/ml

0.79

277

1681

Poisoning by medicine

294

3247

0.90

0.98

1.2

1.1

1.84

2.28

u/ml

0.37

176

1731

Corneal degeneration

1.68

0.98

1.1

1.05

1.87

u/ml

—

Periodontal disease, other/unspecified

232

1.39

0.98

1.0

1.1

1.27

1.77

u/ml

0.29

128

Erythema multiforme

173

1.46

0.98

1.2

1.1

0.82

3.62

u/ml

1.91

Struck by thrown, projected or falling objec

612

1.23

0.98

1.2

1.1

0.54

2.63

u/ml

5.45

337

Colorectal neuroendocrine tumor and carcinoma

1.65

0.98

1.1

0.57

1.86

u/ml

—

Delivery, wide proxy

431

2488

0.92

0.98

1.1

3.04

2.44

u/ml

0.46

244

1316

Symptoms and signs involving emotional state

389

1.30

0.98

1.3

1.2

1.62

3.23

u/ml

0.73

211

Hypersomnia

116

1.57

0.97

1.2

1.1

3.92

2.65

u/ml

—

Other follicular disorders

110

932

1.19

0.97

1.2

1.1

1.84

2.09

u/ml

0.16

478

Long labour

464

3631

1.09

0.97

1.1

2.66

2.16

u/ml

0.42

249

1828

Vertical strabismus

310

1.33

0.97

1.1

1.03

3.50

u/ml

1.54

175

Pilonidal cyst

108

1272

0.84

0.97

1.1

1.05

2.26

u/ml

2.14

650

Malignant melanoma of skin, including Hilmo

860

0.81

0.97

1.1

0.76

1.60

u/ml

1.88

459

Blindness or visual impairment, binocular

0.00

0.97

0.0

1.1

—

1.02

—

Congenital malformations and deformations of the musculoskeletal system

195

1716

1.14

0.97

1.1

1.2

1.49

2.90

u/ml

2.02

119

1034

Fall on and from ladder

460

1.27

0.96

1.2

1.1

2.74

2.21

u/ml

0.10

247

Injury of unspecified body region

731

1.21

0.96

1.1

3.10

2.48

u/ml

0.14

398

Other secondary gonarthrosis

319

1.32

0.96

1.1

1.51

1.79

u/ml

0.09

172

Agranulocytosis

935

0.82

0.96

1.2

1.1

2.53

2.16

u/ml

0.09

517

Asymmetry of jaw

208

1.42

0.96

1.1

2.52

3.31

u/ml

0.19

111

Nontoxic single thyroid nodule

604

1.23

0.96

1.1

1.16

1.99

u/ml

0.55

322

Other abnormal immunological findings in serum

242

1.38

0.96

1.2

2.40

3.45

u/ml

0.38

137

Puerperal sepsis

140

1211

1.16

0.96

1.1

2.70

1.70

u/ml

0.32

634

Other disorders of optic disc

133

1.52

0.95

1.3

1.2

2.86

3.20

u/ml

0.07

Other disorders of breast and lactation associated with childbirth

295

1.34

0.94

1.1

3.62

2.90

u/ml

0.12

151

Entropion and trichiasis of eyelid

259

1.35

0.94

1.1

1.71

1.39

u/ml

0.10

144

Adenocarcinoma and papilloma adenocarcinoma of rectum

444

0.74

0.94

1.1

2.24

1.34

u/ml

0.31

241

Other retinal artery occlusion

1.78

0.94

1.0

1.2

0.82

1.07

u/ml

—

Benign neoplasm: Long bones of lower limb

347

1.31

0.94

1.1

3.85

3.02

u/ml

0.11

198

Drug-induced neutropenia

489

0.75

0.94

1.1

4.67

1.74

u/ml

0.40

274

Other sexually transmitted chlamydial diseases

147

1280

1.16

0.94

1.2

1.1

1.95

2.27

u/ml

0.17

678

Graves ophthalmopathy

200

1.41

0.94

1.0

1.1

0.58

2.41

u/ml

1.90

102

Use of levodopa decarboxylase inhibitor

444

0.74

0.94

1.1

0.93

1.28

u/ml

0.18

246

Spontaneous abortion

750

4719

1.07

0.94

1.1

1.90

2.14

u/ml

0.30

363

2445

Burns and corrosions confined to eye and internal organs

260

1.36

0.94

1.1

1.84

2.92

u/ml

0.43

147

Crohn disease (strict definition, all UC cases excluded)

661

1.22

0.94

1.1

2.35

2.61

u/ml

0.05

357

Other and unspecified injuries of abdomen, lower back and pelvis

150

1.48

0.94

1.2

0.13

4.43

u/ml

3.42

Prolonged pregnancy

303

2842

0.91

0.94

1.1

2.71

2.25

u/ml

0.38

168

1490

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

579

1.23

0.93

1.1

3.46

1.73

u/ml

0.31

321

Arteriovenous malformation of cerebral vessels

1.74

0.93

1.0

1.1

0.30

2.68

u/ml

—

Ingrowing nail

580

1.23

0.93

1.1

2.93

2.82

u/ml

0.02

320

Vitreous haemorrhage

656

0.79

0.93

1.0

1.1

0.86

1.65

u/ml

1.06

351

Open wound of abdomen, lower back and pelvis

348

1.30

0.93

1.2

1.1

2.41

3.79

u/ml

0.38

195

Benign neoplasm of meninges

625

1.22

0.92

1.1

0.67

1.27

u/ml

0.81

337

Melanoma in situ of trunk

1.83

0.92

1.0

1.1

0.45

1.66

u/ml

—

Cerebral palsy

290

0.68

0.92

1.2

2.57

2.46

u/ml

0.02

186

Glomerular disorders in diseases classified elsewhere

886

0.82

0.92

1.2

1.1

2.02

2.28

u/ml

0.07

469

Congenital malformations of the nervous system

428

0.74

0.91

1.1

1.2

2.74

3.08

u/ml

0.08

276

Primary gonarthrosis, bilateral

357

2736

1.09

0.91

1.1

1.15

1.28

u/ml

0.20

204

1414

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

168

1.45

0.91

1.3

1.2

2.76

3.64

u/ml

0.13

Congenital malformations of the urinary system, including avohilmo

818

0.81

0.91

1.1

1.2

1.40

2.80

u/ml

0.76

488

Infectious mononucleosis

190

1688

1.13

0.91

1.1

2.01

2.63

u/ml

0.33

109

926

Infectious mononucleosis, including avohilmo

190

1688

1.13

0.91

1.1

2.01

2.63

u/ml

0.33

109

926

Congenital malformations of the urinary system

774

0.81

0.91

1.1

1.2

1.47

2.85

u/ml

0.70

461

Crohn's disease of small intestine

104

884

1.18

0.91

1.1

1.95

2.23

u/ml

0.08

466

Other specified/unspecified inflammatory spondylopathies

555

1.23

0.90

1.1

1.03

2.55

u/ml

1.96

282

Mandibular retrognathia AND surgery (BSSO)

341

1.30

0.90

1.1

0.62

2.95

u/ml

2.99

173

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

255

0.66

0.90

1.0

1.1

0.32

1.45

u/ml

—

141

Malignant neoplasm of colon, including Hilmo

880

0.82

0.90

1.2

1.1

0.40

1.28

u/ml

3.73

478

Unspecified dementia

175

0.61

0.90

1.2

1.1

0.26

0.85

u/ml

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

648

0.79

0.89

1.1

1.2

1.96

2.97

u/ml

0.48

413

Monoarthritis, not elsewhere classified

350

1.29

0.89

1.1

1.28

2.49

u/ml

0.98

182

Injuries to the head

1737

9900

1.04

0.89

1.2

1.1

2.12

2.23

u/ml

0.16

971

5305

Infections of breast associated with childbirth

575

1.23

0.89

1.2

1.1

3.68

2.26

u/ml

0.22

288

Other and unspecified coagulation defects

611

1.22

0.89

1.2

1.1

1.21

2.53

u/ml

1.09

328

Right hemicolectomy

218

0.64

0.88

1.1

0.12

1.11

u/ml

—

119

Other malignant neoplasms of skin (=non-melanoma skin cancer)

284

2122

0.91

0.88

1.1

1.07

1.37

u/ml

0.41

162

1143

Maternal care for cervical incompetence

422

1.27

0.88

1.1

4.56

2.38

u/ml

0.56

218

Pure hypercholesterolaemia

679

4585

0.94

0.88

1.1

1.16

1.83

u/ml

1.77

394

2402

Other protozoal intestinal diseases

161

1.45

0.88

1.0

1.1

0.83

3.91

u/ml

1.80

Bell's palsy

124

1072

1.16

0.87

1.1

1.95

2.27

u/ml

0.16

567

Other disorders of skin and subcutaneous tissue

832

6640

1.06

0.87

1.1

2.23

1.92

u/ml

0.35

462

3500

Postpartum hemorraghe, parous women as controls

492

3829

1.08

0.87

1.2

1.1

2.41

2.11

u/ml

0.25

245

1956

Hypertrichosis

352

1.29

0.87

1.1

4.98

2.83

u/ml

0.33

178

Gonarthrosis [arthrosis of knee](FG)

804

4365

1.06

0.87

1.1

1.75

1.79

u/ml

0.04

443

2211

Other/unspecified rheumatoid arthritis

705

0.81

0.87

1.1

0.80

1.62

u/ml

0.83

379

Acute pancreatitis

129

1483

0.87

0.86

1.2

1.1

1.34

2.03

u/ml

0.76

772

Retinal detachments and breaks

251

2270

1.11

0.86

1.1

1.17

1.50

u/ml

0.48

134

1197

Bicornuate uterus

1.60

0.86

1.1

0.31

4.30

u/ml

—

Fall involving playground equipment

223

1.39

0.86

1.4

1.3

3.41

3.83

u/ml

0.05

170

Biological medication for rheuma

239

2643

0.90

0.86

1.1

0.53

2.24

u/ml

11.46

126

1416

Abnormal serum enzyme levels

210

1815

1.12

0.86

1.1

1.29

1.70

u/ml

0.30

112

1006

Hydronephrosis

824

0.82

0.86

1.1

6.65

2.33

u/ml

0.83

444

Other conjunctival vascular disorders and cysts

120

1.51

0.86

1.2

1.1

0.79

1.91

u/ml

0.99

Disorders of gallbladder, biliary tract and pancreas

1145

7462

0.95

0.85

1.2

1.1

1.44

1.95

u/ml

1.37

600

3904

Anaemias

455

2704

1.08

0.85

1.2

1.1

2.23

2.54

u/ml

0.22

257

1467

Diabetic maculopathy, excluding more controls

965

0.84

0.85

1.1

3.00

2.12

u/ml

0.22

513

Hypertensive heart and/or renal disease

111

943

0.86

0.85

1.1

0.95

1.08

u/ml

0.21

531

Congenital malformations of breast

283

1.32

0.85

1.2

1.1

2.72

2.96

u/ml

0.06

148

Dystonia

487

1.24

0.85

1.1

2.05

2.09

u/ml

0.01

265

Cauda equina syndrome

1.61

0.85

1.1

1.50

1.44

u/ml

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

197

1.40

0.85

1.2

0.08

2.91

u/ml

3.24

129

Convalescence

442

1.25

0.85

1.2

1.1

1.64

1.92

u/ml

0.11

223

Disorders of synovium and tendon in diseases classified elsewhere

137

1.47

0.84

1.1

2.97

3.01

u/ml

0.01

Intestinal adhesions without obstruction

460

1.24

0.84

1.1

1.37

2.04

u/ml

0.44

265

Transient ischemic attack

291

2539

0.91

0.84

1.1

1.08

1.47

u/ml

0.49

172

1358

Prepatellar bursitis

309

1.30

0.84

1.1

0.74

2.15

u/ml

1.51

144

Osteochondrosis of ankle, juvenile

105

1.56

0.84

1.1

1.2

0.98

2.73

u/ml

—

Other vitreous opacities

248

1.34

0.84

1.1

0.71

1.25

u/ml

0.88

131

Relapsing fevers

1.95

0.83

1.0

1.1

—

1.86

—

Retinoblastoma, including Hilmo

0.00

0.83

0.0

1.0

—

3.35

—

Other congenital malformations of integument

0.00

0.83

0.0

1.0

—

3.49

—

Other disorders of ear

1178

7270

1.05

0.83

1.2

1.1

1.74

2.03

u/ml

0.47

636

3903

Helminthiases, including avohilmo

626

1.21

0.82

1.2

3.60

2.64

u/ml

0.24

358

Enteropathic arthropathies

223

1.36

0.82

1.1

2.07

2.44

u/ml

0.09

118

Inguinal hernia, bilateral

534

1.22

0.82

1.1

2.96

2.19

u/ml

0.14

292

Family history of malignant neoplasm

125

1432

0.87

0.82

1.1

2.39

1.80

u/ml

0.28

745

Dextrocardia

0.00

0.82

0.0

1.3

—

4.22

—

Hyperkinetic disorders (excl. ADHD)

529

1.23

0.82

1.2

1.3

1.14

3.18

u/ml

2.06

375

Parkinson's disease, excluding more controls

429

0.77

0.81

1.1

1.13

1.42

u/ml

0.13

242

Wet age-related macular degeneration

376

1.26

0.81

1.1

1.50

0.76

u/ml

0.39

210

Other facial nerve disorders

215

1.36

0.81

1.3

1.1

0.36

3.00

u/ml

2.63

117

Alcohol abuse, main dg

160

1802

0.89

0.81

1.2

1.1

2.17

2.16

u/ml

0.01

972

Dislocation, sprain and strain of joints and ligaments of elbow

107

923

1.17

0.81

1.3

1.2

3.05

2.29

u/ml

0.25

514

Maternal care for known or suspected disproportion

637

1.20

0.81

1.1

1.80

2.04

u/ml

0.08

307

Alport

0.00

0.80

0.0

1.2

—

4.18

—

Carcinoma in situ of skin

311

1.29

0.80

1.1

0.83

1.38

u/ml

0.39

166

Explicit bacterial Sepsis

850

0.83

0.80

1.1

4.73

2.22

u/ml

0.61

468

Measles

114

1.51

0.80

1.1

0.66

2.16

u/ml

—

Abnormal weight loss

719

1.19

0.80

1.2

2.80

2.25

u/ml

0.15

407

Exposure to sunlight

0.00

0.80

0.0

1.2

—

1.48

—

6-mercaptopurine

497

0.78

0.80

1.1

1.55

2.81

u/ml

0.54

269

Restrictive cardiomyopathy

0.00

0.80

0.0

1.2

—

1.97

—

Malignant melanoma of skin

697

0.82

0.80

1.1

0.59

1.55

u/ml

2.03

378

Congenital nasolacrimal duct obstruction or stenosis

115

1.53

0.80

1.2

0.10

3.55

u/ml

2.26

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

327

0.73

0.79

1.0

1.1

2.14

2.64

u/ml

0.11

159

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.79

0.0

1.3

—

1.05

—

Malignant neoplasm of ureter, including Hilmo

0.00

0.79

0.0

1.1

—

1.34

—

Other and unspecified injuries of forearm

1.58

0.79

1.4

1.1

12.10

2.39

u/ml

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.79

0.0

1.0

—

1.36

—

Other metabolic disorders

170

1515

1.13

0.79

1.1

1.70

2.01

u/ml

0.19

805

Other, unspecified and serous retinal detachments

173

1.39

0.79

1.2

1.1

2.44

1.99

u/ml

0.08

101

Cerebral oedema

0.00

0.79

0.0

1.1

—

1.50

—

Mumps

199

1.37

0.79

1.2

1.1

1.32

1.76

u/ml

0.19

104

Cystic kidney disease

304

0.72

0.78

1.1

3.62

2.92

u/ml

0.09

188

Fracture of neck

316

0.73

0.78

1.3

1.1

1.08

2.34

u/ml

—

170

Presbycusis

282

1.30

0.78

1.2

1.1

0.45

0.81

u/ml

0.79

151

Viral conjunctivitis, including avohilmo

520

1.22

0.78

1.1

1.58

2.36

u/ml

0.36

282

Varicella [chickenpox]

593

1.20

0.78

1.1

1.2

4.30

3.19

u/ml

0.22

344

Gastroduodenal ulcer

140

1229

1.14

0.78

1.1

2.02

1.86

u/ml

0.07

661

Hallux valgus (acquired)

324

2130

1.09

0.78

1.1

1.03

1.71

u/ml

0.93

171

1056

Disorders of purine and pyrimidine metabolism

0.00

0.78

0.0

1.3

—

1.05

—

Crohn's disease of large intestine

621

1.20

0.78

1.1

1.74

2.39

u/ml

0.17

336

Measles, including avohilmo

115

1.50

0.78

1.1

0.66

2.40

u/ml

—

Disorders of continuity of bone

128

1122

1.14

0.78

1.2

1.1

2.73

2.11

u/ml

0.21

590

Open wound of hip and thigh

385

1.26

0.78

1.1

2.11

3.29

u/ml

0.40

210

Thoracic aortic aneurysm

740

1.18

0.77

1.1

2.16

1.56

u/ml

0.24

403

Cardiomyopathy

1126

0.86

0.77

1.2

1.1

0.74

1.79

u/ml

2.66

636

Leisure time condition

227

2059

1.11

0.77

1.1

1.64

2.48

u/ml

1.26

136

1118

Autoimmune diseases related-to ILD

1213

9707

1.04

0.77

1.1

2.13

2.11

u/ml

0.03

636

5168

Calcific tendinitis of shoulder

448

1.23

0.77

1.1

4.61

1.99

u/ml

0.41

217

Arthropathic psoriasis

1072

0.86

0.77

1.2

1.1

0.69

1.87

u/ml

3.04

554

Hodgkin lymphoma, hilmo

245

0.69

0.77

1.3

1.1

1.84

3.27

u/ml

—

141

Isolated growth hormone deficiency

276

0.70

0.77

1.2

1.3

9.98

2.16

u/ml

0.67

219

Bipolar affective disorders

299

2749

1.09

0.77

1.1

1.01

2.31

u/ml

5.19

170

1410

Postpartum haemorrhage due to anatomy

220

1995

1.11

0.77

1.2

1.1

3.22

2.22

u/ml

0.49

109

1027

Labour and delivery complicated by umbilical cord complications

659

1.19

0.77

1.1

2.69

2.30

u/ml

0.16

321

Endometriosis of fallopian tube

1.72

0.76

1.0

1.2

0.31

1.46

u/ml

—

Macular hole

200

1.35

0.76

1.0

1.1

0.41

1.31

u/ml

0.96

114

Presence of other devices

162

1420

1.12

0.76

1.1

2.00

1.70

u/ml

0.14

753

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

138

1219

1.14

0.76

1.2

1.1

1.80

2.10

u/ml

0.17

630

Benign neoplasm: Skin of lower limb, including hip

209

0.67

0.76

1.1

0.66

2.42

u/ml

—

113

Shoulder region

124

1.47

0.76

1.1

0.39

1.56

u/ml

—

Pedestrian injured in collision with car, pick-up truck or van

197

0.66

0.76

1.0

1.1

0.91

2.41

u/ml

—

104

Malignant neoplasm of urinary organs

438

0.77

0.75

1.1

1.77

1.40

u/ml

0.11

239

Other specified/unspecified systemic involvement of connective tissue

504

1.22

0.75

1.1

1.99

2.00

u/ml

0.00

261

Caries in Clefts patients

184

0.64

0.75

1.1

12.92

4.02

u/ml

—

108

Peripheral retinal degeneration

218

1.34

0.75

1.1

2.21

1.45

u/ml

0.23

118

Laparoscopic left hemicolectomy

1.65

0.75

1.2

1.1

0.33

1.05

u/ml

—

Gestational diabetes (for exclusion)

801

5234

1.05

0.75

1.1

2.29

2.26

u/ml

0.03

420

2680

Other bursal cyst

1.58

0.75

1.0

1.1

3.09

1.70

u/ml

—

Hypothyroidism, drug reimbursement

232

1470

1.10

0.75

1.1

2.46

2.07

u/ml

0.24

136

752

Rare circulating lymphoid malignancy, including Hilmo

255

0.70

0.75

1.2

0.85

2.35

u/ml

1.23

172

Intracerebral haemorrhage

493

0.79

0.75

1.2

1.1

0.71

1.63

u/ml

0.97

272

Disorders of psychological development

296

2526

1.09

0.75

1.2

2.42

2.73

u/ml

0.19

189

1512

Carcinoma in situ of breast, intraductal

581

0.81

0.75

1.1

2.77

1.32

u/ml

0.55

307

Other and unspecified acne

219

1.34

0.74

1.1

1.81

3.11

u/ml

0.59

107

LSIL lesion of the cervix uteri, vagina or vulva

198

2189

0.90

0.74

1.2

1.1

2.16

1.90

u/ml

0.18

1100

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

106

921

1.16

0.74

1.1

0.62

2.33

u/ml

3.26

495

Carbimazole or st.post thyroidectomy, condition for graves disease

248

2265

1.10

0.74

1.1

1.51

1.92

u/ml

0.35

136

1163

Contusion of toe(s) without damage to nail

379

1.25

0.74

1.2

1.1

1.76

2.73

u/ml

0.36

200

Other meningitis

150

1.41

0.74

1.0

1.1

2.24

3.33

u/ml

0.24

Benign neoplasm: Tongue

150

1.41

0.73

1.3

1.1

0.21

1.65

u/ml

1.38

Inguinal or femoral hernia, bilateral

542

1.20

0.73

1.1

2.96

2.16

u/ml

0.15

297

Haemolytic anaemias

281

1.29

0.73

1.4

1.1

3.26

2.64

u/ml

0.08

166

Fracture of foot, except ankle

366

3402

1.08

0.73

1.1

1.74

2.38

u/ml

0.80

213

1820

Reimbursement for rheumatic diseases

617

6481

0.94

0.73

1.1

1.18

1.99

u/ml

2.32

317

3449

Calculus of lower urinary tract

207

0.67

0.72

1.1

0.30

1.86

u/ml

—

113

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

646

4302

0.94

0.72

1.1

2.06

1.89

u/ml

0.16

336

2188

Cysts of oral region, not elsewhere classified

534

1.20

0.72

1.1

1.05

2.73

u/ml

1.08

299

Weight loss

848

1.16

0.72

1.2

2.83

2.39

u/ml

0.13

485

Nonalcoholic steatohepatitis

1.64

0.72

1.0

1.1

0.12

2.03

u/ml

—

Serous carcinoma of ovary, including Hilmo

183

0.65

0.72

1.0

1.1

1.13

0.74

u/ml

—

Cystic kidney disease, including avohilmo

333

0.75

0.72

1.1

3.36

2.79

u/ml

0.08

199

Alzheimer’s disease (Atypical or mixed)

157

0.63

0.72

1.3

1.1

0.04

0.88

u/ml

—

Persons with potential health hazards related to communicable diseases

747

7039

1.05

0.72

1.2

1.1

2.61

2.45

u/ml

0.12

399

3898

Special screening examination for neoplasms

398

1.23

0.71

1.2

1.1

2.24

1.86

u/ml

0.11

183

Hereditary corneal dystrophies

168

1.38

0.71

1.3

1.1

0.75

1.46

u/ml

0.76

Major coronary heart disease event

796

5002

0.95

0.71

1.1

2.12

1.77

u/ml

0.40

403

2730

Sequelae of infectious and parasitic diseases, including avohilmo

590

1.19

0.71

1.2

1.1

0.68

1.79

u/ml

1.74

297

Other chromosome abnormalities, not elsewhere classified

156

0.62

0.71

1.3

16.85

1.89

u/ml

—

121

Other congenital malformations, not elsewhere classified

178

1.38

0.71

1.2

1.03

3.35

u/ml

1.48

122

Male infertility

545

1.20

0.71

1.2

1.1

3.38

2.74

u/ml

0.15

294

Other/unspecified reactive arthropathies

637

1.18

0.70

1.1

1.08

2.21

u/ml

1.42

346

Nontraumatic intracranial haemmorrhage

988

0.86

0.70

1.1

0.79

1.65

u/ml

1.62

558

Sequelae of infectious and parasitic diseases

582

1.19

0.70

1.2

1.1

0.70

1.80

u/ml

1.68

294

Malignant neoplasm of cervix uteri, including Hilmo

228

0.70

1.0

1.1

1.88

2.25

u/ml

—

123

Benign neoplasm: Brain, supratentorial

152

1.40

0.70

1.1

1.2

0.97

3.00

u/ml

1.20

Chromosomal abnormalities, not elsewhere classified

506

0.80

0.70

1.2

8.35

2.78

u/ml

0.98

346

Congenital malformations of eye, ear, face and neck

124

1096

1.14

0.70

1.1

1.2

0.70

2.75

u/ml

4.68

637

Basal cell carcinoma, including Hilmo

292

2143

0.92

0.70

1.1

0.73

1.35

u/ml

2.04

166

1152

Malignant melanoma, including Hilmo

1051

0.86

0.69

1.1

0.86

1.71

u/ml

1.55

559

Pedestrian injured in other and unspecified transport accidents

1.54

0.69

1.4

1.2

0.30

1.89

u/ml

—

Ankyloglossia

501

1.21

0.69

1.2

2.19

3.18

u/ml

0.57

340

Diabetes mellitus in pregnancy

730

4408

1.05

0.69

1.1

1.87

2.24

u/ml

0.64

386

2264

Macular cyst

118

1.45

0.69

1.0

1.1

1.13

0.79

u/ml

0.21

Colectomy operation

975

0.86

0.69

1.1

0.79

1.88

u/ml

1.19

527

Short stature, not elsewhere classified

750

1.17

0.69

1.2

1.3

3.35

3.09

u/ml

0.07

527

Melanocytic naevi of upper limb, including shoulder

222

1.32

0.68

1.1

1.02

2.41

u/ml

1.05

110

Meralgia paraesthetica

275

1.28

0.68

1.2

1.1

4.36

2.46

u/ml

0.25

149

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

538

1.20

0.68

1.2

1.1

0.71

1.94

u/ml

1.77

268

Generalized epilepsy, mode (most common among epilepsy diagnosis)

447

1.22

0.68

1.1

1.2

1.31

2.84

u/ml

1.04

253

Other adrenocortical overactivity

128

1.44

0.68

1.2

5.86

3.44

u/ml

0.34

Use of ropinirole

127

1.42

0.68

1.2

1.1

0.80

1.18

u/ml

—

Bursitis of shoulder

170

1.36

0.68

1.3

1.1

0.16

2.80

u/ml

2.06

Nonspecific lymphadenitis

622

1.18

0.67

1.1

1.13

2.35

u/ml

1.30

325

Algoneurodystrophy

375

1.23

0.67

1.2

1.1

0.96

2.54

u/ml

1.60

204

Deep endometriosis

123

1090

1.13

0.67

1.1

1.31

2.26

u/ml

0.59

573

Other disorders of bone density and structure

260

0.73

0.66

1.1

1.38

2.91

u/ml

—

142

Other complications of labour and delivery, not elsewhere classified

247

2377

0.92

0.66

1.1

3.74

2.51

u/ml

0.72

131

1198

Tularaemia, including avohilmo

145

1.39

0.66

1.2

1.1

6.58

2.34

u/ml

—

Hirsutism in women

322

1.25

0.66

1.1

5.26

3.05

u/ml

0.31

162

Lung diseases due to external agents

678

1.17

0.66

1.2

1.1

1.68

2.30

u/ml

0.24

370

L04AC Interleukin inhibitors

809

0.85

0.66

1.1

2.32

2.18

u/ml

0.03

433

Retinal haemorrhage

111

1.45

0.66

1.1

1.2

0.37

1.47

u/ml

—

Routine general health check-up of defined subpopulation

248

0.72

0.66

1.3

1.1

0.86

2.58

u/ml

1.44

115

Hydrocele

632

1.17

0.66

1.1

0.75

2.32

u/ml

2.63

359

Open bite that required surgery (Lefort1 or BSSO)

137

1.41

0.66

1.1

0.22

3.95

u/ml

—

Mumps, including avohilmo

206

1.32

0.66

1.2

1.1

1.32

1.72

u/ml

0.17

108

Dislocation, sprain and strain of joints and ligaments of head

587

1.18

0.66

1.2

1.1

0.87

2.32

u/ml

2.69

313

Malignant neoplasm of kidney, except renal pelvis

417

0.79

0.65

1.1

1.77

1.43

u/ml

0.10

226

Hypertensive Heart Disease

826

0.87

0.65

1.1

0.93

1.04

u/ml

0.16

463

Reactive arthropathies, FINNGEN

726

1.16

0.65

1.1

1.02

2.26

u/ml

1.83

373

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.58

0.65

1.1

0.81

1.97

u/ml

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.58

0.65

1.1

0.46

2.62

u/ml

0.95

Vitamin D deficiency

207

1.32

0.64

1.1

4.27

3.64

u/ml

0.08

114

Complications of internal orthopaedic prosthetic devices, implants and grafts

131

1168

1.12

0.64

1.1

0.85

1.65

u/ml

1.76

623

Lactose intolerance, other/unspecified

305

1.25

0.64

1.1

2.11

3.53

u/ml

0.33

177

Seropositive rheumatoid arthritis, strict definition

104

1180

0.88

0.64

1.1

0.61

1.82

u/ml

2.64

619

Erectile dysfunction

281

0.75

0.64

1.1

1.2

2.17

1.98

u/ml

0.03

162

Visual impairment including blindness (binocular or monocular)

481

0.81

0.63

1.1

0.84

2.40

u/ml

1.65

283

Congenital deformities of hip, including avohilmo

396

1.22

0.63

1.3

1.2

0.66

3.04

u/ml

3.07

242

Other lesions of median nerve

112

1.43

0.63

1.2

1.1

1.22

1.54

u/ml

—

Injuries involving multiple body regions

387

1.22

0.63

1.1

2.93

2.85

u/ml

0.02

211

Streptococcal septicaemia

644

0.84

0.63

1.1

5.51

2.47

u/ml

0.62

366

Infective bursitis

155

1.36

0.63

1.0

1.2

7.55

2.53

u/ml

—

Other and unspecified abdominal hernia

234

1.29

0.63

1.1

2.84

1.84

u/ml

0.19

137

Burkitt lymphoma, helper endpoint

0.00

0.63

0.0

1.1

—

5.05

—

Specific personality disorders

396

3718

1.07

0.63

1.2

1.1

1.34

2.21

u/ml

2.35

232

1954

Pedestrian injured in transport accident

673

1.16

0.63

1.2

1.1

0.63

2.30

u/ml

4.25

366

Paroxysmal tachycardia

304

2346

1.08

0.63

1.1

1.30

1.95

u/ml

1.11

175

1269

Burkitt lymphoma

0.00

0.62

0.0

1.1

—

4.75

—

Burkitt lymphoma, including Hilmo

0.00

0.62

0.0

1.1

—

4.75

—

Dronedarone medication

1.52

0.62

1.2

1.1

0.16

1.17

u/ml

—

Other congenital malformations of ear

262

1.28

0.62

1.1

1.2

1.78

3.37

u/ml

0.58

150

SLE, ICD10

302

0.76

0.62

1.1

0.87

1.76

u/ml

0.74

167

SLE, strict definition

302

0.76

0.62

1.1

0.87

1.76

u/ml

0.74

167

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

128

1144

1.12

0.62

1.1

1.90

2.12

u/ml

0.11

586

Aortic aneurysm

114

990

1.13

0.62

1.1

1.68

1.51

u/ml

0.08

537

Rubella [German measles], including avohilmo

234

0.72

0.62

1.3

1.1

0.33

1.83

u/ml

—

122

Diseases of pulp and periapical tissues, including avohilmo

1624

8130

1.03

0.62

1.1

1.98

2.41

u/ml

0.93

942

4287

Pre-eclampsia or eclampsia

276

2974

0.93

0.62

1.1

2.02

1.87

u/ml

0.09

125

1544

Other and unspecified mononeuropathies, also in other diseases

173

1.34

0.62

1.3

1.1

0.45

2.00

u/ml

—

Sequelae of other and unspecified infectious and parasitic diseases

535

1.18

0.62

1.2

1.1

0.73

1.94

u/ml

1.69

268

Other specified and unspecified disorders of choroid

1.69

0.62

1.2

1.1

0.95

1.09

u/ml

—

Congenital malformations of cardiac septa

110

1199

0.88

0.61

1.1

1.2

4.20

2.76

u/ml

0.36

776

Crohn disease (strict definition, require KELA, min 2 HDR)

862

1.14

0.61

1.1

0.63

2.34

u/ml

2.99

459

Other and unspecified disorders of skin and subcutaneous tissue

480

1.19

0.61

1.1

1.22

2.24

u/ml

0.73

260

Acute disseminated encephalitis/encephalomyelitis

0.00

0.61

0.0

1.1

—

1.46

—

Other osteochondrodysplasias, including avohilmo

139

1.38

0.61

1.1

1.2

0.20

3.73

u/ml

3.24

Injuries to the shoulder and upper arm

1126

8365

1.04

0.61

1.1

2.12

2.09

u/ml

0.03

618

4497

Postinflammatory hyperpigmentation

0.00

0.61

0.0

1.2

—

1.63

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.61

0.0

1.0

—

2.54

—

Abscess of mediastinum

0.00

0.61

0.0

1.2

—

0.71

—

Retinoblastoma

0.00

0.61

0.0

1.0

—

3.36

—

LSIL lesion of the cervix uteri

170

1868

0.91

0.61

1.2

1.1

2.27

2.01

u/ml

0.16

949

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.61

0.0

1.1

—

1.84

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

138

1241

1.12

0.61

1.2

1.1

1.80

2.16

u/ml

0.20

627

Other and unspecified myoneural disorders

0.00

0.61

0.0

1.2

—

1.94

—

Ascites

379

0.79

0.61

1.0

1.1

1.67

1.35

u/ml

0.12

211

Pyoderma

139

1.38

0.61

1.2

1.1

2.58

2.60

u/ml

0.00

Ulcer of oesophagus

271

1.26

0.61

1.2

1.1

1.84

1.71

u/ml

0.06

152

Eccrine sweat disorders

0.00

0.61

0.0

1.2

—

2.09

—

Disorders of adult personality and behaviour

490

4637

1.06

0.61

1.2

1.1

1.49

2.31

u/ml

2.05

290

2438

Undefined dementia

162

0.68

0.61

1.2

1.1

0.26

0.90

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

313

2266

0.93

0.60

1.1

1.00

1.39

u/ml

0.63

177

1210

Burns and corrosions of multiple and unspecified body regions

221

0.72

0.60

1.1

5.96

2.28

u/ml

—

136

Diplopia

120

1070

1.12

0.60

1.2

1.1

0.71

2.22

u/ml

4.14

567

Iron deficiency anaemia secondary to blood loss (chronic)

118

1051

1.12

0.60

1.2

1.1

1.78

1.93

u/ml

0.05

559

Hypoparathyroidism

227

1.28

0.60

1.2

1.1

5.42

1.95

u/ml

0.39

130

Hypotension

694

1.15

0.60

1.2

1.1

1.33

1.97

u/ml

0.42

373

Thrombocytopenia, unspecified

564

0.83

0.60

1.2

1.1

0.78

2.79

u/ml

3.33

322

Personality disorders

448

4231

1.06

0.60

1.2

1.1

1.31

2.26

u/ml

3.17

266

2209

Rubella [German measles]

232

0.73

0.60

1.3

1.1

0.33

1.86

u/ml

—

120

Myocardial infarction, unclassifiable

582

0.84

0.60

1.1

3.66

1.28

u/ml

0.35

330

Venous complications and haemorrhoids in pregnancy

299

0.76

0.60

1.1

1.38

2.13

u/ml

0.24

146

Progressive systemic sclerosis

0.00

0.60

0.0

1.1

—

1.18

—

Hydrocephalus

400

0.80

0.59

1.0

1.2

0.31

2.07

u/ml

3.88

242

Crohn disease (strict definition, require KELA)

874

1.14

0.59

1.1

0.63

2.32

u/ml

2.94

464

Contusion of other and unspecified parts of foot

818

1.14

0.59

1.2

1.53

2.86

u/ml

0.81

452

Achalasia of cardia

1.45

0.59

1.2

1.1

12.34

1.90

u/ml

—

Pre-eclampsia

263

2832

0.93

0.59

1.1

2.08

1.89

u/ml

0.11

118

1470

Habit and impulse disorders

231

0.73

0.59

1.1

1.85

3.17

u/ml

0.36

124

Bacterial, viral and other infectious agents, including avohilmo

121

1082

1.12

0.59

1.1

3.22

2.07

u/ml

0.50

583

Other congenital malformations of circulatory system

210

1.29

0.59

1.1

2.91

2.61

u/ml

0.05

120

Other and unspecified myopathies

498

0.82

0.59

1.0

1.1

3.48

1.74

u/ml

0.29

270

Benign neoplasm of ovary

146

1319

1.11

0.59

1.2

1.1

2.62

1.58

u/ml

0.46

682

Congenital malformations of great arteries

571

0.83

0.59

1.1

1.3

0.96

2.94

u/ml

1.45

413

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.59

0.0

1.0

—

1.46

—

Injury of eye and orbit

197

1807

1.09

0.59

1.1

2.55

1.98

u/ml

0.31

107

968

Benign neoplasm of other and unspecified sites

228

1.28

0.58

1.1

0.85

2.40

u/ml

1.17

122

Other anaemias

271

2727

0.93

0.58

1.1

2.82

1.63

u/ml

0.74

147

1490

Generalized epilepsy, strict definition

346

1.22

0.58

1.2

1.79

3.04

u/ml

0.53

200

Other and unspecified disorders of white blood cells

273

1.25

0.58

1.1

0.87

2.94

u/ml

1.48

152

Malignant neoplasm of rectum, including Hilmo

573

0.84

0.58

1.1

3.74

1.36

u/ml

0.51

316

Other juvenile arthritis

733

0.85

0.58

1.1

1.2

1.10

2.90

u/ml

2.32

429

Prophylactic surgery

1.50

0.58

1.0

1.1

6.21

1.94

u/ml

—

Specific development disorders of speech and language

134

1164

1.11

0.58

1.3

1.2

2.92

2.79

u/ml

0.04

746

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

European house dust mite IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS